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Abstract
Gene expression is a ti ghtly controlled process that is subject to transcripti onal and as post-
transcripti onal regulati on. Current methods for system-wide gene expression analysis detect changes in 
mRNA abundance but neglect regulati on at the level of translati on. The fi rst part of the thesis therefore 
describes the establishment of modifi ed version of the classic SILAC (stable isotope labeling by amino 
acids in cell culture) approach, that is routi nely used in quanti tati ve mass spectrometry to assay 
relati ve changes in protein levels. However, since steady-state protein levels refl ect the net outcome 
of antagonizing protein synthesis and protein degradati on processes, the SILAC method cannot be 
harnessed to explicitly measure diff erences in protein translati on. In contrast, in the newly-devised 
approach termed pulsed SILAC (pSILAC) diff erenti ally treated cell populati ons are simultaneously 
transferred to culture medium supplemented with diff erent versions of stable-isotope labeled heavy 
amino acids. This is advantageous over the classic SILAC strategy as mass spectrometry-based relati ve 
quanti fi cati on is exclusively based on the newly-synthesized heavy protein amounts. This enables the 
specifi c detecti on of diff erences in protein translati on resulti ng from the diff erenti al treatment. The 
second part of the thesis presents the applicati on of the pSILAC approach to globally quanti fy the 
impact of small, non-coding RNAs (microRNAs) as major players in post-transcripti onal regulati on onto 
the proteome. Intriguingly, ectopic over-expression or knock-down of a single microRNA both aff ected 
protein producti on of hundreds of proteins. Notably, pSILAC identi fi ed several target genes as exclusively 
translati onally regulated since changes in corresponding transcript levels measured in parallel by 
conventi onal DNA microarrays were virtually absent. Recording newly-synthesized protein amounts 
with heavy amino acids in a pulsed-labeling approach has also been used to determine turnover rates 
of individual proteins, described in the third part of the present work. Along with transcript turnover 
as well as mRNA and protein levels they form the basis for a dynamic descripti on of gene expression. 
However, a systemati c comparison of those parameters has not yet been performed in any organism. By 
simultaneous applicati on of the nucleoside analogue 4-thiouridine (4sU) and heavy amino acids (SILAC) 
a metabolic labeling of newly-produced mRNAs and proteins in mouse fi broblasts has been achieved. 
This resulted in the calculati on of mRNA and protein lifeti mes for approximately 5,000 genes. On top 
of that, absolute cellular transcript and protein copy numbers were deduced from the exact same 
experimental data. While mRNA and protein levels were overall well correlated, a correlati on between 
mRNA and protein half-lives was virtually absent. Yet this seemingly chaoti c distributi on of mRNA and 
protein half-lives was highly instructi ve since specifi c gene subsets have obviously evolved disti nct 
combinati ons of half-lives that relate to their biological functi ons. For instance, dynamically regulated 
genes (e.g. transcripti on factors) were commonly characterized by both short mRNA and protein 
turnover what opti mizes those gene products towards fast and fl exible gene expression kineti cs. As 
opposed to this, highly abundant and hence energeti cally costly gene products (e.g. structural proteins) 
had high mRNA and parti cularly high protein stabiliti es.
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Zusammenfassung
Die Expression von Genen wird auf verschiedenen Stufen sehr präzise gesteuert, wobei grundsätzlich 
zwischen transkripti onaler und post-transkripti onaler Regulati on zu unterscheiden ist. Mit den derzeit 
verfügbaren Methoden zur Genexpressionsanalyse können zwar relati ve Änderungen von mRNA-
Mengen Mengen global erfasst werden, sie vernachlässigen jedoch den Einfl uss translati onaler Kontrolle. 
Der erste Teil der vorliegenden Arbeit beschreibt daher die Etablierung einer modifi zierten Form des 
klassischen SILAC (engl. für „stable isotope labeling by amino acids in cell culture“) Verfahrens, das in 
der quanti tati ven Massenspektrometrie zur Besti mmung von relati ven Änderungen in Proteinmengen 
benutzt wird. Allerdings kann dieser Ansatz nicht zur expliziten Messung von relati ven Unterschieden 
in der Translati on verwendet werden, da die gemessenen Abundanzunterschiede immer die Summe 
von Proteinneusynthese und Proteindegradati on wiederspiegeln. Im sog. „pulsed SILAC (pSILAC)“ 
Verfahren werden Zellpopulati onen im Zuge einer diff erenti ellen Behandlung zeitgleich in Kulturmedien 
transferiert, die unterschiedlich Isotop-markierte und damit unterschiedlich „schwere“ Aminosäuren 
enthalten. Der entscheidende Unterschied gegenüber dem klassischen SILAC Prinzip besteht nun 
darin, dass die relati ve Quanti fi zierung im Massenspektrum ausschließlich auf dem Verhältnis der 
neusyntheti sierten Proteinmengen beruht und so gezielt Unterschiede in der Produkti on von Proteinen 
präzise besti mmt werden können. Mit Hilfe dieses Verfahrens konnte im zweiten Teil der Arbeit erstmals 
quanti tati v erfasst werden, welche Rolle kleine regulatorische RNA Moleküle, sog. microRNAs, bei der 
post-transkripti onalen Genregulati on spielen. So konnte gezeigt werden, dass sowohl die ektopische 
Überexpression als auch die Repression einzelner microRNAs die Proteinprodukti on hunderter Proteine 
beeinfl ussen kann. Außerdem konnten mitt els pSILAC Gene identi fi ziert werden, die ausschließlich 
translati onal reguliert werden, da parallele Messungen mit herkömmlichen DNA-Microarrays kaum 
Änderungen in den Transkriptmengen feststellen konnten. Die Messung von Proteinneusynthese mitt els 
schwerer Aminosäuren ermöglichte auch die Besti mmung zellulärer Umsatzraten bzw. Halbwertszeiten 
individueller Proteine, dargestellt im dritt en Teil dieser Arbeit. Zusammen mit mRNA-Halbwertszeiten 
sowie Protein- und mRNA-Mengen bilden sie die Grundlage für eine Beschreibung der dynamischen 
Eigenschaft en der Genexpression, wobei eine systemati sche Analyse dieser vier Faktoren bisher noch 
nicht durchgeführt wurde. Durch den gleichzeiti gen Einsatz des Nukleosidanalogons 4-Thiouridin (4sU) 
und von schweren Aminosäuren (SILAC) konnte eine metabolische Markierung neusyntheti serter mRNA 
und Proteine in murinen Fibroblasten erreicht und damit eine Berechnung von Protein- und mRNA 
Halbwertszeiten für ca. 5,000 Gene ermöglicht werden. Darüber hinaus konnten aus den gleichen 
experimentellen Daten zelluläre mRNA- und Proteinkopienzahlen abgeleitet werden. Während mRNA- 
und Proteinenmengen deutlich korrelierten, war zwischen mRNA- und Proteinhalbwertszeiten nur 
eine äußerste schwache Korrelati on zu erkennen. Dennoch stehen mRNA- und Proteinumsatzraten 
nicht einem willkürlichen Zusammhang zu einander, da besti mmte Kombinati onen von mRNA- und 
Proteinhalbwertszeiten eine Opti mierung von Genen hinsichtlich ihrer biologischen Funkti onen 
erkennen ließen. So zeichneten sich dynamisch regulierte Gene (z.b. Transkripti onsfaktoren) durch kurze 
mRNA- und Proteinhalbwertszeiten aus, während abundante und damit energeti sch gesehen” teure” 
Genprodukte (z.b. Strukturproteine) hohe mRNA- und Proteinstabilitäten aufwiesen.
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IntroductionI 
With the rise of high-throughput technologies initi ally used to study enti re genomes, referred 
to as genomics, the suffi  x “-omics” has been added to many fi elds in order to denote studies 
conducted on a global scale. Driven by the concept that studying biological molecules one 
by one cannot enable the understanding of functi on and dysfuncti on of whole organisms to 
a sati sfactory degree, several disciplines have now evolved a multi tude of technologies to 
study transcripts, proteins, metabolites and other biological enti ti es on systems perspecti ves. 
Collecti vely, such approaches consti tute the young yet exciti ng and highly interdisciplinary fi eld 
of systems biology. The bird´s eye view of systems biology and its explicit goal to systemati cally 
integrate data from various disciplines may eventually allow scienti sts to comprehensively 
track signal transducti on on diff erent molecular layers throughout the cell. Ulti mately, insights 
on a systems level will aid in closing the gap between single-molecule properti es and the 
physiology of the enti re cell (BRUGGEMAN Ι WESTERHOFF, 2007).
Based on knowledge about genomic architecture gained by extensive genomic sequencing, 
researchers faced the challenge to annotate and characterize the plethora of proteins deriving 
from the strikingly smaller number of coding genes (CRAVATT et al., 2007). This obvious 
discrepancy arises from the fact that a single gene can give rise to multi ple disti nct proteins 
due to alternati ve splicing, sequence polymorphisms, post-translati onal modifi cati ons and so 
forth.
Despite the availability of exciti ng new technologies for rapid and paralleled analysis, including 
mass spectrometry (MS), protein microarrays, large scale two-hybrid-analyses, high throughput 
protein producti on and crystallizati on, the systemati c analysis of all proteins in an organism, 
a ti ssue or a cell as the explicit goal of “proteomics“ remains elusive so far (WILKINS, 1994; 
AEBERSOLD Ι MANN, 2003). Due to the high degree of complexity of biological samples neither 
the proteome compositi on nor the quanti ty of its consti tuents can be reliably predicted by 
computati onal methods or determined by experimentati on. The dynamic nature of proteomes 
that readily exceeds the dynamic range of any conventi onal analyti cal instrument poses hurdles 
much larger than encountered for 
genome or transcriptome studies 
(MALLICK Ι KUSTER, 2010). 
Among diverse proteomics 
techniques, however, mass 
spectrometry has arguably become 
the dominant technology in the past decade for studying protein producti on and functi on in 
nati ve biological systems. Contributi ons from cognate rapidly evolving disciplines like genomics 
and incremental but conti nuous instrumental innovati ons and improvements have paved the 
way for MS to become an indispensable tool for the emerging fi eld of systems biology. Most 
importantly, the groundbreaking development of specifi c ionizati on techniques (parti cularly 
Cell culture
Sample
preparation/
fractionation
 
Digest
Peptides
t  Trypsin
t  Lys-C
t  SDS-PAGE
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I INTRODUCTION
ESI and MALDI, see below), awarded with the Nobel Prize in 2002, ulti mately rendered 
biological molecules amenable to mass spectrometry and made instruments to become 
widespread in research laboratories (COX Ι MANN, 2007). Due to the ever growing number 
of complete genomic sequences as a crucial resource for protein identi fi cati on, sophisti cated 
computati onal approaches and robust sample preparati on methods, MS has now developed 
to the point at which it is routi nely applied to address various research questi ons. At present, 
mass spectrometry based proteomics has become the method of choice to study diff erences 
in global protein compositi ons, for detecti on of post-translati onal modifi cati ons (PTMs) and 
protein-protein interacti ons (PPIs) as well as for protein biomarker discovery (MALLICK Ι 
KUSTER, 2010).
In the present thesis, mass spectrometry was used as the central technology to address various 
biological questi ons on a systems-level. As already apparent from the ti tle of the thesis, those 
topics are all centered around cellular protein dynamics given by regulated protein translati on 
and protein turnover. Since in parti cular protein translati on could not be sati sfactorily 
approached with currently available mass-spectrometry assays, the thesis therefore also has 
a methodological focus that describes the establishment of a method tailored to explicitly 
quanti fy diff erences in protein synthesis. For that reason, the following introducti on will fi rst 
describe the basic workfl ow and quanti tati ve aspects of mass spectrometry and then discuss 
the biological context in which the technology was uti lized to study cellular protein dynamics.
Mass spectrometry in a nutshellI.1. 
Instrumentation and workflow of mass spectrometryI.1.1.  
Modern mass spectrometers are able to accurately determine the mass (more precisely, 
the mass-to-charge rati o, m/z) of biological molecules. Knowing the exact mass of any given 
protein is, however, not suffi  cient for unique identi fi cati on in a complex mixture as enti rely 
diff erent proteins may yet have identi cal masses. Moreover, protein handling, e.g. with regard 
Peptide
separation
t  HPLC
Sample
ionization
t  ESI
Data
analysis
Spray
needle
Peptide
ions
t  MALDI
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MS MS/MS
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Fig. I.1 | Common workfl ow in mass spectrometry-based proteomics. Following sample preparati on from a biological 
source (e.g. cell culture), proteins are subjected to enzymati c digesti on. In order to decrease sample complexity, additi onal 
fracti onati on steps (e.g. SDS-PAGE) can opti onally be performed before the digest (via trypsin or Lys-C). The generated pepti de 
mixture is separated using reversed phase high performance liquid chromatography (rpHPLC) and directly subjected to mass 
spectrometry analysis via electrospray ionizati on (ESI). Alternati vely, pepti de ionizati on can be achieved by matrix-assisted 
laser desorpti on/ionizati on (MALDI). Given a LTQ-Orbitrap instrument, accurate mass determinati on of ionized pepti des is 
performed in the Orbitrap part, while top N most abundant ions are concurrently selected and fragmented in the LTQ part 
to obtain sequence informati on. Finally, pepti de-sequencing data deduced from acquired mass spectra are searched against 
sample specifi c protein databases for protein identi fi cati on (Illustrati on taken and modifi ed from STEEN Ι MANN, 2004). 
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to protein solubility and ubiquitous protein modifi cati ons do further limit the capability to 
analyze intact proteins (STEEN Ι MANN, 2004). Hence, robust protein identi fi cati on requires 
pepti de informati on, and mass spectrometers work most effi  cient at pepti de lengths up to 20 
amino acids. Following protein isolati on from any biological source (e.g. cell culture), proteins 
therefore usually undergo proteolyti c digesti on (cf. Fig. I.1). Although sample complexity 
even increases dramati cally, the cleavage products are now much more amenable to mass 
spectrometry analysis. Digesti on of most 
proteins produces at least some soluble 
pepti des which also readily ionize and 
fragment, two requirements indispensable 
for eff ecti ve mass spectrometry analysis. 
As pepti de mixtures comprise thousands of 
pepti des spanning several orders of magnitude 
in abundance, they cannot be sati sfactorily 
analyzed all at a once. Therefore, separati on 
techniques aiming at reducti on of sample 
complexity have become key elements in 
proteomics experiments. One widely used 
and powerful setup is liquid chromatography 
mass spectrometry (LC-MS) where a high 
performance liquid chromatography (HPLC) 
system is coupled in-line with the mass 
spectrometer (STEEN Ι MANN, 2004). Of note, 
reversed-phase HPLC (rpHPLC) provides the 
highest resolving power for pepti de mixtures 
currently available in proteomics. In rpHPLC, 
following injecti on of pepti des onto microscale 
capillary columns fi lled with reversed-phase 
material, pepti des sequenti ally elute in order 
of their hydrophobicity when a gradient with 
an increasing fracti on of organic solvent is 
applied. 
As mass spectrometric measurements are 
carried out in the gas phase on ionized 
molecules, pepti des eluti ng from the column 
are electrostati cally dispersed by means 
of high voltage applied to the column that 
generates positi vely charged pepti de ions. 
This process is referred to as electrospray 
ionizati on (ESI) which rendered in-line coupling 
Fig. I.2 | Tandem mass spectrometry (MS/MS). (A) Total ion current 
(TIC) that is the sum of all ion intensiti es from all mass spectra being 
recorded during the LC-MS run as a functi on of ti me. (B) Survey/
precursor-ion scan depicti ng pepti de ions within a m/z range of 300 
- 1,700 arising from pepti des eluti ng at a certain ti me point (here at 
72.2 min). The insert shows the isotopic distributi on (isotope cluster) 
of a given pepti de ion (m/z of 611.32). A clear separati on of individual 
isotope masses is indicati ve of a high resoluti on instrument. (C) 
Fragment or tandem MS spectrum of the pepti de ion of interest (m/z 
of 611.32). Disti nct mass increments between individual peaks allow 
for deducti on of the amino acid sequence.
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of HPLC systems with mass spectrometers possible in the fi rst place. Another widespread used 
ionizati on techniques is MALDI (matrix-assisted laser desorpti on/ionizati on), where a laser 
beam triggers ionizati on of biomolecules embedded in a chemical matrix. ESI and MALDI are 
both soft  ionizati on techniques that enable the ionizati on of fragile biological molecules such 
as pepti des without disrupti ng them. Upon ionizati on, pepti de ions enter the instrument via 
transfer capillary and can be guided and manipulated by applying electric fi elds for further 
analysis.
By defi niti on, a typical mass spectrometer is composed of three basic components that are an 
ion source, a mass analyzer and an ion detector (GUERRERA Ι KLEINER, 2005). As all described 
experiments in the present thesis were exclusively analyzed using a LTQ-Orbitrap system, all 
further remarks refer to that type of instrument. In brief, the LTQ-Orbitrap instrument is a latest 
generati on hybrid mass spectrometer combining the strengths of two conceptually disti nct 
mass analyzers in one device. To be exact, the LTQ-Orbitrap combines a linear trap quadropole 
(LTQ) and an Orbitrap mass analyzer (SCIGELOVA Ι MAKAROV, 2006).
ESI produces positi vely charged molecules that are fi rst trapped in an electrostati c fi eld moving 
around a central electrode referred to as orbital trap, or Orbitrap. To avoid unfavorable collision 
with any other form of matt er, mass spectrometers operate in high-vacuum atmospheres. 
The mass analyzer now uses individual ion oscillati ons from pepti des with diff erent masses to 
accurately compute respecti ve m/z values (inferred from oscillati on frequencies) and signal 
intensiti es (inferred from oscillati on amplitudes). When all the signal intensiti es being detected 
across the enti re mass range are summed up and plott ed against the ti me given by the length 
of the HPLC gradient, the total ion current (TIC) is obtained (cf. Fig. I.2 A). Looking specifi cally 
at all masses present in the Orbitrap at a specifi c point in ti me yields the so called survey or 
precursor ion scan (cf. Fig. I.2 B). Since a mass spectrometer separates and detects ions of 
slightly diff erent masses, high mass resoluti on instruments easily discern diff erent isotopes of 
a given pepti de. Hence, ionized pepti des do usually not appear as single, isolated peaks but as 
so called isotope clusters refl ecti ng the natural 12C/13C rati o (cf. Fig. I.2 B insert) (CANAS et al., 
2006).
In order to unambiguously discern pepti des of the same mass but diff erent amino acid order, 
sequence informati on is a necessity. This is achieved by employing a strategy termed tandem 
mass spectrometry (MS/MS) that involves breaking of isolated pepti de ions into smaller 
fragments by collision with inert gas molecules (termed collision induced dissociati on, CID). 
The process of recording such fragment mass spectra (cf Fig. I.2 C) is referred to as fragment or 
product ion scanning (DOMON Ι ABERSOLD, 2006). The resulti ng randomly occurring pepti de 
breaks produce fragment ions of specifi c m/z values from which the amino acid sequence 
can be deduced. In practi ce, tandem mass spectrometry is performed in the LTQ-part of the 
instrument. While a precursor ion spectrum is acquired in the Orbitrap, top N most abundant 
precursor ions are concurrently selected for CID fragmentati on in the LTQ (cf. Fig. I.2.C), a 
process called data-dependant analysis (DDA). Spati ally and functi onally separati ng the 
acquisiti on of precursor and product ion spectra assures that the unique analyti cal capabiliti es 
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of either part of the LTQ-Orbitrap instrument are fully exploited. In mass spectrometry-based 
proteomics, several key parameters have been used to describe the performance characteristi cs 
of an instrument such as sensiti vity, speed, dynamic range and resoluti on. The sensiti vity of a 
mass spectrometer is determined by the smallest quanti ty of an analyte that can be detected, 
which is in the sub-femtomol range for pepti des (corresponds to protein copies/cell < 100). 
The instrument´s speed is used to assess the number of spectra that can be acquired per unit 
ti me and basically depends on the cycle ti me (the ti me needed to go through a cascade of one 
survey scan (MS spectrum) followed by multi ple product ions scans (MS/MS spectra)). While 
the dynamic range of an instrument denotes the range between the highest and lowest signal 
of an analyte detected in a single analysis, the resoluti on indicates the ability to disti nguish 
pepti de signals of slightly diff erent m/z values (cf. Fig. I.2 B). As sensiti vity and speed are 
crucial parameters to obtain thousands of instructi ve fragment spectra in a single run, CID is 
performed in the LTQ-part of the instrument whereas the acquisiti on of full scans requiring a 
high dynamic range and a high resoluti on is carried out in the Orbitrap-part.
Having acquired individual pepti de mass and sequence informati on, a “probability-based” 
matching algorithm is applied that compares the acquired spectra to theoreti cal spectra 
obtained by in silico digesti on and fragmentati on of candidate pepti des. Once a tandem 
mass spectrum is assigned a pepti de sequence, a protein database is searched to identi fy the 
proteins where the pepti de sequence is part of. 
Collecti vely, the aforementi oned trypti c digest of proteins followed by tandem MS in order to 
obtain pepti de mass and sequence informati on form the central concept of what is commonly 
termed shotgun, bott om-up or pepti de-centric proteomics. Shotgun proteomics is one of the 
most powerful and widespread approaches for characterizati on of complex protein samples 
so far (MARCOTTE, 2007). At present, if extensive sample pre-fracti on and exhausti ve precursor 
ion sequencing is applied, samples can be analyzed to an impressive depths of more than 6,000 
proteins. Due to its unparalleled high sampling depth, shotgun proteomics is oft en said to be 
ideally suited for “open discovery experiments”, where even novel proteins may potenti ally be 
detected (DOMON Ι AEBERSOLD, 2010).
Pepti de-centric proteomics does, however, have intrinsic limitati ons that should always kept 
in mind when conducti ng the actual measurement and interpretati on of the obtained data 
aft erwards. First, as the selecti on of precursor ions for fragmentati on is done in an automati c 
fashion (DDA), it is inherently biased towards more abundant pepti de species displaying proper 
signal-to-noise rati os. Minimizing the resulti ng systemati c under-sampling of highly interesti ng 
but low abundant proteins is therefore a major challenge towards a holisti c proteome analysis 
(STATES et al., 2006). Second, since signals intensiti es of the very same pepti de may substanti ally 
diff er between runs due to technical constraints (cf. I.1.2), DDA-based mass spectrometry 
results are intrinsically to some degree irreproducible. Consequently, diff erent subsets of the 
proteome are identi fi ed aft er repeated analysis of identi cal samples and the apparent absence 
of a certain pepti de cannot be construed as evidence for the absence of the corresponding 
protein. Identi fi cati on of pepti des may simply fail due to (i) being present at very low amounts 
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only, (ii) fragment spectra of poor quality, (iii) absence of the sequence from the database or 
(iv) extensive post-translati onal modifi cati ons that aggravates pepti de identi fi cati on (DUNCAN 
et al., 2010).
Third, although tremendous eff ort has been devoted to opti mize computati onal algorithms 
that match the measured fragment spectra to those obtained by in silico fragmentati on, 
protein assembly in shotgun proteomics remains a non-trivial, probability-based central 
challenge to robust protein identi fi cati on. Although the use of sequence-specifi c proteases 
along with profound mechanisti c understanding on how and where pepti des break apart 
vastly facilitates the assembly of proteins thereaft er, the process is oft enti mes compared to a 
jigsaw puzzle with billions of parts (MARCOTTE, 2003). Correct pepti de assignment is further 
complicated as precedent protein digesti on results in the loss of intact protein informati on. 
This applies especially to degenerated pepti des, i.e. pepti des shared by multi ple proteins, 
where the enzymati c cleavage renders a defi nite precursor fi nding impossible. Although the 
bulk spectra can be eventually correctly assigned to pepti de sequences, an appreciable amount 
of fragment ions go unmatched and remain unnoti ced. Amongst them, spectra of multi ply 
modifi ed pepti des but also spectra from novel pepti des are assumed (NING et al., 2010).
Lastly, conducti ng shotgun proteomics virtually always means perpetual de novo discovery of 
a proteome, as the analysis can inherently not be restricted to a certain subset of proteins. 
Consequently, a large number of proteins with no relevance to the actual questi on are 
identi fi ed making pepti de-centric proteomics a relati vely highly ti me-consuming and costly 
process. Thus, if only a well defi ned set of proteins is of interest so called “targeted” MS 
approaches consti tute reasonable alternati ves (DOMON Ι AEBERSOLD, 2010). This being said, 
such approaches, however, require comprehensive a priori knowledge for both target selecti on 
and assay design - knowledge that is normally gained in upfront shotgun proteomics.
Quantitative approaches in mass spectrometry-based I.1.2.  
proteomics
Relative MS-based quantification with heavy stable-isotopesI.1.2.1 
Robust protein identi fi cati on has become straightf orward, yet various pressing questi ons cannot 
be reasonably addressed without additi onal quanti tati ve informati on. Current improvements 
in genomic sequencing technologies, though imperfect, made whole transcriptomes accessible 
to quanti tati ve descripti ons (SCHUSTER , 2008; WANG et al., 2009). Unfortunately, mRNA 
abundances show only poor correlati on with corresponding protein levels (LU et al., 2007; 
GYGI et al., 1999; GREENBAUM et al., 2003). Thus, the ability to monitor changes in protein 
abundance, preferably on a global scale, is a key prerequisite for interpretati on of virtually 
all targeted perturbati ons of biological systems. Moreover, any kind of modeling study taking 
dynamic data as input is inconceivable without a quanti tati ve dimension (HANKE et al., 2008).
Unfortunately, mass spectrometry inherently is a non-quanti tati ve method. Specifi cally, the 
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raw pepti de signal intensity is not directly proporti onal to the quanti ty of the pepti de present 
in the sample due to multi ple error-prone processing steps in MS. Diff erenti al accessibility of 
proteins to respecti ve proteases, varying pepti de solubility, diff erences in detector sensiti vity 
for certain pepti des and, most importantly, inconsistent ionizati on effi  ciencies do all aff ect raw 
pepti de signal intensiti es (ONG Ι MANN, 2005). Yet the systemati c character of those factors 
allows for relati ve comparison of ion signals, either between two samples analyzed in the same 
manner or within the same analysis by means of stable-isotopes (AEBERSOLD Ι MANN, 2003).
In recent years, several methods uti lizing stable isotopes for mass spectrometry- based 
quanti fi cati on have been successfully established. Though diff ering in the way stable-isotope 
labeling is accomplished, all approaches share the key principle that pairs of chemically 
equivalent pepti des of diff erent stable-isotope compositi on can be disti nguished by the 
mass spectrometer owing to the mass shift  introduced by the label (BANTSCHEFF et al., 2007). 
Provided that the instrument is capable to detect and diff erenti ate both the labeled and the 
unlabeled form, quanti fi cati on is achieved by comparing the respecti ve signal intensiti es. If 
thoroughly performed, stable-isotope labeling is characterized by outstanding quanti fi cati on 
accuracy since comparison of signal intensiti es of the two pepti de forms is performed within 
the same LC-MS run. Thus, diff erences in sample preparati on and most notably in ionizati on 
effi  ciencies between runs do not apply here and therefore fundamentally disti nguish isotope-
labeling from so called “label-free” approaches menti oned thereinaft er. 
Stable-isotope labels are usually introduced by chemical tagging of pepti des (termed ICAT 
for isotope-coded affi  nity 
tag introduced by GYGI et al., 
1999) or proteins (referred 
to as iTRAQ for isobaric tag 
described  in  ROSS  et al., 2004) 
and also by transfer of heavy 
oxygen (18O) during enzymati c 
protein digesti on (YAO et al., 
2001). Apart from chemical and 
enzymati c labeling strategies, 
metabolic incorporati on 
of heavy stable-isotopes is 
frequently used (cf. Fig.I.3). In 
essence, metabolic labeling is 
based on supplementi ng growth 
media of living cells with heavy 
stable-isotope molecules (ONG 
Ι MANN, 2005; AEBERSOLD Ι 
MANN, 2003, BANTSCHEFF et al., 
2007). Through cellular growth 
Cells or
tissue
Protein
Peptides
MS
sample
Purification or
fractionation
ICAT iTRAQ 15N/SILAC
Metabolic labeling
SILAC
Chemical modification
Fig. I.3 | Quanti tati ve mass spectrometry workfl ows employing heavy stable-
isotopes. Colors represent diff erent experimental conditi ons being compared. 
Depending on the approach used to introduce stable-isotopes samples are combined 
at diff erent steps during sample preparati on, indicated by horizontal lines between 
boxes. Latest techniques enable multi plexing of samples, that is, comparing up to four 
samples in iTRAQ and up to three protein populati ons in stable isotope labeling by 
amino acids in cell culture (SILAC). While metabolically labeled samples (15N/SILAC) 
are combined at the earliest possible step, that is, at the stage of intact cells, parallel 
sample processing (indicated by dashed lines/boxes) in chemical labeling methods 
such as ICAT and iTRAQ before mixing is potenti ally error-prone. (Scheme taken from 
Ong & Mann, 2007)
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and protein turnover labeled metabolic precursors are gradually incorporated into virtually 
all proteins. Accordingly, cells are either grown in light (unlabeled) or heavy (labeled) growth 
media resulti ng in two diff erent cell/protein populati ons disti nguishable only by MS due to the 
disti nct mass shift . As labeling takes place in living cells and therefore at the earliest possible 
stage, the samples of interest can be combined prior to lysis, fracti onati on and purifi cati on. 
This implies that errors introduced by the aforementi oned sample preparati on steps cancel 
out because they apply equally to both samples - a unique feature of metabolic labeling (cf. 
Fig. I.3). 
Metabolic labeling can be disti nguished in two major approaches given by 15N labeling and 
stable isotope labeling by amino acids in cell culture (SILAC). Since all relati ve quanti fi cati on 
experiments described in the present thesis were exclusively performed using SILAC, further 
specifi cati ons of chemical, enzymati c and 15N-labeling assays are beyond the scope of the thesis 
and shall remain unnoti ced. Strengths and weaknesses, limitati ons and recent applicati ons of 
the SILAC approach, however,  will be discussed in greater detail in the following chapter.
Stable isotope labeling by amino acids in cell cultue (SILAC)I.1.2.2 
In recent years, a straightf orward yet simple and widely applicable metabolic labeling strategy 
termed SILAC (stable isotope labeling by amino acids in cell culture) has gained wide popularity. 
SILAC was originally developed in the lab of Matt hias Mann in 2002 and involves the growth of 
cells in culture medium supplemented with heavy stable isotope versions of essenti al amino 
acids like heavy arginine and/or heavy lysine containing a fi xed number of 13C, 15N and/or 2H 
atoms (ONG et al., 2002). In SILAC, potenti ally all pepti des are amenable to labeling as the 
amino acids are uniformly incorporated into all newly synthesized proteins. Even proteins with 
extremely low turnover rates will be labeled due to diluti on of unlabeled counterparts aft er 
several rounds of cell doubling (ONG Ι MANN, 2006). Thus, a typical SILAC experiment involves 
culti vati on of two diff erent cell populati ons in either light medium containing amino acids 
with natural isotopes or heavy medium containing the respecti ve heavy amino acids (cf. Fig. 
I.4). In contrast to radioacti ve labeling commonly used in biology (POLLARD, 1996), such as 
pulse–chase experiments with 32P- or 35S-Met, SILAC seeks to completely replace light amino 
acids by their heavy labeled counterparts throughout the proteome. As menti oned above, 
sample combinati on right aft er the actual experiment minimizes errors introduced by sample 
processing. As labeling does not aff ect chromatographic characteristi cs, co-eluti ng pairs of 
chemically equivalent pepti des emerge in the mass spectrum at the same ti me but can sti ll be 
disti nguished from each other due to the constant mass increment introduced by heavy amino 
acids. Hence, comparing signal intensiti es of heavy and light pepti de peaks allows for accurate 
relati ve quanti fi cati on of thousands of proteins in one LC-MS/MS experiment (ONG Ι MANN, 
2005). 
Combining SILAC labeling with trypti c cleavage occurring specifi cally at the carboxyl-termini of 
arginine and lysine residues typically generates pepti des carrying only one labeled amino acid 
which signifi cantly facilitates subsequent data analysis. Knowing the exact mass diff erence 
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introduced during metabolic labeling is a fundamental diff erence to 15N labeling where the 
number of atoms incorporated can vary depending on the pepti de sequence (ONG Ι MANN, 
2006). Also, proteolyti c cleavage aft er heavy amino acids basically enables quanti fi cati on of all 
pepti des except for the C-terminal pepti de of a protein.
Depending on the label used in SILAC, light and heavy pepti de peaks diff er in mass from at least 
four up to ten Dalton. This is usually suffi  cient to allow for a clear-cut discriminati on between 
the respecti ve isotope clusters, which is a major prerequisite for accurate quanti fi cati on. 
Although SILAC works most convenient with immortalized cell lines where usually ~97 % of 
all proteins are present in the heavy state 
aft er fi ve cell doublings in appropriate 
growth medium (ONG Ι MANN, 2006), 
recent studies demonstrate that the labeling 
approach can also be expanded to higher 
organisms. Despite of high costs and laborious 
experimental work, in vivo SILAC labeling of 
Mus musculus was achieved in 2008 (KRUGER 
et al., 2008). The “SILAC mouse” allowed for 
the fi rst ti me ever organ and ti ssue specifi c 
proteome-wide relati ve quanti fi cati on and 
represents undoubtedly a milestone in stable-
isotope labeling. Alternati vely, SILAC labeling 
of Drosophila melanogaster as an animal 
model amenable to straightf orward geneti c 
manipulati on has also been accomplished 
(SURY et al., 2010). The approach is simple, 
fast, and cost-eff ecti ve which makes SILAC fl ies 
an att racti ve model system for the emerging 
fi eld of in vivo quanti tati ve proteomics.
Despite its appealing simplicity, SILAC does 
of course have limitati ons. For instance, the 
use of fetal calf serum (FCS) in cell culture is 
a potenti al source of unlabeled amino acids. 
Therefore, dialyzed FCS (dFCS) has to be used 
that is, however, incompati ble with some rare 
cell lines relying on growth factors lost by 
dialysis. Moreover, certain cell types exhibit 
some degree of arginine to proline conversion. 
Fortunately, the conversion can be alleviated 
by ti trati ng the amount of arginine used in the 
media (ONG Ι MANN, 2006). Lastly, cell lines 
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Fig. I.4 | Quanti tati ve mass spectrometry using the SILAC approach. 
Cells of two diff erent experimental conditi ons are either grown in 
culture medium containing unlabeled, natural amino acids (light 
medium) or in medium supplemented with heavy stable isotope 
versions of essenti al amino acids (heavy medium). As heavy amino 
acids 13C6
15N4 L-arginine (mass shift  of ten Dalton to its unlabeled 
counterpart) and 13C6
15N2 L-lysine (mass shift  of eight Dalton to its 
unlabeled counterpart) are preferably used. Cell growth, i.e. protein 
synthesis and turnover lead to uniform metabolic incorporati on 
of the SILAC amino acids throughout the enti re proteome. Intact 
cells from the two populati ons being compared are combined, 
processed, and subjected to mass spectrometry analysis. Here, 
pairs of chemically equivalent pepti des emerge with a disti nct mass 
shift  (Δm/z) introduced by the labeling in the same mass spectrum. 
Comparing signal intensiti es of heavy and light pepti de peaks allows 
for accurate relati ve quanti fi cati on of thousands of proteins in one 
LC-MS/MS analysis.
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with extremely slow cell division rates (e.g. Schwann cells) can make a proper labeling highly 
ti me-consuming. As all of the aforementi oned issues potenti ally aff ect proper SILAC labeling 
and hence quanti fi cati on accuracy, they should be explicitly addressed before conducti ng the 
actual experiments. 
Due to its straightf orward implementati on in existi ng workfl ows and its robust and highly 
accurate quanti fi cati on of thousands of proteins in parallel, SILAC has become the method 
of choice for addressing various research subjects - from whole proteome scale comparisons 
(GRAUMANN et al., 2008) to acquisiti on of temporal profi les (ANDERSEN et al., 2005) and analysis 
of changes in post-translati onal modifi cati ons like phosphorylati ons (BLAGOEV et al., 2004).
Absolute quantification of proteinsI.1.2.3 
Stable-isotope based quanti fi cati on has so far solely been discussed with regard to comparison 
of perturbed biological samples relati ve to an untreated control sample. Relati ve quanti fi cati on, 
however, cannot provide informati on about absolute protein abundance. Especially in a 
medical context, knowing absolute amounts of disease-specifc biomarkers can provide 
diagnosti c informati on of high relevance (HANKE et al., 2008). Also, modeling approaches 
require absolute molecule numbers to quanti tati vely describe dynamic systems (BEN-TABOU 
DE-LEON Ι DAVIDSON, 2009).
Stable-isotope labeling can also be employed to obtain absolute protein quanti fi cati on. 
Historically, digesti on in heavy water was the fi rst method used for absolute quanti fi cati on 
(DESIDERIO & KAI, 1983). More recent approaches employ spiking of known amounts of a 
stable-isotope labeled pepti des or an enti re protein as an internal standard to the protein 
mixture, two concepts termed “AQUA” (GERBER et al., 2003) or “Absolute SILAC” (HANKE et al., 
2008), respecti vely. Despite of its high precision in quanti fi cati on, laborious and costly stable-
isotope pepti de/protein synthesis limits the approach so far to small scale protein studies. 
Alternati vely, absolute quanti fi cati on is oft en performed without heavy stable isotopes in so 
called “label-free” approaches, which are briefl y discussed in the following chapter.
Label-free approachesI.1.2.4 
Conceptually diff erent to isotope labeling are so called “label-free” approaches for relati ve and 
absolute quanti fi cati on. Most methods rely on the observati on that more abundant proteins 
are also more likely to be detected at the pepti de level in a shotgun experiment (LIU et al., 2004). 
These approaches either involve counti ng of fragment spectra obtained for a given protein 
(referred to as spectral counti ng) or measuring MS signal intensiti es of pepti des derived from 
the same protein (referred to as extracted ion current, XIC). Spectral counti ng-based absolute 
quanti fi cati on provides an esti mate of absolute protein amounts, especially when corrected for 
the number of theoreti cally observable pepti des (exponenti ally modifi ed protein abundance 
index, emPAI) (ISHIHAMA et al., 2005) or sequence length (normalized spectral abundance 
factor, NSAF) (MOSLEY et al., 2009). Combined with complex computati onal algorithms 
predicti ng the probability of identi fying pepti des using machine learning techniques (absolute 
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protein expression measurements, APEX) (LU et al., 2007), spectral counti ng has gained more 
precision in quanti fi cati on. Sti ll, a limitati on of spectral counti ng-based approaches is that they 
fully ignore pepti de intensiti es as a possible source of quanti tati ve informati on. Alternati vely, 
an XIC-based approach taking into account raw intensiti es of the three most intense pepti des 
matching to a specifi c protein has been demonstrated to correlate with absolute levels (SILVA 
et al., 2006; MALMSTROM et al., 2009). However, this approach neglects informati on from 
intensiti es of all other matching pepti des and yields a smaller number of quanti fi able proteins 
because the identi fi cati on of three pepti des per protein cannot be guaranteed in all cases. 
Relati ve quanti fi cati on employing label-free methods is further complicated by the fact that the 
comparison of pepti de abundance is performed across LC-MS runs, whereas signal intensiti es 
of stable-isotope labeled pepti des are directly compared within a single run (cf. Fig. I.5). Thus, 
diff erences in ionizati on effi  ciency and more important, slightly varying chromatographic 
retenti on ti mes between runs may dramati cally aff ect relati ve quanti fi cati on in label-free 
approaches.
Fig. I.5 | Strategies used in quanti tati ve mass spectrometry. While isotope labeling approaches such as SILAC compare peak 
intensiti es of diff erenti ally labeled pepti de pairs with a specifi c mass shift  in the same LC-MS/MS run, label-free methods for 
relati ve quanti fi cati on of protein abundance are performed across runs.
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Biological implications of mass spec-I.2. 
trometry-based quantitative proteomics
Translational regulation of gene expression I.2.1.  
Gene expression is ti ghtly regulated at all levels from mRNA transcripti on to protein translati on 
and hence transcripti onal and post-transcripti onal regulati on has to be disti nguished. While the 
former one is crucial for mRNA synthesis, post-transcripti onal control aff ects mRNA stability 
as well as disti nct steps during translati on (GEBAUER & HENTZE, 2004). In the past decades, 
much eff ort has been invested to study transcripti on regulati on, while translati onal regulati on 
largely remained unnoti ced.
Comparati ve genomic and proteomic profi ling conducted in diff erent species have revealed a 
substanti al lack of correlati on between mRNA and protein levels thereby clearly stressing the 
relevance of post-transcripti onal regulati on for gene expression (GYGI et al., 1999; GREENBAUM 
et al., 2003; LU et al., 2007). This observati on implies that DNA-microarrays which have 
become a powerful and straightf orward tool to routi nely study quanti tati ve changes of the 
transcriptome cannot be employed to study changes occurring at the level of translati on. 
Translati onal regulati on provides the cell with the plasti city needed to rapidly adapt gene 
expression to changes in environmental conditi ons such as cellular stress (e.g. heat shock, 
hypoxia or nutrient deprivati on), but also for fi ne-tuning of protein levels during cell cycle, 
proliferati on and diff erenti ati on (HOLCIK & SONENBERG, 2005; CALKHOVEN et al., 2002). In the 
cell, translati onal control is either exerted globally, thereby aff ecti ng basically all mRNAs or 
more selecti vely, in which translati on of merely defi ned groups of mRNAs is modulated without 
aff ecti ng overall biosynthesis (GEBAUER Ι HENTZE, 2004). While global control of translati on 
is primarily mediated by modifying translati on initi ati on itself, specifi cally modulated mRNAs 
frequently carry cis-regulatory sequence moti fs targeted by RNA-binding proteins upon 
environmental changes (LUNDE et al., 2007). Apart from proteins a class of small RNAs 
referred to as  microRNAs (miRNAs, see below) has also been found to have a major impact 
on translati onal regulati on by hybridizing to specifi c sequences usually located in untranslated 
regions (UTRs) (FLYNT Ι LAI, 2008). Translati on of localized mRNAs via functi onallly disti nct 
compartments represents another powerful means of translati onal control (BESSE Ι EPHRUSSI, 
2008). Consistently, a growing catalogue of human diseases is linked to mutati ons in gene 
products that are either part of the translati on machinery or directly controlling translati onal 
regulati on (SCHEPER et al., 2007).
Regulation of gene expression exerted by microRNAsI.2.2.  
Since their discovery in the early 1990, intense research on gene regulati on exerted by 
microRNAs (miRNAs) has undoubtedly added a new dimension to the complexity of post-
transcripti onal regulati on. As things turned out soon, this class of small non-coding RNAs 
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was more than a mere curiosity of nematode 
biology (LEE et al., 1993; WIGHTMAN et al., 
1993). Due to their vital role in virtually every 
biological process under investi gati on, aberrant 
expression levels are nowadays observed in 
a growing number of human pathologies, 
including cancer and neurodegenerati ve 
disorders (ESQUELA-KERSCHER Ι SLACK, 2006; 
KOSIK, 2006; CHANG Ι MENDELL, 2007). Despite 
of their ubiquitous nature, progress towards 
an exhausti ve mechanisti c understanding by 
which miRNAs act post-transcripti onally has 
been diffi  cult as results from studies conducted 
in diff erent systems and diff erent laboratories 
have oft en been contradictory. 
Metazoan microRNAs, typically 21-23 
nucleoti des in length, base-pair imperfectly 
with target mRNAs to down-regulate gene 
expression by either destabilizati on of the 
transcript or by translati onal repression (cf. Fig. 
I.6) (HE Ι HANNON, 2004; BRODERSEN Ι VOINNET, 
2009). The most stringent requirement for target 
selecti on is a consecuti ve and perfect Watson-
Crick base pairing of the miRNA nucleoti des 
2–8, representi ng the “seed” region, with one 
or multi ple complementary cis-regulatory sites 
in the 3´UTR of target messages (STARK et al., 
2003; RAJEWSKY Ι SOCCI, 2004). While many 
target mRNAs undergo degradati on, most likely 
initi ated by removal of the poly(A) tail, other, 
stable target mRNAs are obviously repressed at 
the initi ati on or elongati on stage of translati on 
(EULALIO et al., 2008; FILIPOWICZ et al., 2008).
Bioinformati c predicti ons accounti ng for the 
above menti oned miRNA-mRNA binding 
characteristi cs indicate that mammalian miRNAs potenti ally regulate up to 30% of all protein-
coding genes (RAJEWSKY, 2006). However, of the hundreds of known human miRNAs only very 
few have been experimentally linked to specifi c functi ons. The fact that microRNAs can alter 
mRNA stability has been exploited to study the impact of microRNAs following ectopic over-
expression on global mRNA levels by conventi onal microarray technique (LIM et al., 2005). 
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Fig. I.6 | MicroRNA biogenesis and putati ve mode of acti on 
in mammals. Following transcripti on of microRNA genes, the 
transcripts undergo a series of endonucleolyti c maturati on steps. 
First, primary miRNA transcripts (pri-miRNA) are processed 
into precursor miRNA (pre-miRNAs) stem loops by the RNaseIII 
enzyme Drosha and the double-stranded RNA binding-domain 
protein DiGeorge syndrome criti cal region gene 8 (DGCR8). 
Pre-miRNAs are then acti vely transported to the cytoplasm 
via Exporti n 5 and cleaved into short double-stranded RNA 
duplexes by Dicer (complexed with TAR RNA binding protein 
(TRBP)). Only one strand (guide strand) of the duplex is selected 
and assembled together with specifi c Argonaute proteins (Ago 
1-4) into the RNA-induced silencing complex (RISC). Finally, 
RISC represses target gene expression by either interfering 
with translati on initi ati on/elongati on or by deadenylati on 
followed by destabilizing of target mRNAs. RISC also mediates 
RNA interference (RNAi) where full complementarity between 
small interfering RNAs (siRNAs) and target mRNAs results 
in endonucleolyti c cleavage thereof. (Illustrati on taken and 
modifi ed from FILIPOWICZ et al., 2008)
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In contrast, experimental evidence demonstrati ng that microRNAs can also directly aff ect 
protein translati on is restricted to a small set of genes (MATHONET et al., 2007; THERMANN 
Ι HENTZE, 2007; WAKIYAMA et al., 2007). Evidently, these results do not reveal how much 
control miRNAs exert globally on protein synthesis. Given that protein synthesis is one of the 
most important quanti ti es for the phenotype, fundamental questi ons about gene regulati on 
mediated by microRNAs therefore remain unanswered. Likewise, it is unclear whether sequence 
determinants beyond seed pairing can explain diff erences of individual microRNAs in targeti ng 
mRNAs for degradati on or translati onal repression. 
Recently, ribosome profi ling has been described to detect changes in protein synthesis by 
specifi c analysis of acti vely transcribed mRNAs (INGOLIA et al., 2009). However, as the method 
strictly speaking provides informati on about the associati on of mRNAs with ribosomes, it cannot 
directly quanti fy protein producti on. Regulati on at the level of translati on is thus typically 
investi gated on a gene by gene basis with radioacti ve amino acids (e.g. 35S-methionione; 
POLLARD, 1996) or by expression of arti fi cial reporter constructs, e.g. luciferase reporter assays 
(DYER et al., 2000). As this is impracti cal for system-wide investi gati ons new techniques for the 
global analysis of cellular protein translati on are required.
In recent years, mass spectrometry-based proteomics has developed to a point where 
it is routi nely applied to tackle various pressing questi ons that are not or not suffi  ciently 
approachable with conventi onal techniques. Mass spectrometry-based proteomics can identi fy 
hundreds of proteins in complex mixtures and recently developed methodologies off er the 
opportunity to obtain quanti tati ve proteomic informati on. Although such approaches can 
be harnessed to monitor global protein expression changes upon perturbati ons, measuring 
changes in protein steady-state levels upon miRNA over-expression or depleti on is not ideally 
suited for assessing the eff ect on protein synthesis. Due to individual protein turnover ti mes, 
a given miRNA that for instance completely shuts off  protein producti on will rapidly alter 
steady-state levels of high turnover proteins while stable proteins will be aff ected later. In 
fundamental biological processes such as diff erenti ati on, however, the expression of miRNAs 
is strongly induced (or switched off ) in a relati vely small ti me window (STEFANI Ι SLACK, 2008). 
Thus, to assess endogenous regulati on of mRNA translati on by miRNAs a technique is needed 
to directly measure genome-wide changes in protein synthesis shortly aft er changes in miRNA 
expression and irrespecti ve of individual protein turnover.
The complex relationship between mRNAs and proteinsI.2.3.  
The central dogma of molecular biology states that geneti c informati on is transferred from 
DNA via mRNA to proteins. At each step gene expression is ti ghtly regulated by the complex 
interplay of transcripti onal, post-transcripti onal and post-translati onal control mechanisms 
(BEN-TABOU DE-LEON Ι DAVIDSON, 2009). Transcripti on depends on cis- and trans-regulatory 
elements, histone modifi cati ons and chromati n structure (KIM et al., 2009; KOUZARIDES, 
2007). RNA-binding proteins and microRNAs regulate mRNA stability and translati on into 
proteins (AMBROS, 2008; GEBAUER Ι HENTZE, 2004; KEENE, 2007; SONENBERG Ι HINNEBUSCH, 
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2009). Protein degradati on is regulated by specifi c post-translati onal modifi cati ons such as 
phosphorylati on and ubiquiti nati on (ELSASSER Ι FINLEY, 2005; HERSHKO Ι CIECHANOVER, 1998; 
JESENBERGER Ι JENTSCH, 2002; KING et al., 1996; KIRKPATRICK et al., 2005; MAYER, 2000). Although 
these regulatory processes are well-characterized mechanisti cally, litt le is known about how 
their combined eff ect shapes cellular gene expression. 
Recently, high-throughput approaches have been used to simultaneously measure protein 
and mRNA concentrati ons (reviewed in: DE SOUSA ABREU et al., 2009; MAIER et al., 2009). 
Most reports comparing mRNA and protein levels arrived at the conclusion that the overall 
correlati on is poor and varies widely across organisms, with a squared Pearson’s correlati on 
coeffi  cient (R2) between 0.30 and 0.50. Since R2 refl ects to what extent the variati on in one 
variable can be explained by changes in another variable, less than 50% of the variance in 
protein levels can be explained by diff erences in mRNA levels. Thus, diff erences in mRNA 
expression determined by mRNA transcripti on and decay are obviously insuffi  cient to fully 
explain diff erences in protein abundance given by translati on and degradati on. However, the 
available data suff er from several limitati ons rendering data interpretati on diffi  cult. 
First, most studies are limited to a few hundred genes, mainly due to the technical challenges 
involved in large scale protein quanti fi cati on (GYGI et al., 1999; NIE et al., 2006; TIAN et al., 
2004). Also, several studies report only relati ve changes in protein and mRNA concentrati ons 
and cannot be used to compare protein and mRNA levels directly (LIN et al., 2005; UNWIN et 
al., 2006; ORNTOFT et al., 2002; BERGER et al., 2004; BEAK et al., 2008; SELBACH et al., 2008). 
Absolute concentrati ons are certainly more diffi  cult to obtain and hence less available than 
relati ve concentrati ons (cf. I.1.2.4). While genome-scale studies employing next-generati on 
sequencing render absolute mRNA quanti fi cati ons feasible, though with intrinsic limitati ons 
(MORTAZAVI et al., 2008; NAGALAKSHMI et al., 2010), data of comparable magnitude and quality 
remain elusive for proteins (STEEN Ι PANDEY, 2002). Absolute protein concentrati ons in yeast 
have been approached using libraries of TAP/GFP-fusion proteins, however, such laborious 
studies are confi ned to only very few organism (GHAEMMAGHAMI et al., 2003; HOWSON et al., 
2005; COHEN et al., 2008). Alternati vely, mass specrometry-based quanti fi cati on of cellular 
protein concentrati ons of the human pathogen Leptospira interrogans has recently been 
described (MALMSTROEM et al., 2009) employing syntheti c stable isotope-labeled pepti des 
as internal references. The generati on of such syntheti c pepti des readily amenable to mass 
spectrometry analysis, however, requires several rounds of opti mizati on which signifi cantly 
hampers the straightf orward applicati on in other organisms (MALLICK, 2007). As the ability 
to precisely and comprehensively measure mRNA and protein concentrati ons signifi cantly 
impinges on the observed protein and mRNA correlati on, further instrumental improvements 
will certainly foster the generati on of data of high(er) biological relevance. For instance, in a 
recently developed approach termed ribosome footprinti ng, next-generati on sequencing was 
applied to measure ribosome-bound, acti vely translated mRNAs in yeast (INGOLIA et al., 2009). 
By comparison to publicly available protein measurements, the analysis yielded a genome-wide 
correlati on between mRNA and protein levels of R2 = 0.42 which fi ts well to previous studies 
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(see above). Although the study was well-controlled, of impressive magnitude and hence of 
reasonable validity, it struggles with another frequently observed constraint in integrati ve 
analyses. Levels measured in one experiment are oft enti mes compared to concentrati ons 
determined in a diff erent experiment performed at a diff erent ti me in a diff erent lab, making 
it diffi  cult to interpret the degree of correlati on. In the high-resoluti on study menti oned above 
measurements of mRNAs obtained by ribosome footprinti ng were compared to measurements 
of protein concentrati ons performed several years ago using a collecti on of TAP/GFP-tagged 
yeast strains (GHAEMMAGHAMI et al., 2003). Since fl uorescence- and Western blot-based 
detecti on of tagged proteins is intrinsically error-prone, the true correlati on can expected to be 
higher. Along these lines, the correct assessment of technical and experimental error is crucial 
for a reasonable interpretati on of integrati ve studies. Ideally, studies aiming for comparison 
of mRNA and protein levels should be designed in a way that both quanti ti es are acquired 
simultaneously in the exact same experiment.
Second, several studies were performed in bacteria and neglect regulatory mechanisms 
specifi c for higher eukaryotes. In contrast to prokaryotes, transcripti on and translati on is 
temporally and spati ally uncoupled, i.e. eukaryoti c translati on takes place in the cytoplasm 
aft er transcripti on inside the nucleus, leading to much more elaborate regulati on of eukaryoti c 
gene expression. Upon mRNA synthesis several factors potenti ally impact on various steps 
of translati on in eukaryotes. For instance, ribosomes can encounter upstream open reading 
frames (uORFs) situated in the mRNA’s 5´UTR and change levels of translati on of the main 
open reading frame in a competi ti ve manner (CALVO et al., 2009). Secondary structures aff ect 
translati on by slowing down ribosome passage as well as a sub-opti mal Kozak sequences 
impair translati on initi ati on (KOZAK, 1987). Also, translati on is infl uenced by cis-regulatory 
sequence features primarily situated in 3´ untranslated regions (3´UTR) recognized by specifi c 
trans-acti ng factors, e.g. RNA-binding proteins (RBPs) and microRNAs. 
Third and perhaps most importantly, conventi onal mRNA and protein expression profi ling 
experiments measure steady-state concentrati ons which always refl ect the net outcome 
of antagonizing synthesis and degradati on processes. Since steady-state levels, however, 
cannot be used to disentangle the relati ve contributi ons of mRNA and protein synthesis and 
degradati on, the actual dynamic parameters of gene expression that are subject to extensive 
transcripti onal and post-transcripti onal regulati on remain elusive. To illustrate, an increase in 
the level of expression of a given transcript or protein can be achieved by enhanced rates of 
synthesis or reduced rates of degradati on. To this end, mRNA and protein turnover have globally 
been investi gated with drugs inhibiti ng transcripti on or translati on, respecti vely, followed by 
quanti fi cati on of mRNA and protein decay (BELLE et al., 2006; RAGHAVAN et al., 2002; YANG 
et al., 2003). Classically, transcripti onal inhibiti on by acti nomycin and translati onal inhibiti on 
with cycloheximide has been employed. However, due to cellular toxicity of the applied drugs, 
turnover is measured when overall mRNA or protein synthesis is abrogated and thus may 
not refl ect the actual turnover rate under physiological growth conditi ons. The stability of 
enzymes governing degradati on itself might also be aff ected what further complicates the 
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accurate measurement of turnover rates.
In a recent study, protein stability profi ling of roughly 8,000 human proteins using fl uorescently 
tagged proteins has been described (YEN et al., 2008). Intrinsic limitati ons of the approach arise 
from the fact that tagging potenti ally impairs protein stability by aff ecti ng folding or obscuring 
degradati on signals. Fusion proteins may also exhibit diff erent cellular localizati ons compared 
to their wild-type counterparts what likely impinges on protein degradati on. Hence, traditi onal 
radioacti ve pulse-chase experiments are the gold standard method to determine half-lives of 
individual mRNAs and proteins (KENNEY, 1967; PUCKETT et al., 1975), albeit they are impracti cal 
for large scale studies. Recently, variants of these approaches uti lizing non-radioacti ve tracers 
have been developed that allow for global analysis of mRNA and protein turnover (PRATT et al., 
2002; BEYNON Ι PRATT, 2005; GOUW et al., 2010; DOELKEN et al., 2008). Concurrent with recent 
advances in quanti tati ve mass spectrometry, SILAC-based approaches have been developed 
to determine individual protein turnover. When non-labeled (light) cells are transferred to 
heavy SILAC growth medium, newly synthesized proteins incorporate the heavy label while 
pre-existi ng proteins remain in the light form. Consequently, the rati o of heavy (H) to light 
(L) pepti des indicates the turnover rate of the respecti ve protein. However, due to technical 
constraints given by limited sensiti vity and dynamic range, protein turnover ti mes have so far 
only be determined for a few hundred proteins (DOHERTY et al., 2009). 
Conceptually similar to the labeling of newly-produced proteins with stable-isotope labeled 
amino acids, newly synthesized RNA can be marked with the nucleoside analogue 4-thiouridine 
(4sU) in the mode of transcripti on. 4sU containing mRNA can be specifi cally bioti nylated and 
recovered from total RNA by column-based affi  nity purifi cati on. Subsequent comparison of 
newly synthesized and pre-existi ng mRNA fracti ons enables global quanti fi cati on of mRNA 
half-lives (DOELKEN et al., 2008).
Once such quanti tati ve measurements are available, mathemati cal models can be used to 
simulate biological systems and the underlying organizati onal principles (KOMUROV Ι WHITE, 
2007). Mathemati cal models att empti ng to quanti tati vely describe gene expression dynamics 
have been used for decades, though with varying success since the quality of the model and 
predicti ons thereof vastly depend on the quality of biological data used as input. However, 
even ordinary models built on confi ned experimental measurements have already proven 
useful in the deducti on of fundamental kineti c parameters of gene expression (reviewed 
in: DE SOUSA ABREU et al., 2009; BEN-TABOU DE-LEON & DAVIDSON, 2009). Specifi cally, with 
measurements of mRNA and protein levels and half-lives the predicti on of transcripti on and 
translati on rates becomes possible and a comprehensive descripti on of gene expression comes 
within reach. Although it is clear that the combined eff ect of transcripti on, translati on, mRNA 
decay and protein degradati on shapes gene expression, their relati ve contributi ons to steady-
state protein concentrati ons remain unknown (VOGEL et al., 2010). A dynamic descripti on of 
gene expression will therefore help to illuminate the discrepancies observed in the complex 
relati onship between transcriptome and proteome. However, even though recent technical 
advances have rendered dynamic properti es amenable, a systemati c comparison of those 
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parameters acquired from a single source has not yet been performed in any organism.
Outline and objectives of the thesisI.3. 
Moti vated by the lack of methods to explicitly investi gate diff erences in protein translati on 
across diff erent cellular conditi ons on a proteome-wide scale, a modifi ed version of the classic 
SILAC approach ought to be established (cf. III.1). Unlike in “classic” SILAC, the labeling in the 
modifi ed version is conducted for a defi ned ti me period only (pulsed labeling), and more 
importantly, by means of a second heavy isotope label. As the approach exclusively labels 
newly-synthesized proteins, relati ve changes in protein translati on rates between two cellular 
conditi ons can be accurately quanti fi ed. 
The pulsed SILAC approach is thus ideally suited to study post-transcripti onal regulati on 
exerted by microRNAs. Over the past decade, microRNAs have ermerged as a major class of 
regulatory genes that play a crucial role in diverse biological processes. miRNA mutati ons or 
misexpressions are therefore correlated with various human diseases including cancer and 
neurological disorders. Animal microRNAs regulate gene expression by inhibiti ng translati on 
and/or inducing degradati on of target messenger RNAs. While microarray analyses have  proven 
useful to assess global regulati on exerted by microRNAs on the transcriptome, the impact onto 
the proteome given by control of mRNA stability and protein translati on remains elusive. To 
this end, the pSILAC approach is applied to examine the full regulatory potenti al of microRNAs 
on a systems perspecti ve (cf. III.2). In that context, robust microRNA target identi fi cati on bears 
the potenti al to pinpoint disease-related genes which might prove useful in the diagnosis and 
treatment of human diseases.
Pulse labeling of newly-synthesized proteins with stable isotopes can also be uti lized to 
analyze fundamental dynamic features of gene expression. Steady-state mRNA and protein 
levels are the result of a ti ghtly controlled balance between the relati ve rates of producti on 
and degradati on. While genome-wide profi ling of both the transcriptome and proteome has 
been employed to elucidate relati ve changes in amounts upon external perturbati ons, it can 
obviously not disentangle the nature of those changes. Hence, knowledge about the relati ve 
contributi on of synthesis and decay rates (commonly referred to as turnover) to gene expression 
is key to understand the underlying dynamics properti es of the system. Though methods to 
study mRNA and protein turnover ti mes are now available, a systemati c comparison of mRNA 
and protein half-lives and abundances has not yet been performed in any organism. In order 
to simultaneously measure protein and mRNA turnover in mammalian cells, metabolic pulse 
labeling with heavy stable isotope encoded amino acids (SILAC) and the nucleoside analogue 
4-thiouridine is employed (cf. III.3). Sample analysis is performed by mass spectrometry and 
next generati on sequencing which also allows the deducti on of absolute mRNA and protein 
levels, two parameters indispensable to quanti tati vely describe basic gene expression. A 
global characterizati on of mRNA and protein turnover will likely shed more light on how their 
combined eff ect shapes cellular gene expression.
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General suppliersII.1. 
If not stated otherwise all chemicals were purchased from Roth (Karlsruhe), Sigma-Aldrich 
(Steinheim) or Merck (Darmstadt).
General solutions and buffersII.2. 
10x TBS
200 mM Tris base, 1.4 M NaCl, adjusted to pH 7.4
1x TBS-T
0.1 % [v/v] Tween 20 in 1x TBS
10x PCR buff er
100 mM Tris base, 500 mM KCl, adjusted to pH 8.3, stored at -20°C.
TBE
890 mM Tris base, 890 mM boric acid, 20 mM EDTA-NA2, adjusted to pH 7.4
Transfer buff er
25 mM Tris-HCl pH 8.5, 190 mM glycine, 10% methanol [v/v], 0.1% SDS [w/v]
Stripping buff er
68 mM Tris-HCl, pH 7.5, 2% SDS [w/v], 0.8% β-mercaptoethanol [v/v]
LB medium
10 g Bacto tryptone (BD), 5 g Bacto yeast extract (BD), 5 g NaCl, ad 1 L with ddH2O
adjusted to pH 7.4; for plates 1.5% [w/v] agar was added
5x DNA loading buff er
50 % glycerol (85%) [v/v], 0.5 x TBE, 0.2% SDS [w/v], dash bromphenol blue
Radioimmunoprecipitati on assay (RIPA) buff er
50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1mM EDTA, 1% [v/v] Triton-X 100, 1% [w/v] Na-
Deoxycholate,  0.1% [w/v] SDS. Complete Protease Inhibitor cocktail (Roche) (1:25) and 
Phosphatase Inhibitor Mix 1 (Sigma) (1:100) were added.
Fixati ve soluti on
50% methanol [v/v], 10% aceti c acid [w/v]
Blocking soluti on
1x TBS-T supplemented with 5% [w/v] non-fat dry milk powder
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Solutions and buffers for LC-MS/MS sample preparation II.3. 
and instrumentation
ABC buff er
50 mM ammonium bi-carbonate (NH4HCO3, ABC) in water (pH 8.0). Stored at RT.
Destaining buff er
25 mM NH4HCO3 / 50% ethanol (EtOH). Equal volumes of digesti on buff er and 100% EtOH were 
combined and stored at RT.
Reducti on buff er 
10 mM dithiothreitol (DTT) in 50 mM ABC buff er. Stored in small aliquots at -20°C. 
Alkylati on buff er
55 mM iodoacetamide in 50 mM ABC buff er. Stored in small aliquots at -20°C and kept in the 
dark.
Extracti on buff er
3% trifl uoroaceti c acid (TFA) / 30% acetonitrile (ACN). Stored at RT.
Denaturati on buff er
6 M urea/2 M thiourea in 10 mM HEPES (pH 8.0). Stored in small aliquots at – 80°C.
Buff er A
5% acetonitrile, 0.1% formic acid in water (LiChrosolv grade, Fischer Scienti fi c). Stored at RT.
Buff er B
0.1% formic acid, 80% acetonitrile in water (LiChrosolv grade, Fischer Scienti fi c). Stored at RT.
Cell culture and preparation of SILAC mediumII.4. 
Cell culture for pulsed SILAC (pSILAC)II.4.1.  
For iron treatment experiments, HeLa cells obtained from LGC Promochem were culti vated in 
SILAC medium at 37°C with 5% CO2 and split every second or third day.
For luciferase inducti on experiments, HeLa Tet-On cells with an inducible luciferase transgene 
were used. HeLa M2 cells expressing a modifi ed version of a reverse tetracycline controlled 
transacti vator have been described previously (HAMPF Ι GOSSEN, 2007). These cells were 
stably transfected with a fi refl y luciferase gene under control of pTET, a promoter responsive 
to tetracycline controlled transacti vators (GOSSEN Ι BUJARD, 1992). The resulti ng clonal double 
stable cell line therefore shows a Tet-On type response, as luciferase expression is induced 
upon additi on of the tetracycline derivate doxycycline.
Yeast haploid strain BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0) strain was grown in SILAC 
YPD liquid medium at 30°C and 220 rpm.
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Cell culture for determination of mRNA and protein half-lifeII.4.2.  
For half-life determinati on experiments NIH3T3 (mouse fi broblasts, obtained from ATCC) cells 
were used and culti vated in SILAC medium at 37°C with 5% CO2 and split every second or third 
day.
Cell culture for microRNA/LNA transfection experimentsII.4.3.  
All experiments were performed with HeLa cells obtained from LGC Promochem. Cells were 
culti vated in SILAC medium at 37°C with 5% CO2 and split every second or third day.
Cell culture for intensity based absolute quantification (iBAQ)II.4.4.  
E.coli strain DH10B (F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacΧ74 recA1 araD139 
Δ(ara-leu) 7697 galU galK rpsL (StrR) endA1 nupG λ-) was grown over night in Luria-Bertani 
(LB) broth at 37°C and 250 rpm.
NIH3T3 cells were culti vated at 37°C with 5% CO2 in Dulbecco’s Modifi ed Eagle’s Medium 
(DMEM) Glutamax (Gibco) supplemented with 10% fetal bovine serum (Gibco) and harvested 
at 70% confl uence. NIH3T3 cell numbers were determined using haemocytometers (C-Chips™) 
and protein concentrati on was measured using Bradford assay (Pierce).
Preparation of SILAC mediaII.5. 
Preparati on of SILAC media was essenti ally done as described previously (ONG &MANN, 
2006)For preparati on of SILAC media for mammalian cells, Dulbecco’s Modifi ed Eagle’s 
Medium (DMEM) Glutamax lacking arginine and lysine (a custom preparati on from Gibco) 
supplemented with 10% dialyzed fetal bovine serum (dFBS, Gibco) was used. “Heavy” and 
“medium-heavy” SILAC media were prepared by adding 84 mg/l 13C6
15N4 L-arginine plus 
146 mg/l 13C6
15N2 L-lysine or 84 mg/l 
13C6-L-arginine plus 146 mg/l D4-L-lysine, respecti vely. 
Labeled amino acids were obtained from Sigma Isotec (13C6-L-arginine, 
13C6
15N4 L-arginine and 
13C6
15N2 L-lysine) and Cambridge Isotope Laboratories (D4-L-lysine). To prepare “light” SILAC 
medium, the corresponding non-labeled amino acids (Sigma) were added.
Yeast haploid strain BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0) strain was completely SILAC 
labeled in the traditi onal way by culti vati ng them over night in minimal media (cf. Table II.1) 
supplemented with light (L), medium-heavy (M) or heavy lysine (H). 
Table II.1: SILAC yeast culture medium1
Component Catalog No. Solvent Final concentrati on
YNB without amino 
acids and ammonium 
sulfate
Y1251 Milli-Q water 1.7 g/l
D-Glucose G7528 Milli-Q water 20 g/l
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Ammonium sulfate A4418 Milli-Q water 5 g/l
Adenine hemisulfate A9126 Milli-Q water 200 mg/l
L-tyrosine T3754 0.5 M NaOH 100 mg/l
L-histi dine·HCl·H2O H8125 0.5 M NaOH 10 mg/l
L-leucine L8000 0.5 M HCl 60 mg/l
L-methionine M9625 PBS 10 mg/l
L-phenylalanine P2126 0.5 M HCl 60 mg/l
L-tryptophane T0254 0.5 M NaOH 40 mg/l
Uracil U0750 Milli-Q water 20 mg/l
L-arginine·HCl2,3 A5131 PBS 100 g/l
L-lysine·HCl4,5 L5501 PBS 146 g/l
1 Filter-sterilize the medium through a 0.22 μm fi lter (Millipore Express PLUS fi lter membrane, Billerica, MA, USA). Store at 
4°C.
2,3 To prepare light (L) medium, L-arginine-12C6·HCl (Arg-0) was used. For medium-heavy (M) and heavy (H) medium, L-arginine-
13C6·HCl (Arg-6) and L-arginine-
13C6
15N4·HCl (Arg-10) were used, respecti vely.
4,5 To prepare “light” medium, L-lysine-12C6
14N2·HCl (Lys-0) was used. For “medium-heavy” and “heavy” medium, D4-lysine 
(Lys-4) and L-lysine-13C6
15N2·HCl (Lys-8) were used, respecti vely. Arg-6 (Cat.# 643440), Arg-10 (Cat.# 608033), Lys-4 (Cat. 
#616192) and Lys-8 (Cat.# 608041) were obtained from Sigma Isotec; all the other chemical components were from Sigma-
Aldrich.
Quantification of luciferase expression by pulsed SILAC II.6. 
and luminescence
In order to validate the pulsed SILAC approach, mass spectrometry-based quanti fi cati on of 
gene expression was compared with the commonly used luciferase reporter system. A 10 h 
ti me course experiment was designed that allowed for parallel measurement of SILAC- and 
luminescence-based relati ve quanti fi cati on of luciferase expression. Fourteen 10 cm dishes 
with TET-On cells grown to 80 % confl uency in DMEM Glutamax were prepared. Cells from 
seven of these dishes were washed with D-PBS (Gibco) and transferred to medium-heavy 
(M) SILAC medium. Simultaneously, luciferase expression was induced by adding 500 ng/ml 
doxycycline to the cell culture medium followed by incubati on for the indicated lengths of ti me 
(1, 2, 4, 6, 8 and 10 h). In parallel, the remaining seven cell culture dishes were washed and 
transferred to heavy (H) SILAC medium, treated with 500 ng/ml doxycycline and incubated for 
10 h. These cells refl ect maximum luciferase expression aft er 10 h of inducti on and serve as an 
internal reference for SILAC-based relati ve quanti fi cati on. 
Cells were lysed with 500 μl PBS containing 0.5 % Triton X-100 and complete protease inhibitors 
w/o EDTA (Roche) for 10 minutes on ice. The lysates were cleared for 10 min by centrifugati on 
(14,000 rpm at 4°C). 10 μl aliquots of medium-heavy (M) sample were mixed with 100 μl of 
25 mM glycylglycine, 15 mM MgSO4, 5 mM ATP and 0.05 mM luciferin and assayed for luciferase 
acti vity in a microplate luminometer (TR717 Tropix Perkin Elemer, Applied Biosystems) using 
the integral mode (10 s). The background signal measured in extracts of TET-On HeLa cells that 
were not induced by Dox (0 h sample) was indisti nguishable from instrumental background 
(100-150 relati ve light units (rlu)/10 s). The luminescence-based relati ve quanti fi cati on of 
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luciferase expression was performed by referring the absolute luminescence intensiti es for the 
diff erent incubati on ti mes (labeled medium-heavy (M)) to the 10 h ti me point (control cells, 
indicati ng the maximum gene expression and maximum luminescence intensity, heavy (H) 
labeled). For pulsed SILAC-based quanti fi cati on, lysates from the seven dishes transferred to 
heavy (H) cell culture medium for 10 h were pooled and mixed in a 1:1 rati o with the medium-
heavy (M) lysate of each indicated sample ti me point. The mixed lysates were concentrated 
using Vivaspin columns (Vivascience AG) with a 3 kDa cut-off , supplemented with 4x SDS-
sample buff er and separated by SDS-PAGE (Novex 4-12 % gradient gel, Invitrogen). The gel 
was stained with Coomassie Blue and gel slices in the expected molecular weight range of the 
luciferase protein (62 kDa) were cut out. 
Treatment of HeLa cells with iron (FAC) or iron chelator II.7. 
(DFO)
Two 10 cm dishes of HeLa cells were grown to 60 % confl uency in DMEM Glutamax. Cells from 
one dish were washed with PBS and transferred to heavy (H) SILAC medium with simultaneous 
additi on of ferric ammonium citrate (FAC) or deferoxamine (DFO) to a fi nal concentrati on of 
100 μM. In parallel, cells from the second dish were washed and transferred to medium-heavy 
(M) SILAC medium without additi onal iron. Aft er 14 h of incubati on, the cells from both dishes 
were scraped off , combined and spun down (10 min, 600 g, 4°C). Cell pellets were lysed in SDS 
sample buff er, separated by SDS-PAGE (Novex 4-12% gradient gel) and processed by in-gel 
digesti on using standard protocols (12 gel slices in total).
The eff ect of iron has also been investi gated in a ti me-course experiment to allow for a ti me-
resolved acquisiti on of protein changes. FAC treatment and SILAC labeling were performed as 
described above and cells were harvested 4 h, 6 h, 8 h and 12 h upon perturbati on.
microRNA or LNA transfection and pulsed SILAC labelingII.8. 
HeLa cells were transfected with syntheti c miRNAs (Dharmacon) or locked nucleic acids (LNAs) 
(BioTez) using DharmaFECT1 (Dharmacon) according to the manufacturer’s instructi ons. Cells 
were plated in 15 cm dishes in light (L) SILAC medium the day before transfecti on to a confl uency 
of 30-40%. Syntheti c miRNAs/LNAs were used at a fi nal concentrati on of 100 nM. Control 
transfecti ons were carried out in parallel under the same conditi ons but using water instead 
of the miRNAs/LNAS (MOCK-transfecti on). At 8 h post transfecti on, cells were trypsinized. 
2/5 of the cell suspension was used for RNA isolati on (8 h ti me point). The remaining cells 
were transferred into two new 10 cm dishes each (3/10 of all cells per plate). One of the two 
plates containing miRNA/LNA transfected cells was transferred to medium-heavy (M) SILAC 
medium and one of the MOCK-transfected cells to heavy (H) SILAC medium for pulsed SILAC 
labeling. The two remaining plates were kept in normal light (L) medium for mRNA analysis. 
Aft er 24 h, cells of the two SILAC plates were scraped off , combined and spun down (10 min, 
600 x g, 4°C) for protein analysis. The corresponding plates were harvested for total RNA 
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isolati on (32 h ti me point). Reproducibility was checked by performing two independent miR-1 
transfecti on experiments on diff erent days. Both samples were processed and analyzed by 
mass spectrometry (each on 15 slices measured in triplicates). 2,287 proteins were identi fi ed 
and quanti fi able according to the applied quanti fi cati on criteria aft er removal of 5% outliers 
(Grubb´s test).
Synthetic miRNAsII.8.1.  
Syntheti c miRNAs mimicing mature endogenous miRNAs were obtained from Dharmacon as 
annealed, 2’-deprotected and desalted duplexes. miR-1 was exactly designed as described in 
the study of LIM et al. 2005, that is carrying one mismatch in the duplex to facilitate acti vati on 
of the sense strand (LIM et al., 2005; KHVOROVA et al., 2003).
RNA duplexes were synthesized as follows (sense 5’-3’ / anti sense 3’-5’): 
miR-1: UGGAAUGUAAAGAAGUAUGUAA / AUAACUUACAUUUCUUCAUACA
miR-16: UAGCAGCACGUAAAUAUUGGCG / AUAUCGUCGUGCAUUUAUAACC
miR-30a: UGUAAACAUCCUCGACUGGAAG / CGACAUUUGUAGGAGCUGACCU
miR-155: UUAAUGCUAAUCGUGAUAGGGGU / ACAAUUACGAUUAGCACUAUCCC
let-7b: UGAGGUAGUAGGUUGUGUGGUU / CCACUCCAUCAUCCAACACACC
LII.8.2.  ocked nucleic acids (LNAs)
LNAs (locked nucleic acids) (WAHLESTEDT et al., 2000; STENVANG & KAUPPINEN, 2008) purchased 
from BioTez were designed to bind endogenous mature miRNAs with perfect complementarity. 
The following LNAs (5’-3’) were used in this study:
LNA-anti -let-7b: AACCACACAACCTACTACCTCA
LNA-anti -miR-21: TCAACATCAGTCTGATAAGCTA (used as control for LNA-anti -let-7b luciferase 
experiment)
Analysis of transfection efficiencyII.9. 
The BLOCK-iT fl uorescent oligo (Invitrogen) is a fl uorescein-labeled, non-targeted dsRNA 
oligomer allowing for visual monitoring of transfecti on effi  ciency. Cells were transfected with 
BLOCK-iT fl uorescent oligos as described for miRNAs/LNAs. 8 h post transfecti on cells were 
washed with 1x PBS (Gibco) and fi xed with 4% paraformaldehyde (PFA) in PBS. Transfecti on 
effi  ciency was assessed by comparing the amount of transfected, fl uorescing cells with non-
transfected cells using epifl uorescence microscopy (Leica DM-R).
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Mapping of protein and mRNA IDs and identifi cation of se-II.10. 
quence motifs correlated with changes in protein production
Microarray data analysis as described below was conducted by Zhou Fang, bioinformati cian 
in the group of Nikolaus Rajewsky at the Berlin Insti tute for Medical Systems Biology (BIMSB, 
Robert-Rössle Str. 10, D-13125 Berlin, Germany):
MappingII.10.1.  
Protein identi fi ers were fi rst mapped to NCBI Entrez Gene gene numbers by the IPI cross-
reference fi le (version 3.37) from EBI database (htt p://www.ebi.ac.uk). The gene2refseq fi le 
(downloaded on 28th of Sep, 2007) from the NCBI database (ft p://ft p.ncbi.nlm.nih.gov) was 
used to map NCBI Entrez Gene gene numbers to Refseq identi fi ers. For each protein group, 
the fi rst protein identi fi er in a group was assigned to corresponding Refseq identi fi ers. If the 
fi rst protein did not have any corresponding Refseq identi fi ers the mapping was done for the 
second protein in the protein group. 
Identification of correlated sequence motifs II.10.2.  
Human 3’ UTR, 5’ UTR and CDS sequences based on human reference sequence (NCBI Build 
36.1) were extracted from UCSC Genome Browser (htt p://genome.ucsc.edu). In order to assign 
characteristi cs (number of seeds) to unique protein identi fi ers, the maximum number of seeds 
from all transcript identi fi ers mapped to the protein was used. Then, a linear regression model 
was employed to identi fy signifi cant moti fs in mRNA 3’ UTRs, 5´UTRs and coding sequences 
which correlated best with the global changes in protein synthesis (BUSSEMAKER et al., 2001; 
SOOD et al., 2006).
Generation of luciferase reporter constructsII.11. 
If not stated otherwise, standard methods were used for agarose gel electrophoresis, isolati on 
of plasmids by alkaline lysis, polymerase chain reacti on (PCR), DNA digesti on by restricti on 
enzymes and ethanol/isopropanol precipitati on. The equipment used is up to latest laboratory 
standard.
For pSILAC validati on, luciferase reporters carrying 3’ UTRs of genes found to be down-regulated 
by pSILAC upon microRNA over-expression were constructed. The 3’ UTRs were PCR-amplifi ed 
from HeLa cDNA (purchased from BioCat, Catalog No.: C1255811) and cloned into XhoI (NEB) 
and NotI (NEB) sites immediately downstream of the stop codon in the pRL-TK CXCR4 4x vector 
(a kind gift  of Phil Sharp) coding for Rr-luc. The arti fi cial CXCR4 4x target site has been removed 
by digesti on beforehand. All constructs were checked by sequencing.
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3’ UTRs of the following genes were selected for cloningII.11.1.  
c-Met (NM_000245), RDH10 (NM_172037), CAP1 (NM_006367), TAGLN2 (NM_003564), 
ADPGK (NM_031284), MTX1 (NM_002455), SLC25A1 (NM_005984), ATP6V0A1 (NM_005177)
Primers (5’-3’)II.11.2.  
All synthesized primers (BioTez) contain fl anking restricti on sites (5’-3’ FW primer = XhoI site; 
5’-3’ RW primer = NotI site) for site-directed inserti on of the PCR product into the target 
vector. 
Table II.2: Primers for generation of reporter constructs
Gene Accession ID Sequence 5´->3´
CMET NM_000245_FW CGGCTCGAGTGCTAGTACTATGTCAAAGCAA
CMET NM_000245_RV ATAGTTTAGCGGCCGCTGCATGATTTATCAGAACAACT
RDH10 NM_172037_FW CGGCTCGAGGAATCTTTTTGTATGGAATATT
RDH10 NM_172037_RV ATAGTTTAGCGGCCGCCAGTCATTTATAAAACTCCCCA
TAGLN2 NM_003564_FW CGGCTCGAGTCCCACCCCAGGCCTTGCCC
TAGLN2 NM_003564_RV ATAGTTTAGCGGCCGCCAAAAATGACAAATTCTTTA
MTX1 NM_002455_FW CGGCTCGAGTTTGTCCTCACGCTCCCAAG
MTX1 NM_002455_RV ATAGTTTAGCGGCCGCCAGTGTGAGTGGCTTTATTC
SLC25A1 NM_005984_FW GCTCTAGAGCCTAGAGAGGCCGCAAGGG
SLC25A1 NM_005984_RV ATAGTTTAGCGGCCGCGCAACAGGATCCGGTTTATT
CAP1 NM_006367_FW CGGCTCGAGGCGAAGTGCCACTGGGTTCT
CAP1 NM_006367_RV ATAGTTTAGCGGCCGCCAAGTTTGGTATTAACTTTA
ADPGK NM_031284_FW CGGCTCGAGGAAGATTCTTAGGGGTAATT
ADPGK NM_031284_RV ATAGTTTAGCGGCCGCCCTGAAATGTAAATTGTTTT
ATP6V0A1 NM_005177_FW CGGCTCGAGGTCCCTGTGAGGGCCGTGTG
ATP6V0A1 NM_005177_RV ATAGTTTAGCGGCCGCCCGGGGAAGTCAAACATACT
Polymerase chain reaction (PCR)II.11.3.  
Standard polymerase chain reacti on was used to amplify 3´UTR cDNA fragments for cloning. 
PCR reacti on master mix was assembled on ice (50 ng Template; 50 pmol forward primer; 
50 pmol reverse primer; 5 μl 10x Taq-buff er (NEB); 1 μl dNTP Mix 10 mM; 2.5 U Taq DNA 
polymerase (NEB); ad. 50 μl ddH2O). PCR was performed using a Gene Amp 2400 cycler (Perkin-
Elmer) according to the following program: fi rst denaturati on 2 min 94°C, followed by 35 cycles 
of 30 s denaturati on at 94°C, 60 s of annealing at 55°C, 50 s of elongati on at 72°C and a fi nal 
polymerizati on step of 7 min at 72°C. 
Agarose gel electrophoresisII.11.4.  
For the preparati ve analysis of DNA fragments obtained by PCR or excision of specifi c DNA 
fragments aft er restricti on reacti ons, gel electrophoresis was performed. Separati on is achieved 
as DNA fragments migrate according to their size diff erently along an electrical fi eld in the 
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agarose gel. Separati on and detecti on of DNA fragments in the gel was performed with 0.4-
1.2 % [w/v] of agarose in 0.5x TBE buff er supplemented with 1 μg/mL ethidiumbromide and 
applying 80-140 V for the aspired ti me. Prior to loading the samples on the gel, probes were 
mixed with DNA loading buff er. Visualizati on of DNA was achieved using a Gene Genius device 
(Syngene) thereby detecti ng the fl uorescence of the DNA-intercalati ng dye ethidiumbromide. 
To identi fy size of nucleic acids, standard markers (DNA ladder 1kb or 50 bp; Fermentas) 
were used. DNA fragments of interest were eluted from agarose gels using the QIAquick gel 
extracti on kit (Qiagen) according to manufacturer’s instructi ons.
Enzymatic DNA digestion II.11.5.  
In order to open or cut out DNA fragments from the plasmid pRL-TK CXCR4 4x and also to 
prepare PCR products for ligati on reacti ons the restricti on enzymes XhoI and NotI (all from 
NEB) were used. DNA was purifi ed before digesti on using a PCR purifi cati on kit (Qiagen). 
Enzymes were diluted in appropriate restricti on buff ers and digesti on was allowed to proceed 
at 37°C for 2 h. Reacti on products were purifi ed again by gel electrophoresis.
Ligation of DNA fragmentsII.11.6.  
Ligati ons of DNA fragments with the target vector were carried out by employing the Rapid 
DNA Ligati on Kit (Roche). For each mixture, 10 μL of pre-aliquoted ligati on buff er containing 
ATP was used. A molecular fragment:plasmid rati o of 3:1 was employed and the ligati on 
reacti on was incubated for 15-30 min at RT, transferred on ice and then purifi ed using the PCR 
purifi cati on kit (Qiagen).
Preparation of plasmid DNAII.11.7.  
For isolati on of plasmid DNA from bacteria a mini or midi prep kit from Qiagen was used according 
to the manufacturer’s instructi ons. The DNA concentrati on was measured spectrometrically 
using a Nanodrop ND-1000 device (Peqlab).
DNA SequencingII.11.8.  
DNA sequencing was performed on-campus by Invitek DNA sequencing service (Berlin-Buch).
Co-transfection of synthetic miRNAs and 3’ UTR reporter II.12. 
constructs
HeLa cells were co-transfected with syntheti c miRNAs and diff erent 3’ UTR luciferase reporter 
constructs using Lipofectamine 2000 (Invitrogen) following the manufacturer’s instructi ons 
(Lipofectamine™ 2000 siRNA - plasmid co-transfecti on protocol). The day before transfecti on, 
cells were seeded in 24-well plates in light (L) SILAC medium (1x 105 cells/well). The following 
day the 80-90% confl uent cells were transfected with 180 ng of the respecti ve reporter 
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plasmid and 20 ng pGL3 control plasmid (Promega). Syntheti c miRNAs were co-transfected 
at a fi nal concentrati on of 100 nM. DNA, RNA and Lipofectamine 2000 were diluted in serum-
free DMEM upfront. All transfecti ons were performed in triplicates. Control transfecti ons were 
performed with miR-155 as a control since this miRNA did not signifi cantly aff ect synthesis of 
the tested proteins (data not shown). On the next day the medium was changed and cells were 
harvested 48 h post transfecti on in 100 μl 1x Passive Lysis Buff er (Promega) according to the 
manufacturer’s instructi ons. Cell lysates were cleared by centrifugati on in a microcentrifuge 
for 5 min at 16,000x g, 4°C.
Dual-Luciferase AssayII.13. 
Dual-Luciferase Assays (Promega) were performed 48 h post transfecti on following the 
manufacturer’s protocol and detected with a MicroLumat Plus LB 96V luminometer (Berthold 
Technologies). Each cell lysate was measured three ti mes (three technical replicates) in a 96-
well plate (Nunc). Renilla luciferase acti vity of the pRL-TK reporter constructs was normalized 
to the acti vity of the fi refl y luciferase of the pGL3 control plasmid (Promega) which served as 
internal transfecti on control. Errors bars were calculated as follows: First, relati ve errors of 
the three biological replicates of the respecti ve reporter and its corresponding control were 
computed. Second, the relati ve error of the reporter and the control were added up according 
to the law of error propagati on. The resulti ng relati ve error was used to calculate absolute errors 
of the normalized expression values. To esti mate the pSILAC error we calculated the standard 
deviati on of all protein quanti fi cati on for two biological replicates of the miR-1 transfecti on 
experiment aft er 5% outlier removal (Grubb´s test). Error bars are shown as +/- two standard 
deviati ons.
Immunoblotting (Western blotting)II.14. 
Validation of putative miRNA targetsII.14.1.  
In order to validate selected miRNA targets identi fi ed by the pulsed SILAC approach, HeLa 
cells were transfected with either one of the syntheti c miRNAs or the LNA targeti ng let-7b as 
described above. 32 h post transfecti on cells were harvested. For microRNA target validati on, 
primary anti bodies against CEBPβ (sc-150), Kras (sc-30), Annexin2 (sc-48397), Tropomyosin 
(sc-28543), Twinfi lin-1 (sc-51241), FGF-2 (sc-74412), Integrin α2 (sc-53353), α-Adducin (sc-
25731), EGFR (sc-03), PICALM (sc-6433), SNX6 (sc-50373), IMP-1( sc-21026) and cMet (sc-161) 
were purchased from Santa Cruz Biotechnologies or Sigma-Aldrich (β-Acti n, A5441). 
Validation of protein half-livesII.14.2.  
For protein half-lives validati on, cellular protein degradati on was monitored aft er blockage of de 
novo protein synthesis via cycloheximide treatment. Primary anti bodies against CEBPβ (sc-150), 
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JNK (sc-7345), Hells (sc-46665), JunB (sc-46) were purchased from Santa Cruz Biotechnologies 
or Cell Signaling (GSK3β, 9315) or Sigma-Aldrich (β-Acti n, A5441) or BD Biosciences (556470, 
CCND1).
Detection of proteinsII.14.3.  
Harvested cells were lysed in appropriate amounts of RIPA buff er for 20 min on ice. The lysates 
were cleared by centrifugati on for 10 min (14,000 rpm at 4°C) and transferred to fresh tubes. 
SDS-PAGE was performed with whole-cell lysates using NuPAGE Novex 4 to 12% gradient 
gels (Invitrogen) under reducing conditi ons according to the manufacturer’s instructi ons. 
Gels were blott ed onto PVDF (Perkin-Elmer) membranes either using the iBlot dry blotti  ng 
system (Invitrogen) according to the manufacturer’s instructi ons or the XCell II Blot Module 
(Invitrogen). In the latt er case, 1 mA of current per cm2 of membrane for 2 h was applied and 
the membrane was acti vated prior to use with 100% methanol and washed once in transfer 
buff er. Unspecifi c binding sites were blocked with 5% dry milk powder in 1x T-BST at RT for 30 
min followed by washing three ti mes for 10 min with 1x T-BST. In order to visualize specifi c 
protein bands, the membrane was incubated with the respecti ve primary anti body at a 1:1,000 
diluti on in blocking soluti on at 4°C overnight with shaking. Blots were washed 3x in T-BST and 
incubated either with an anti -mouse, an anti -rabbit or an anti -goat secondary anti body (all 
from Amersham) conjugated to horseradish peroxidase diluted 1:3,000 in T-BST for 1 h at RT. 
Aft er three more washing steps in TBST for 10 min each the signal of the bound secondary 
anti bodies were detected by applying Western Blot Chemiluminescence Reagent Plus for ECL 
immunostaining (PerkinElmer) to the membrane followed by expositi on to X-ray fi lms (GE 
Healthcare). For sequenti al detecti on of diff erent proteins on the same membrane, the PVDF 
membrane was stripped in stripping buff er (50 °C, 20 min), washed once with isopropanol and 
thoroughly with disti lled H2O. Subsequently, the membrane was blocked again and treated as 
described above.
Microarray data analysisII.15. 
Microarray data analysis as described below was conducted by Zhou Fang, bioinformati cian 
in the group of Nikolaus Rajewsky at the Berlin Insti tute for Medical Systems Biology (BIMSB, 
Robert-Rössle Str. 10, D-13125 Berlin, Germany):
The output of microarrays was normalized by the standard rma() functi on from the 
Bioconductor R-library (www.bioconductor.org). To annotate Aff ymetrix probe sets to Refseq 
identi fi ers, the current NetAff x Annotati on fi le was downloaded from the Aff ymetrix website 
(htt p://www.aff ymetrix.com). For the transcript (RefSeq) with multi ple probes, the average 
logarithm expression values for all corresponding probes were taken. Fold-changes were 
defi ned as diff erences between the intensiti es of misexpressions and controls (log2 rati os). 
The MOCK-transfected control corresponding to the same miRNA transfecti on experiment was 
used where applicable (three control samples for miR-1 and two samples for miR-30a). For the 
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other miRNA transfecti on experiments the median of three controls or two controls taken at 
the 8 h and 32 h ti me point were used, respecti vely.
RNA isolationII.16. 
Total RNA was extracted using Trizol Reagent (Invitrogen) following the manufacturer’s 
instructi ons. Cells were washed once with 1x D-PBS (Gibco) and cells were harvested by 
trypsinizati on. Alternati vely, the culture fl ask/dish was put on ice, cells were scraped off  using 
a cell scraper and resuspended in ice-cold D-PBS. Cells were pelleted by centrifugati on for 
5 min at 300x g, 4°C with a Heraeus Multi fuge 3 S (Heraeus). The supernatant was carefully 
removed and the cells were lysed by adding 1 ml Trizol Reagent. To ensure homogenizati on, 
the cell lysate was passed 8-10 ti mes through a 20G needle. Aft er adding 200 ul of chloroform 
(Invitrogen), the mixture was transferred to a Phase-Lock-Gel tube (5Prime), vigorously mixed 
and centrifuged at full speed (20,000 g) for 5 min at 4°C. The upper, RNA containing aqueous 
phase was removed and transferred to a fresh, RNase-free tube (Ambion). To precipitate 
RNA, 1/10 reacti on volume of 5 M NaCl and an equal volume of 2-propanol were added and 
incubated for 10 min at RT. Precipitated RNA was collected through centrifugati on at full speed 
(20,000 g) for 30 min at 4°C. The pellet was washed with an equal volume of 75% ethanol and 
precipitated again at 20,000g for 20 min. RNA pellets were resuspended in 20 μl RNase-free 
sterile water and RNA quanti ty was assessed spectrophotometrically using the NanoDrop ND-
1000 UV-VIS Spectrophotometer (Thermo Fisher). 
Double pulse-labeling of NIH3T3 cells with heavy amino II.17. 
acids and 4-thiouridine
Aft er growing NIH3T3 cells to 60-70 % confl uency in light (L) SILAC medium, the fi broblasts 
were thoroughly washed three ti mes with pre-warmed PBS and transferred to heavy (H) 
SILAC medium. Only SILAC medium of cells designated for RNA isolati on was additi onally 
supplemented with 4-thiouridine (4sU) to a fi nal concentrati on of 400 μM. Pulse-labeling of 
proteins was performed for 1.5, 4.5 and 13.5 h, while labeling of newly transcribed RNA was 
conducted for 2 h. At the indicated ti me points, cells were scraped off , spun down (10 min, 600 
g, 4 °C) and used either for protein or RNA isolati on. 
Preparation of newly-synthesized and pre-existing RNAII.18. 
Apart from minor changes, all steps described in the following were essenti ally performed as 
described previously (DOELKEN et al., 2008):
Biotinylation and purification of 4sU-labeled RNA II.18.1.  
Bioti nylati on of 4sU-labeled RNA was performed using EZ-Link Bioti n-HPDP (Pierce) dissolved 
in dimethylformamide (DMF) at a concentrati on of 1 mg/mL and stored at 4°C. Bioti nylati on 
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was carried out in RNase-free water (Invitrogen)) with 10 mM Tris-HCl (pH 7.4), 1 mM EDTA 
and 1 mg/ml Bioti n-HPDP (Perbio) at a fi nal RNA concentrati on of 1 μg/μl RNA for 3 h in the 
dark at RT. In general 500 μg total RNA were used for the bioti nylati on reacti on. 
To purify bioti nalyted RNA from excess of Bioti n-HPDP, a Phenol:Chloroform:Isoamylalkohol 
(v/v = 25:24:1, Invitrogen) extracti on was performed. Phenol:Chloroform:Isoamylalkohol was 
added to the reacti on mixture in a 1:1 rati o, transferred to a Phase-Lock-Gel tube (5Prime), 
vigorously mixed and centrifuged at full speed (20,000 g) for 5 min at 4°C. The upper, RNA 
containing aqueous phase was removed and transferred to a fresh, RNase-free tube (Ambion). 
To precipitate RNA, 1/10 reacti on volume of 5 M NaCl and an equal volume of 2-propanol were 
added and incubated for 10 min at RT. Precipitated RNA was collected through centrifugati on 
at full speed (20,000x g) for 30 min at 4°C. The pellet was washed with an equal volume of 75% 
ethanol and precipitated again at 20,000x g for 20 min. Finally, RNA was reconsti tuted in 25-50 
ul of RNase-free water.
Separation of biotinylated 4sU-RNA from unlabeled RNAII.18.2.  
For specifi c isolati on of bioti nylated 4sU-RNA streptavidin coated magneti c beads (μMACS, 
Miltenyi) were used. To avoid unfavorable secondary RNA structures which potenti ally impair 
the binding to the beads, the RNA was fi rst denatured at 65°C for 10 min followed by rapid 
cooling on ice for 5 min. 4sU-bioti nylated RNA was incubated with μMACS streptavidin beads 
(usually 20 μg labeled RNA with 200 μl beads) for 15 min at RT with rotati on. Actual separati on 
of 4sU-RNA from unlabeled RNA was achieved by applying the mixture onto an μColumn 
(Miltenyi) in the magneti c fi eld of the μMACS separator (Miltenyi). Before, μColumns were 
equilibrated with 100 μl equilibrati on buff er that is part of the Miltenyi μBeads Kit. To recover 
unlabeled, pre-existi ng RNA the column fl ow-through (FT) has been collected. Then, μColumns 
were washed three ti mes with 0.5 mL 55°C washing buff er (100 mM Tris-HCl, pH 7.4, 10 mM 
EDTA, 1 M NaCl, 0.1% Tween20). All washing fracti ons were discarded. Eluti on of labeled RNA 
from the beads was achieved by adding 100 μl of freshly prepared 100 mM dithiothreitol 
(DTT) onto the column followed by a second eluti on round 3 min later with the columns being 
retained in the magneti c fi eld. Lastly, RNA from the FT and eluti on step was recovered using 
the RNeasy MinElute kit and reconsti tuted in 25-50 μl of RNase-free water.
Determination of separation efficiency of 4sU-labeled RNAII.18.3.  
For combined 4sU and radioacti ve RNA labeling the medium was supplemented with 125 nM 
5-3-H-cyti dine (25 Ci/mmol, Sigma) and 400 μM 4sU. In order to remove unincorporated 
5-3-Cyti dine, RNA was extracted using the RNeasy kit (Qiagen). Column-based separati on 
was performed as described above. Radioacti vity of the column fl ow-through, the washing 
fracti ons (all three washing fracti ons were pooled), the eluti on fracti ons (the two eluti on 
fracti ons were pooled) and of the beads was determined with a Tri-Carb Liquid Scinti llati on 
Counter (PerkinElmer). Radioacti vity measured for the diff erent fracti ons was summed up and 
set to 100% (input).
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Estimation of the doubling time of NIH3T3 cellsII.18.4.  
To esti mate the cell cycle ti me of NIH3T3 cells during the double pulse-labeling of RNAs and 
proteins, two 15 cm culture dishes with cells transferred to “heavy” SILAC medium were 
pooled and counted (n = 6) with haemocytometers (C-Chips™) at 0.75 h, 5 h, 9 h, 13.25 h aft er 
the onset of the experiment. The doubling ti me was esti mated assuming exponenti al growth 
given by the following equati on:
N(t) = N02
t/tcc
N(t) is the number of fi broblasts at ti me t, N0 the number of cells at the onset of the experiment 
and tcc denotes the doubling ti me. Final cell cycle durati on was calculated by applying linear 
regression to individual cell cycle ti mes obtained at the respecti ve ti me points.
mRNA sample preparation and sequencingII.19. 
mRNA sample preparati on for sequencing was performed by Na Li, PhD student in the group 
of Wei Chen at the Berlin Insti tute for Medical Systems Biology (BIMSB, Robert-Rössle Str. 10, 
D-13125 Berlin, Germany):
Total RNA from bulk RNA, pre-existi ng RNA and newly-synthesized RNA were subjected to Solexa 
deep-sequencing, following the mRNA sequencing protocol provided by Solexa. Briefl y, poly(A) 
RNA was purifi ed from 10 μg of total RNA with two rounds of hybridizati on to Dynal oligo(dT) 
beads (Invitrogen). The poly(A) RNA was fi rst fragmented by using 5x fragmentati on buff er 
(200mM Tris acetate, pH 8.2, 500 mM potassium acetate and 150 mM magnesium acetate) 
and heati ng at 94 °C for 3.5 min in a thermocycler. The fragmented RNA was precipitated and 
used for fi rst- and second- strand cDNA synthesis with random hexamer primers. Both ends 
of the cDNA fragments were then repaired by T4 polymerase and Klenow DNA polymerase, 
and T4 polynucleoti de kinase. Using Klenow exo (3´ to 5´ exo minus), a protruding “A” base 
was added to the 3´ end of the DNA fragments for ligati on with Solexa adaptors (with a “T” 
overhang). Aft er ligati on, the cDNA with size of 200 +/- 25 bp was selected and followed by 15 
cycles of PCR amplifi cati on. Finally the adapter-ligated DNA was sequenced for 36 cycles on 
the Solexa/GAIIX, according to the manufacturer’s instructi ons.
Calculation of mRNA half-livesII.20. 
Analysis of sequencing results and calculati on of mRNA half-lives were performed by Wei Chen, 
head of the scienti fi c genomics platf orm at the Berlin Insti tute for Medical Systems Biology 
(BIMSB, Robert-Rössle Str. 10, D-13125 Berlin, Germany):
The Solexa sequencing reads were mapped to mouse genome reference sequence (NCBI Build 
37/mm9, July 2007) by using SOAP2 with a maximum of 2 mismatches allowed. Only uniquely 
mapped reads were retained. The mRNA abundance was esti mated as the number of reads 
mapped within the exonic regions divided by the total number of reads uniquely mapped on 
the genome (in Million) and the cumulated exon length (in Kb) (RPKM). Only the transcripts 
- 44 -
II MATERIAL & METHODS
with RPKM values > 1 in all three samples were retained for further analysis. Newly synthesized 
transcripts containing more 4sU molecules are more prone to be pulled down and thus to be 
subsequently sequenced. To correct for such a bias in pulldown effi  ciency of mRNAs containing 
diff erent numbers of uridines, local regression with the LOWESS method was applied (cf. Fig. 
II.1): 
Aft erwards, the normalizati on of the measurement in the three samples (newly transcribed, 
pre-existi ng and total RNA) was performed by linear regression analysis exactly as described 
before (DOELKEN et al., 2008). The mRNA half-lives were then calculated based on the 
normalized rati os given by newly transcribed RNA/total RNA and preexisti ng RNA/total RNA, 
according to the formula:
T(1/2)=-t*ln(2)/ln(1-1/(1+Rati o(existi ng/total)/Rati o(new/total)))  
Calculation of absolute mRNA copy numbersII.21. 
Absolute cellular mRNA copy numbers were determined based on the measured cellular 
amount of poly-adenylated mRNA and the number of sequencing reads obtained for the 
unfracti onated mRNA sample (i.e. newly synthesized and preexisti ng mRNA) similar to the 
method described previously (MORTAZAVI et al., 2008). First, the yield of total RNA extracted 
per 3T3 cell was measured to as 25.5 pg using a NanoDrop ND-1000 UV-VIS spectrophotometer 
(Thermo Fisher). In three independent experiments obtained 331.92, 304.56 and 360 ng of 
polyadenylated mRNA from 10 μg total RNA. Therefore, the fracti on of mRNA in the cellular 
RNA pool is 3.3 %, corresponding to 8.5 x 10-18 g mRNA per cell. The base compositi on of the 
3T3 mRNAs transcriptome was 0.4 : 0.2 : 0.2 : 0.2 (A:C:G:U) according to the obtained reads. 
Consequently, the average molecular weight per nucleoti de is 323 g/mole. This allows for 
calculati on of the total amount of mRNA nucleoti des per cell (T, 2.6x10-15 mole/cell). The cellular 
copy numbers of individual mRNAs (x) can be calculated from the number of sequencing reads 
mapping uniquely to the transcript (reads_transcript), the total number of reads (reads_total) 
and the transcript length (L) according to the equati on
Fig. II.1 | Correcti on of 4sU bias by LOWESS 
regression. Plotti  ng the number of uridines 
per transcript against newly-synthesized/
total RNA rati os obtained by RNA-Seq reveals 
the bias in pulldown effi  ciency (left  plot). 
Correcti on was done by applying localized 
regression by locally weighted scatt erplot 
smoothing (LOWESS) (right plot). Note the 
diff erently scaled y-axis between the plots.
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For example, the popular “housekeeping” mRNA of GAPDH was identi fi ed with 19,392 reads 
out of 10,854,285 total reads. With a transcript length of 1,232 nucleoti des one arrives at 2,270 
copies, respecti vely. A previous study carefully determined GAPDH copy number in NIH3T3 
cells by single-cell quanti tati ve real-ti me PCR or bulk measurements (MARCUS et al., 2006).
The calculated value falls almost exactly between the previously two published values for bulk 
and single cell data (1,840 and 2,940, respecti vely). Note that due to the presence of many 
GAPDH pseudogenes in the mouse genome all reads mapping to a single GAPDH transcript 
were counted rather than the corrected uniquely mappable fracti on (see below).
Correction for different transcript mappabilitiesII.21.1.  
Correcti on of diff erent transcript mappabiliti es was performed by Wei Chen, head of the 
scienti fi c genomics platf orm at the Berlin Insti tute for Medical Systems Biology (BIMSB, Robert-
Rössle Str. 10, D-13125 Berlin, Germany):
Absolute mRNA quanti fi cati on is complicated by the fact that some mRNAs have a high degree 
of sequence identi ty to other mRNAs or pseudogenes which results in a smaller percentage of 
uniquely mappable reads. To correct for this eff ect the fracti on f of all the exonic positi ons on 
which 36nt sequencing reads that can be uniquely mapped for all mRNAs was determined by in 
silico simulati on. Briefl y, 36nt Solexa sequencing reads were fi rst simulated from every Refseq 
transcripts with each positi on along the transcript (except the last 35 nt) as the fi rst base of 
one sequencing read. Simulated reads were then mapped to the mouse genome reference 
sequence and used to esti mate transcript abundance using the same procedure as for the 
real data. The average value of f was 72%. mRNAs with f < 10% were excluded from further 
analysis. For all other genes, the raw mRNA copy numbers were multi plied by 72 / f to correct 
for diff erent mappability.
Quantitative real-time (qRT) PCRII.22. 
To validate RNA-sequencing results used for mRNA half-life calculati ons, the abundance of 
19 randomly selected genes was analyzed via quanti tati ve reverse-transcripti on polymerase 
chain reacti on. Using the exact same eluate (E) and fl ow-through (Ft) samples for qRT-PCR as 
used for RNA-Seq allowed the direct comparison of the obtained E/Ft abundance rati os.
Single-stranded cDNA was generated by reverse transcripti on of total RNA in a 20 μl reacti on 
volume using SuperScript III Reverse Transcriptase (Invitrogen) according to the manufacturer’s 
instructi ons. Each 20 μl reacti on contained 1.5 μg of total RNA, 250 ng of random hexamer 
primers (Invitrogen), 1 μl of 10 mM dNTP Mix (10 mM each dATP, dGTP, dCTP and dTTP), 4 μl 
5x First Strand Buff er, 2 μl 0.1 M DTT, 1 μl RNasin (Promega), 1 μl of SuperScript III Reverse 
Transcriptase and RNase-free water. Each gene was run in technical triplicates employing 
primer pairs targeti ng mRNAs (cf. Table II.3). Primer pairs were designed using the Primer3 
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(htt p://frodo.wi.mit.edu/primer3/) and purchased from BioTez. To eliminate the possibility of 
genomic DNA amplifi cati on all primers were spanning exon-exon boundaries.
qPCR reacti on master mix was assembled on ice (25-50 ng cDNA template per reacti on; 1 μl of 
10 μM forward and reverse primer mix; 2.5 μl 10 x Taq-buff er (Roboklon); 1 μl of 10 mM dNTP 
Mix; 1.25 μl 50x BSA (NEB), 2.5 μl of 2.5 mM MgCl2 (Roboklon), 1 μl 20x SYBR green (Applied 
Biosystems), 0.4 μl Perpetual Taq DNA polymerase (2.5 U) (Roboklon); ad. 25 μl ddH2O). 
Changes in reporter signal (SYBR green) was recorded in real ti me with an iQ5 cycler (Bio-Rad). 
The program was as follows: initi al denaturati on for 2 min 94°C, followed by 40 cycles of 20 
sec at 94°C, 30 sec at 58°C and 40 sec at 72°C. Relati ve changes in mRNA levels of target genes 
were computed by normalizing the amount of transcripts to the levels of Ccnd1 (NM_007631) 
mRNA as an internal control and according the 2-ΔΔCt method (LIVAK & SCHMITTGEN, 2001).
Table II.3: Primers for qRT-PCR
Gene Accession ID Sequence 5´->3´
Bax NM_007527_FW ATGCGTCCACCAAGAAGCTGA
Bax NM_007527_RW AGCAATCATCCTCTGCAGCTCC
Cav1 NM_007616_FW ACGTAGACTCCGAGGGACAT
Cav1 NM_007616_RW CGCGTCATACACTTGCTTCT
Ccnd1 NM_007631_FW CTGGATGCTGGAGGTCTGT
Ccnd1 NM_007631_RW AAGCGGTCCAGGTAGTTCAT
Hars NM_008214_FW ATCAAGGCTGAGCTGCTGTA
Hars NM_008214_RW CTTGAGTTCCTGCTCACCAA
Hsp90ab1 NM_008302_FW TTTGGTGTCGGATTCTACTCG
Hsp90ab1 NM_008302_RW CAGACGACTCCCAGGCATAC
Rac1 NM_009007_FW GAAAGAGATCGGTGCTGTCAA
Rac1 NM_009007_RW CAACAGCAGGCATTTTCTCTT
Rpl13a NM_009438_FW AGCGCCTCAAGGTGTTGGA
Rpl13a NM_009438_RW GAGTGGCTGTCACTGCCTGGTA
Fth1 NM_010239_FW CCTGCAGGATATAAAGAAACCA
Fth1 NM_010239_RW TAGCCAGTTTGTGCAGTTCC
Elavl1 NM_010485_FW ACCTCCCTCAGAACATGACC
Elavl1 NM_010485_RW CCAAGCTGTGTCCTGCTACT
Igf1r NM_010513_FW GACTCGGATGGCTTCGTTAT
Igf1r NM_010513_RW AGTACATGCTCTGGGTGCTG
Ntan1 NM_010946_FW TCCAATCATTTATGGCATCG
Ntan1 NM_010946_RW GCTAATCATTGGGCCTCCT
Tuba1a NM_011653_FW AAGGAGGATGCTGCCAATAA
Tuba1a NM_011653_RW GCTGTGGAAAACCAAGAAGC
Vim NM_011701_FW CAGAGAGAGGAAGCCGAAAG
Vim NM_011701_RW GTGCCAGAGAAGCATTGTCA
Ccl5 NM_013653_FW ATATGGCTCGGACACCACTC
Ccl5 NM_013653_RW GTGACAAACACGACTGCAAGA
Xpo4 NM_020506_FW CTGAGCACTGAGGTTCTCCC
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Xpo4 NM_020506_RW ATTCCACGGTAACTGCAAGC
Tbl1x NM_020601_FW TTGTGCCTGGAATCCTGTTA
Tbl1x NM_020601_RW TAAGGTTCCATATCCTCGCA
Cox6c NM_053071_FW GGGAAGGACGTTGGTGTAGA
Cox6c NM_053071_RW CTTATAGGCAGCGGCAACTC
Vps4a NM_126165_FW CGCCATCAAATATGAAGCAC
Vps4a NM_126165_RW GGTACTGCATGCACTTTGCT
Acaca NM_133360_FW GAAGTCAGAGCCACGGCACA
Acaca NM_133360_RW GGCAATCTCAGTTCAAGCCAGTC
Lmnb1 NM_010721_FW GGCGGCACTAAACTCTAAGG
Lmnb1 NM_010721_RV ATGCTTCTAGCTGGGCAATC
Ipo9 NM_153774_FW GTGGATTCGGATGGAGAAGT
Ipo9 NM_153774_RV TAGGGCATGGACAAACTCAA
Cycloheximide-chase analysisII.23. 
To validate protein stability determined by pulsed SILAC, classic cycloheximide-chase analysis 
was performed with proteins spanning a reasonable range of protein half-lives (1 - 60 h). 
For this purpose, protein synthesis of NIH3T3 cells was blocked by adding cycloheximide 
directly to the culture medium at a fi nal concentrati on of 50 μg/ml. Cells were harvested aft er 
cycloheximide treatment at indicated ti me points followed by protein extracti on, SDS-PAGE 
and immunoblotti  ng to visualize protein degradati on of respecti ve proteins.
 Liquid-chromatography mass spectrometry (LC-MS)II.24. 
In-gel digestionII.24.1.  
To decrease sample complexity, proteins were separated based on their molecular weight by 
1-D disconti nuous SDS-PAGE prior to digesti on (SHEVCHENKO et al., 2006). Cell pellets were 
lysed in appropriate amounts of RIPA buff er for 20 min on ice. The lysates were cleared by 
centrifugati on for 10 min (14,000 rpm at 4°C) and transferred to fresh tubes. SDS-PAGE was 
performed with whole-cell lysates using NuPAGE Novex 4 to 12% gradient gels (Invitrogen) 
under reducing conditi ons according to the manufacturer’s instructi ons. Proteins were fi xed in 
fi xati ve soluti on and stained aft erwards with the Colloidal Blue staining Kit (Invitrogen). Whole 
gel lanes were cut into several gel slices (up to 20 slices) and washed three ti mes with ABC 
buff er to remove Coomassie staining and detergents (SDS). Aft erwards, reducti on buff er was 
applied to each slice for 30 min at 56°C for reducti on of disulfi de bonds followed by alkylati on 
with iodoacetamide (IAA) for 30 min at 37°C in the dark. Aft er another washing step, the 
gel pieces were dehydrated in 100% ethanol. The gel slices were rehydrated with sequence 
grade modifi ed trypsin (protein:enzyme rati o of 50:1) resolved in ABC buff er and incubated 
overnight at 37°C. Protease acti vity was quenched by adding trifl uoroaceti c (Uvasol grade, 
Merck) acid to adjust the pH to < 2. Pepti de extracti on from the gel matrix was performed by 
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incubati ng the gel pieces twice with extracti on buff er for 20 min each followed by complete 
dehydrati on of the gel pieces with 100% acetonitrile (HPLC gradient grade, Fischer Scienti fi c). 
Aft er each incubati on step, the gel pieces were spun down, supernatants were recovered 
and fi nally combined. Lastly, samples were dried in a vacuum concentrator (Eppendorf) unti l 
10-20% original volume to remove the acetonitrile and applied to StageTips (see below) for 
desalti ng and further sample concentrati on.
In-solution digestionII.24.2.  
Cells were lysed in appropriate amounts of denaturati on buff er for 20 min on ice. The lysates 
were cleared by centrifugati on for 10 min (14,000 rpm at 4°C) and transferred to fresh tubes. 
Protein samples were reduced for 30 min at RT in 10 mM dithiothreitol (DTT) soluti on followed 
by alkylati on for 20 min by 55 mM iodacetamide (IAA) in the dark at RT. The endoproteinase LysC 
(Wako) was added (protein:enzyme rati o of 50:1) and incubated for 4 h at room temperature. 
Aft er diluti on of the sample with four ti mes ABC buff er, sequence grade modifi ed trypsin 
(Promega; protein:enzyme rati o of 50:1) was used for overnight digesti on. Trypsin and Lys-C 
acti vity was quenched by adding trifl uoroaceti c acid to adjust the pH to < 2, and pepti des were 
extracted and desalted using StageTips (see below). 
Preparation of Stop and Go Extraction Tips (StageTips)II.24.3.  
StageTips (RAPPSILBER et al., 2003) were assembled by punching out small discs of C18 Empore 
(3M) fi lter using a 22 G syringe and ejecti ng the discs into 200 μl pipet ti ps. The resulti ng 
C18 Empore columns were conditi oned by methanol and equilibrated with buff er A. Pepti de 
soluti ons from in-soluti on or in-gel digests were adjusted to pH<2.5 and forced through the 
C18 Empore column by centrifugati on at a maximum speed of 6,000 rpm. The columns were 
washed once with buff er A. Pepti des were eluted from the StageTips by applying 60 μl of buff er 
B to the microcolumns. Pepti des were directly eluted into an HPLC autosampler plate and 
concentrated in a vacuum concentrator (Eppendorf) down to 2-3 μl. Aft er mixing the pepti de 
soluti ons with an equal amount of buff er A the samples were ready for LC-MS/MS analysis.
HPLC and mass spectrometryII.24.4.  
Basic instrumental setup of reversed-phase liquid chromatography (rpHPLC) mass spectrometry 
is depicted in Fig. II.2. RpHPLC was performed with either the Agilent HPLC 1200 or Eksigent 
NanoLC – 1D Plus system using self-made fritless C18 microcolumns (ISHIHAMA et al., 2002) 
(75  m ID packed with ReproSil-Pur C18-AQ 3-μm resin, Dr. Maisch GmbH) connected on-line to 
the electrospray ion source (Proxeon) of a LTQ-Orbitrap mass spectrometer (classic, XL or Velos 
instruments, Thermo Fisher). Pepti de samples were picked up by the autosamples and loaded 
onto the column with a fl ow rate of 500 nl/min (Agilent HPLC 1200) or 250 nl/min (Eksigent 
HPLC) and subsequently eluted with a fl ow rate of 200 nl/min with a 10 to 60 % acetonitrile 
gradient over up to 6 h in 0.5% aceti c acid for online MS analysis. The LTQ-Orbitraps were 
operated in the data dependent mode (DDA) with the full scan in the Orbitrap followed by 
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consecuti ve MS/MS scans in the LTQ. The precursor ion scans (m/z 300–1700) were acquired 
in the Orbitrap part of the instrument (resoluti on R = 60,000; target value of 1 x 106). In parallel, 
the fi ve (classic, XL) or 20 (Velos) most intense ions were isolated (target value of 5,000 for 
classic and XL instruments, 3,000 for the Velos instrument; monoisotopic precursor selecti on 
enabled) and fragmented in the LTQ part of the instrument by collision induced dissociati on 
(CID; normalized collision energy 35 %; wideband acti vati on enabled). Ions with an unassigned 
charge state and singly charged ions were rejected. Former target ions selected for MS/MS 
Fig. II.2 | Basic instrumental setup of liquid chromatography-mass spectrometry (LC-MS). (A) Following sample processing, 
pepti de mixtures are stored at 6°C in 96 well plates in the PAL autosampler. The autosampler injects the pepti de mixture into 
a fused silica capillary (B) that is connected to the actual reversed-phase column. Pepti des are retained on the column as it 
is packed with hydrophobic alkyl chain (octadecyl carbon chain, C18) bonded silica consti tuti ng the stati onary phase. As the 
fracti on of organic solvent (e.g. acetonitrile) in the mobile phase increases, pepti des elute sequenti ally according to their 
hydrophobicity. Notably, by using nanoHPLC systems fl ow rates at nanoscale (200 nl/min) are achieved thereby increasing the 
sensiti vity of the mass spectrometer. (C) Pepti des eluti ng from the C18 column are immediately ionized in close proximity to 
the entrance of the mass spectrometer by means of a high electric potenti al applied to the end of the column, referred to as 
electrospray ionizati on (ESI).
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were dynamically excluded for 60 s. Total cycle ti me for one full scan plus up to 20 MS/MS 
scans was approximately 2 s.
Processing of mass spectrometry dataII.24.5.  
Identi fi cati on and quanti fi cati on of proteins was carried out with the MaxQuant soft ware 
package (COX et al., 2008) (version 1.0.7.3 for the pSILAC method development and microRNA 
target identi fi cati on; version 1.0.13.13 for half-lives measurements and the establishment of 
the iBAQ approach). In essence, isotope clusters and SILAC doublets/triplets were extracted, 
re-calibrated and quanti fi ed in the raw data fi les with Quant.exe (medium labels: Arg6 and Lys4, 
heavy labels: Arg10 and Lys8; maximum of three labeled amino acids per pepti de; polymer 
detecti on enabled; top 6 MS/MS peaks per 100 Da). The generated peak lists (msm fi les) were 
submitt ed to a MASCOT search engine (version 2.2, MatrixScience) and searched against an in-
house curated concatenated target-decoy database of forward and reversed proteins. Species-
specifi c IPI protein databases (version 3.37 of the IPI human database for the pSILAC method 
development and microRNA target identi fi cati on; version 3.64 of the IPI mouse database for 
protein half-lives measurements and the establishment of the iBAQ approach) and the E. coli 
database (also for the establishment of the iBAQ approach, obtained from: htt p://cmr.jcvi.
org/cgi-bin/CMR/shared/MakeFrontPages.cgi?page=batchdownload) were employed and 
supplemented with common contaminants (e.g. trypsin, BSA). Databases used in the iBAQ 
approach were additi onally supplemented with UPS2 protein sequences. Full trypti c specifi city 
was required and a maximum of two missed cleavages and a mass tolerance of 0.5 Da for 
fragment ions was applied. The initi al mass accuracy cut-off  on the parent ion was 7 ppm but 
subsequently narrowed down by fi ltering based on hits to reversed pepti des in the target-
decoy database. Oxidati on of methionine and acetylati on of the protein N-terminus were used 
as variable modifi cati ons, carbamidomethylati on of cysteine as a fi xed modifi cati on. Filtering 
of putati ve MASCOT pepti de identi fi cati ons, assembly of proteins and re-quanti fi cati on was 
performed with Identi fy.exe (part of MaxQuant). A minimum pepti de length of 6 amino acids 
and a minimum of two pepti des per protein group (with at least one of the two being unique 
in the database) was required. False discovery rates were esti mated based on matches to 
reversed sequences in the concatenated target-decoy database (ELIAS et al., 2007). A maximum 
false discovery rate of 1% at both the pepti de and the protein level was allowed. Pepti des 
were assigned to protein groups (that is a cluster of a base protein plus additi onal proteins 
matching to a subset of the same pepti des). Protein groups containing matches to proteins 
from the reversed database or contaminants were discarded. To quanti fy changes in protein 
producti on (pSILAC method development and microRNA target identi fi cati on), the median 
of all H/M pepti de rati os using only unique pepti des and non-unique pepti des assigned to 
the protein group with the highest number of pepti des (“razor” pepti des) were calculated. 
Likewise, de novo protein synthesis (measurement of protein half-lives) given by the median 
of all H/L pepti de rati os for a specifi c protein was quanti fi able. For subsequent data analysis, 
only protein quanti fi cati ons based on at least three independent rati o measurements were 
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considered (for protein half-life measurements, at least three pepti de rati os at all three ti me 
points combined were required).
Application of the Universal Proteomics Standard (UPS) II.25. 
The Universal Proteomics Standard (UPS2, Sigma-Aldrich) consists of 48 accurately quanti fi ed 
human proteins in lyophilized form (10.6 μg total). The whole standard was dissolved in 20 μl 
denaturati on buff er and mixed with the samples as follows: UPS2 alone (3.2 μg UPS2), in 
combinati on with E. coli lysate (2.1 μg UPS2 + 1.5 μg E. coli and 1.1 μg UPS2 + 3.0 μg E. coli), 
yeast lysate (4.24 μg UPS2 + 12 μg yeast ~ 6.4 x 106 cells) and NIH3T3 lysate (4.24 μg UPS2 + 
13 μg NIH3T3 ~ 2.8 x 105). All samples were subjected to in-soluti on digest.
Calculation of cellular protein copy numbers by intensity-II.26. 
based absolute quantification (iBAQ)
MaxQuant computes protein intensiti es as the sum of all identi fi ed pepti de intensiti es (maximum 
detector peak intensiti es of the pepti de eluti on profi le, including all peaks in the isotope cluster). 
These protein intensiti es were divided by the number of theoreti cally observable pepti des 
(calculated by in silico protein digesti on with a PERL script, all fully trypti c pepti des between 6 
and 30 amino acids were counted while missed cleavages were neglected). The resulti ng iBAQ 
intensiti es were log-transformed and plott ed against known log-transformed absolute molar 
amounts of the spiked-in standard proteins (UPS2 standard). Linear regression was used to 
fi t iBAQ intensiti es to absolute standard protein amounts. The slope and intercept from this 
linear regression was then used to convert iBAQ intensiti es to mole amounts for all identi fi ed 
proteins. Cellular copy numbers were derived by dividing through the number of cells used 
in the respecti ve experiment. In doing so, for NIH3T3 cells absolute cellular copy numbers for 
almost 2,000 proteins were obtained. To arrive at cellular copy numbers for the 6,445 proteins 
identi fi ed (in-gel digest, 20 slices) in the half-life measurements, the copy/numbers obtained 
in the in-soluti on digest were used to scale the protein intensiti es from the in-gel digest by 
linear regression.
Cluster analysis of gene ontology (GO) termsII.27. 
In order to test whether specifi c genes with certain combinati ons of mRNA and protein 
stability have disti nct biological functi ons, regimes were defi ned as follows: First, genes were 
separately sorted according to their mRNA and protein half-lives. Second, the top third of 
mRNA half-lives was combined with either the upper or lower third of protein half-lives, and 
vice versa for protein half-lives. This resulted in four regions comprising disti nct combinati ons 
of mRNA and protein half-lives. Next, gene ontology analysis using the DAVID Bioinformati cs 
Database (DAVID Bioinformati cs Resources, htt p://david.abcc.ncifcrf.gov/) (HUANG DA et al., 
2009) was performed with the IPI protein identi fi er of genes in each region to fi nd enriched 
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biological processes. Calculati on of over-represented GO terms was done using the enti re list 
of identi fi ed proteins as background (threshold count = 2; EASE score = 1). Terms with a p-value 
<0.01 in at least one regime were selected, log- and z-transformed, hierarchically clustered 
and plott ed as a heatmap using an in-house Perl and R script.
Statistical analysis II.28. 
Stati sti cal data analysis and linear regression was done using the R project for Stati sti cal 
Computi ng (R Foundati on for Stati sti cal Computi ng, Vienna, Austria) or Prism 4.0 (GraphPad 
Soft ware, San Diego, CA, USA).
Determination of protein half-lives, response times and II.29. 
mathematical modeling of gene expression
All the maths required for derivati on of the following equati ons to quanti tati vely describe the 
dynamic properti es of gene expression was contributed by Dorothea Busse, scienti st in the group 
of Jana Wolf termed “Mathemati cal Modelling of Cellular Processes” at the Max-Delbrück-
Centrum for Molecular Medicine (MDC, Robert-Rössle Str. 10, D-13125 Berlin, Germany):
Calculation of protein half-livesII.29.1.  
SILAC enables the determinati on of protein turnover by measuring the rati o (r) of protein 
labeled with heavy amino acids (PH) and light amino acids (PL) at diff erent ti me points (1.5 h, 
4.5 h and 13.5 h):
[E1]
L
H
P
Pr =  
Proteins labeled with light amino acids (PL) are assumed to decay exponenti ally with the 
degradati on rate constant (kdp):
[E2]
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L
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Protein labeled with heavy amino acids (PH) can be expressed as the diff erence between total 
number of a specifi c protein (Ptotal) and PL. The total number (Ptotal) is assumed to double during 
the durati on of one cell cycle:
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P0 is the protein copy number at the onset of the experiment (t = 0) and tcc is the durati on 
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of one cell cycle. The rate constant of the protein decay (kdp) can then be obtained by linear 
regression using equati ons E1-E3:
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where m is the number of ti me points (ti) considered and  the rati o of the light and heavy 
amino acids containing fracti on of a specifi c protein (equati on E1) at each ti me point. The 
half-life of a protein (T1/2) is then given by:
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Of all identi fi ed proteins (n = 6,445) only those were taken which were counted at least three 
ti mes by the mass spectrometer regardless at how many ti me points. As a quality test of linear 
regression, the coeffi  cient of determinati on (R2) was calculated from the correlati on coeffi  cient 
between measured and esti mated rati os (two or three ti me point measurements, cf. Fig. II.16 A 
and B). Half-lives were only calculated for fi ts that sati sfy R2 ≥ 0.9 (n = 4,906) or measurements 
of one ti me point with a minimum three counts (n = 95). For very unstable proteins the rati o 
measurements saturated at the late ti me point. Therefore, for proteins that failed the quality 
check (R2 < 0.9) but had a rati o r ≥ 0.5 at the fi rst ti me point (1.5 h), only this ti me point was 
used to calculate the half-life.
Quantitative model of gene expressionII.29.2.  
A minimal descripti on of the dynamics of transcripti on and translati on includes the synthesis 
and degradati on of mRNA and protein only:
PkRk
dt
dP
Rkv
dt
dR
dpsp
drsr
−=
−=
The mRNA (R) is synthesized with rate vsr and degraded proporti onal to the number of mRNAs 
with the rate constant kdr. Proteins (P) are synthesized depending on the number of mRNA 
molecules and the translati on rate constant (ksp). Protein degradati on is determined by kdp and 
the protein level. This system of ordinary diff erenti al equati on can be solved analyti cally. The 
experimental data introduced in this thesis are mean mRNA and protein levels in a populati on 
of growing non-synchronous cells. Assuming a homogenous distributi on of cells over the 
durati on of one cell cycle (tcc), mean mRNA and protein levels of the populati on are equal to 
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the averaged copy numbers of one cell cycle
∫= cc
t
cc
dttX
t
X
0
1 )( ,
where X represents either mRNA (R) or protein (P) copy numbers. The dynamics of mRNA (R(t)) 
and protein (P(t)) is given by the soluti on of ordinary diff erenti al equati on system described 
above. The initi al conditi ons of mRNA and protein copy numbers are given by R(0) = R0 and P(0) 
= P0, respecti vely. The copy numbers are assumed to double over one cell cycle to balance the 
distributi on of mRNA and protein between the two daughter cells aft er cell division, therefore 
X(tcc) = 2X0. Solving this equati on for mRNA and protein allows describing the relati onship 
between mean cellular mRNA and protein levels, synthesis and degradati on rates.
Response timesII.29.3.  
The above presented model of quanti tati ve gene expression (cf. II.29.2) can also be used to 
calculate characteristi c response ti mes τ that describe how fast protein levels relax towards the 
steady-state aft er perturbati on. Response ti mes were fi rst defi ned and used to characterize the 
response to fl ux changes in metabolic networks (HEINRICH Ι RAPOPORT 1975; CASCANTE et al., 
1995), and more recently adapted to signaling networks (HEINRICH et al., 2002; KLIPP, 2009). A 
plain descripti on of the characteristi c ti me for the linear gene expression model is given by: 
0
0
PP
dttPP
ss
ss
protein −
−
=
∫∞ )(
τ
Here the response ti me (τprotein) characterizes the approximati on of the protein level in the 
steady state (Pss = (vsrksp)/(kdrkdp)). The protein kineti cs (P(t)) is again determined by the soluti on 
of the ordinary diff ernti al equati on system. The response ti me (τprotein) is then given by
0
01
PP
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k
k ss
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dpdr
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where kdr and kdp are the degradati on rate constants of mRNA and protein, respecti vely. The 
parameter ksp is the translati on rate constant and R0, Rss  and P0, Pss are the initi al and steady-
state levels of mRNA and protein, respecti vely. Assuming (i) a perturbati on which aff ects both 
mRNA and protein levels and (ii) steady-state conditi ons before and aft er the perturbati on, 
the response ti me only depends on the degradati on rate constants of mRNA (kdr) and protein 
(kdp):
dpdr
protein kk
11
+=τ
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Energy calculationsII.30. 
With the quanti ti ati ve model (cf. II.29.2) the esti mati on of the theoreti cal energy costs (in high 
energy phosphate bonds) to synthesize mRNAs (i.e. primary transcripts) and proteins from their 
building blocks (nucleoti de monophosphates and amino acids, respecti vely) was possible. For 
transcripti on, two ATP molecules are needed for adding a single nucleoti de (elongati on) plus 
another two ATPs for the initi ati on step (VOET, 1995). For protein synthesis, four ATP molecules 
are need for the additi on of single amino acids to the nascent chain (2 ATPs for tRNA loading 
and 2 ATPs for elongati on) plus another 2 ATPs for initi ati on and one for terminati on (MOLDAVE, 
1995). By multi plicati on of the above menti oned costs per building block (nucleoti de or amino 
acid) with transcripti on/translati on rates and mRNA/protein lengths overall energy expenses 
for mRNA and protein synthesis were obtained with:
mRNA synthesis = (transcripti on rate * primary transcript lengths * 2 ATP) + 2 ATP
protein synthesis = (translati on rate * protein length * 4 ATP) + 3 ATP
Structural features affecting mRNA and protein stabilityII.31. 
3’UTR, 5´UTR and CDS sequence lengths, AU-rich elements and Pum2 binding sites 
Mouse 3’UTR, 5´UTR and CDS sequences based on the mouse the reference sequence (NCBI 
Build 37/mm9) were extracted from UCSC Genome Browser (htt p://genome.ucsc.edu) and 
the lengths were counted. 3´UTR sequences were searched for AU-rich core moti fs (“ATTTA”; 
BARREAU et al., 2006) and Pumilio2 binding sites (“TGTA(A|T|C|G)ATA” with “I” referring to 
“or”; HAFNER et al., 2010) using an in-house Perl script. The average number of either moti f in 
bins of 100 genes were plott ed against averaged mRNA half-lives of the same bins. To account 
for stochasti c moti f occurences due to vastly diff erent 3´UTR lengths, moti f densiti es (moti fs/
nucleoti de) were calculated by dividing the number of either moti f counted per 3´UTR by 
3´UTR sequence length.
Correlati on of amino acid sequence frequency and protein stability
A possible relati onship between the presence of certain amino acids and protein stability 
was examined as follows: First, relati ve fracti ons of amino acids per protein were calculated. 
Second, relati ve amino acid fracti ons were plott ed against protein half-lives in bins of 100 
genes. Third, Spearman Rank correlati on coeffi  cients (Rs) were used to assess the stati sti cal 
signifi cance of possible correlati ons.
Correlati on of the degree of protein disorder with protein stability
As a proxy for a protein´s “unstructuredness”, a publicly available mouse protein database 
(htt p://bioinfadmin.cs.ucl.ac.uk/disodb/) was used that predicts potenti ally disordered amin 
acid residues in a context-specifc manner and also assigns confi dence values accordingly. 
The overall percentage of potenti ally disordered amino acids was extracted from the 
database for individual proteins. A possible correlati on was investi gated by plotti  ng averaged 
“unstructuredness” in bins of 100 genes against averaged protein half-lives of the same bins.
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Global analysis of cellular protein trans-III.1. 
lation by pulsed SILAC (pSILAC)
DNA-microarrays have become a powerful means to routi nely study qualitati ve and quanti tati ve 
changes of the transcriptome. However, microarrays cannot be employed to study changes 
occurring at the level of translati on. While translati onal regulati on is therefore investi gated on 
a gene by gene basis with radioacti ve amino acids (e.g. 35S-methionione; POLLARD, 1996) or by 
expression of arti fi cial reporter constructs, e.g. luciferase reporter assays (DYER et al., 2000), 
tools for a  system-wide investi gati on of protein translati on are lacking.
Mass spectrometry-based proteomics can identi fy hundreds of proteins in complex mixtures 
and recently developed methodologies off er the opportunity to obtain quanti tati ve proteomic 
informati on. For instance, the SILAC approach can highlight diff erences in protein compositi on 
between samples and has also recently been adapted to measure protein turnover in model 
organisms like yeast but also in vertebrates (DOHERTY et al., 2005; PRATT et al., 2002; MILNER 
et al., 2006). In this case, the organism of interest is pulse labeled with heavy amino acids 
for a certain period of ti me. The rati o of heavy (H) to light (L) pepti des indicates the turnover 
rate of the respecti ve protein. However, as protein turnover is aff ected by both synthesis and 
degradati on the H/L rati o does not directly provide informati on about the translati on rate. For 
instance, a high H/L rati o could either indicate a high translati on rate of a stable protein or a 
low translati on rate of a protein that is rapidly degraded.
Establishment of a pulsed SILAC approach with two III.1.1.  
heavy-stable isotopes
As SILAC metabolically labels exclusively newly-synthesized proteins, a direct comparison 
of translati on rates between two samples should be achievable by introducti on of a second 
heavy-stable isotope label. The concept of this pulsed SILAC (pSILAC) strategy is depicted in 
Fig. III.1. Cells are fi rst culti vated in standard growth medium with the natural light (L) amino 
acids. Concomitantly with diff erenti al treatment (e.g. applicati on of a certain chemical), cells 
are transferred to culture medium containing heavy (H) or medium-heavy (M) amino acids (cf. 
Material & Methods II.4 and II.5). During the following incubati on phase all newly synthesized 
proteins will appear in the H or M form, respecti vely. Subsequently, both samples are combined 
and analyzed together by mass spectrometry. In contrast to classic SILAC (cf. Fig. I.4), ionized 
pepti des now emerge as triplicates according to their respecti ve label in the mass spectrum. 
The abundance rati o of the H versus the M pepti de form now exclusively refl ects diff erences in 
translati on of newly-synthesized proteins resulti ng from a diff erenti al treatment. Pre-existi ng 
protein amounts, that is, proteins present in the sample before the treatment remain in the 
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L form and can be eff ecti vely ignored. The traditi onal SILAC approach seeks to completely 
replace light amino acids by their heavy labeled counterparts throughout the proteome. 
Given that proteins exhibit vastly diff erent turnover rates, changes in gene expression induced 
by any kind of treatment will aff ect steady-state protein levels with diff erent kineti cs and of 
diff erent magnitude. Since the pSILAC approach exclusively accounts for diff erences in protein 
producti on, the method is independent of diff erences in protein stability that would otherwise 
interfere with accurate quanti fi cati on. Degradati on will to some extent also aff ect newly-
synthesized proteins, however, this degradati on will occur for proteins in both the M and the 
H form to the same degree and will therefore not generally aff ect diff erences in translati on 
rates given by H/M rati os.
pSILAC - as good as the traditionals?III.1.2.  
In order to evaluate the quanti tati ve parameters of pSILAC, the method was fi rst compared to 
the well established luciferase assay traditi onally used to measure translati onal regulati on. More 
precisely, a stable HeLa cell line with a fi refl y luciferase gene under control of pTET (cf. Material 
Light (L)
 m/z
Medium-heavy (M) Heavy (H)
 m/z
 m/z
 m/z
H/M ratio reflects 
differences in 
translation rates
differential treatment
mix extracts 1:1
Fig. III.1 | Principle of the pulsed SILAC approach. Concurrently with a diff erenti al treatment, cells culti vated in light (L) 
medium are either transferred to heavy (H) or medium-heavy (M) SILAC medium. From this ti me point on cells are pulse 
labeled, that is, newly-synthesized proteins incorporate either the H or the M amino acids. Aft er the labeling phase the two 
cell populati ons are mixed and analyzed by mass spectrometry. The rati o of peak intensiti es of H versus M pepti des refl ects 
diff erences in translati on of the corresponding proteins.
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& Methods II.4.1), a promoter responsive to tetracycline controlled transacti vators (GOSSEN 
Ι BUJARD, 1992) was employed as follows. The kineti c of luciferase inducti on by treati ng cells 
with doxycycline (a tetracycline derivati ve) in M medium for diff erent lengths of ti me (1 h, 2 h, 
4 h, 6 h, 8 h, 10 h) has been monitored (cf. Material & Methods II.6). In parallel, control cells 
were treated with doxycycline for 10 h in H medium which corresponds to maximal luciferase 
inducti on. Following cell lysis, cells in M medium (treated for variable lengths of ti mes) were 
mixed in a 1:1 rati o with the control lysate (treated for 10 h) and proteins were separated by 
SDS-PAGE (cf. Material & Methods II.6). Gel slices in the expected molecular weight range 
of the luciferase protein were excised, reduced, alkylated and trypsin digested (cf. Material 
& Methods II.24.1). Extracted pepti des were analyzed by liquid chromatography-tandem 
mass spectrometry (LC-MS/MS) on a high performance mass spectrometer (cf. Material & 
Methods II.24.4). Despite of more than 500 proteins commonly found in excised gel slices, 
unequivocal identi fi cati on of several luciferase pepti des for each ti me point was achieved (cf. 
Supplementary Table VII.1). 
In Fig. III.2 A and B two typical mass spectra of a luciferase derived pepti de obtained with 
the pSILAC approach are depicted. The increasing pepti de intensity of the M form over ti me 
allowed for quanti fi cati on of de novo translati on of the luciferase protein relati ve to the control 
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Fig. III.2 | Evaluati on of the pulsed SILAC approach. (A, B) Mass spectra of a luciferase-derived pepti de (GGVVFVDEVPK) at 
2 and 8 h post inducti on. Luciferase expression was induced by treati ng transgenic HeLa cells with doxycycline in M medium 
for diff erent lengths of ti me. Cells treated for 10 h in H medium were used as an internal reference. The increase in the M 
form relati ve to the H form is apparent. Of note, small amounts of luciferase-derived pepti des in the light form were also 
detected. (C) Time course of luciferase inducti on relati ve to the reference as measured by pSILAC and luminescence readouts. 
(D) Plotti  ng pulsed SILAC-based quanti fi cati on against luminescence-based quanti fi cati on shows that both methods yielded 
very similar results. Error bars represent standard deviati ons calculated by comparing three luminescence measurements or 
by quanti fying diff erent luciferase pepti des (pSILAC).
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in the H form. In parallel, luciferase expression using the standard luminescence approach was 
analyzed in the same samples. Here, luminescence-based relati ve quanti fi cati on of luciferase 
inducti on was performed by referring the absolute luminescence intensiti es for the diff erent 
incubati on ti mes (M samples) to the control cells (H sample) (cf. Material & Methods II.6). 
Notably, a small amount of luciferase-derived pepti des in the L form (cf. Fig. III.2 A, B) was also 
detected. As luciferase was not expressed while cells were culti vated in the light medium this 
peak most likely originates from recycling of light amino acids or the use of light amino acids 
sti ll present in the cellular precursor pool aft er transfer to M or H medium.
Direct comparison of results obtained by pSILAC and luminescence readout is shown in Fig. 
III.2 C. Overall, pSILAC based quanti fi cati on was found to be very similar to the highly sensiti ve 
luciferase assay. Standard deviati ons given by error bars for SILAC quanti fi cati on became 
smaller over ti me. This observati on can likely be att ributed to the fact that stable-isotope based 
quanti fi cati on works best with pepti de ions displaying proper signal-to-noise rati os. More 
specifi cally, while decent amounts of newly synthesized luciferase 8 h post-inducti on made 
identi fi cati on of the M pepti de peak relati vely straightf orward (cf. Fig. III.2 B), unambiguous 
peak detecti on was more challenging at 2 h post-inducti on (cf. Fig III.2 A). Consequently, H/M 
pepti de rati os obtained at very early ti me points exhibit higher deviati ons than at later ti me 
points.
Plotti  ng SILAC quanti fi cati on against luminescence-based quanti fi cati on demonstrated excellent 
overall correlati on (Pearson R=0.99, cf. Fig III.2 D). Linearity was observed for abundance rati os 
between 0.015 and 1, corresponding to 1.5 % and 100 % inducti on of luciferase expression, 
respecti vely. Hence, pSILAC can accurately determine diff erences in translati on rates over at 
least two orders of magnitude in complex protein mixtures provided that a mass spectrometer 
with a suffi  ciently high dynamic range is employed.
pSILAC accurately quantifies over a high range of ex-III.1.3.  
pression levels
In order to validate that pSILAC accurately quanti fi es also other proteins than luciferase, 
experiments with SILAC labeled yeast as a model system were conducted. Yeast cells (strain 
BY4742 lys2:kanMX4) were completely SILAC labeled in the traditi onal way by culti vati ng them 
over night in minimal media supplemented with light (L), medium-heavy (M) or heavy lysine (H) 
(cf. Material & Methods II.5 and Table II.1). To simulate diff erent translati on rates (i.e. diff erent 
H/M rati os) the labeled yeast populati ons were mixed in four diff erent L:M:H rati os (0.5:1:1, 
0.5:1:2, 0.5:1:4, 0.5:1:8) spanning a reasonable range of variati ons in translati on. The mixtures 
were subjected to in-soluti on digests (cf. Material & Methods II.24.2) and analyzed via mass 
spectrometry (cf. Material & Methods II.24.4). In each sample, several hundred proteins in 
all three forms could readily be detected. Log2 fold changes of the obtained H/M rati os were 
plott ed as a functi on of summed pepti de intensiti es (cf. Fig. III.3). The analysis demonstrated 
that pSILAC can accurately measure H/M rati os for hundreds of proteins in parallel. Even large 
deviati ons in the amount of the H compared to the M form (e.g. an H/M rati o of 8:1) simulati ng 
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vast diff erences in translati on 
rates centered closely around 
the expected log2 fold change of 
three.  As expected, quanti fi cati on 
was more accurate for the more 
highly expressed proteins, that 
is, proteins represented by 
more pepti des with higher peak 
intensiti es. However, also less 
abundant proteins rarely deviated 
more than 0.3 log2 fold change 
from the true value indicati ng that 
pSILAC can accurately quanti fy 
protein changes over a high range 
of expression levels.
Applying pSILAC to iron homoeastasis - a proof of principleIII.1.4.  
Next, the pSILAC approach was employed to study translati on in a biologically relevant system. 
Cellular iron homeostasis has been found to be an ideal model for translati onal regulati on as it 
has been extensively studied for many years (HENTZE et al., 2004). Here, iron regulatory proteins 
(IRPs) interact with iron-responsive elements (IREs) which are conserved cis-acti ng hairpin 
structures found in untranslated regions (UTRs) of mRNAs of iron-related proteins. Binding of 
IRPs to single IREs in the 5’ UTR of mRNAs encoding ferriti n heavy (FTH1) and light (FTL) chains 
is known to block translati on of these iron storage proteins. In contrast, interacti on between 
IRPs and multi ple IREs in the 3’ UTR of the mRNA encoding for the transferrin receptor (TFRC) 
protects this message from degradati on. Cellular iron inhibits the interacti on between IRPs and 
IREs or targets IRPs for degradati on. Consequently, iron regulates protein synthesis either by 
altering mRNA stability or by directly interfering with translati on initi ati on. To investi gate the 
global eff ect of iron availability on protein synthesis rates, HeLa cells were washed with PBS and 
transferred to H SILAC medium with simultaneous additi on of ferric ammonium citrate (FAC) 
to a fi nal concentrati on of 100 μM (cf. Material & Methods II.7). In parallel, control cells were 
washed and transferred to M SILAC medium without additi onal iron. Aft er 14 h of incubati on, 
FAC-treated and untreated control cells were harvested, combined and analyzed by LC-MS/
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Fig. III.3 | Benchmark test of pSILAC using yeast as a model system. L, M 
and H labeled yeast cells were mixed in diff erent rati os and analyzed. Log2 
fold changes of H versus M proteins were plott ed as a functi on of summed 
pepti de intensiti es. Note the marked correlati on between the measured 
values and the mixing rati os.
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MS. In total, 1,311 proteins could be identi fi ed with extremely high confi dence (cf. Material & 
Methods II.24.5). 
Exemplary for the vast majority of proteins detected with H:M rati os around 1:1, indicati ng 
that the translati on of those has not been signifi cantly aff ected by iron (cf. Fig.III.4 D), the 
spectrum of a pepti de derived from the Heat shock protein 5 (HSPA5) is shown in Fig. III.4 A 
(cf. Supplementary Table VII.3 for additi onal examples). As opposed to this, ferriti ns were 
found to be 13 ti mes (log2 fold change of ~3.7) more abundant in the H than in the M form, 
demonstrati ng that translati on of these iron storage proteins was strongly acti vated (cf. Fig. 
III.4 B and Supplementary Table VII.2). Consistent with the aforementi oned model of iron 
regulati on, a signifi cant down-regulati on of the transferrin receptor in response to iron additi on 
could be detected (cf. Fig. III.4 C and Supplementary Table VII.2). 
In order to validate these fi ndings, experiments with diff erent incubati on ti mes with iron and 
a complementary approach with the iron chelator deferoxamine (DFO) were performed. All 
experiments confi rmed technical robustness and reproducibility of the pulsed SILAC method. 
Consistently, in all fi ve biological experiments the ferriti ns and the transferrin receptor were 
found to be among the most strongly regulated proteins (cf. Fig. III.5), indicati ng that pulsed 
SILAC can accurately identi fy proteins regulated at the post-transcripti onal level. 
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Fig. III.4 | Changes in cellular protein translati on rates in response to iron. HeLa cells were treated with iron in H medium or 
transferred to M medium without additi onal iron. (A) Translati on rates of most proteins were not altered as shown by similar 
intensiti es of the H and the M peak. (B) Synthesis of the ferriti n heavy (FTH1) and light chains (FTL) was strongly sti mulated 
by iron. (C) Translati on of the transferrin receptor protein (TFRC) was repressed by iron treatment. (D) H/M rati os of 1,311 
identi fi ed proteins show that FTH1, FTL and TFRC have the highest fold changes. Protein synthesis of these proteins was 
signifi cantly up- or down-regulated by iron (p < 0.01, Grubbs’ outlier test).
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Fig. III.5 | Summary of changes in protein producti on in HeLa cells in response to iron derived from fi ve independent pSILAC 
experiments. Cells were either treated with 100 μM ferric ammonium citrate (FAC) for diff erent lengths of ti me (4, 6, 8 and 12 
h) or with the iron chelator deferoxamine (DFO) for 12 h (cf. Material & Methods II.7). Changes in producti on of all identi fi ed 
proteins relati ve to untreated controls are plott ed as a histogram of log2 fold changes of H/M rati os. Producti on of most 
proteins was not signifi cantly aff ected by iron as seen by the huge peak in the histogram at a log2 fold change of 0. In contrast, 
ferriti n light (FTL) and heavy (FTH1) chain, two proteins known to be translati onally regulated by iron availability, were strongly 
up-regulated by additi on of iron at all four ti me points, while the transferrin receptor (TFRC) was consistently down-regulated. 
Note that removing iron with DFO resulted in down-regulati on of FTH1 and up-regulati on of TFRC. 
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Widespread changes in protein synthesis III.2. 
induced by microRNAs
As menti oned in the introducti on, quanti tati ve approaches to monitor global protein expression 
changes upon perturbati ons are now available. However, since microRNAs act at the post-
transcripti onal level, that is, by aff ecti ng mRNA stability and/or mRNA translati on, changes in 
steady-state protein levels upon miRNA over-expression or depleti on are not ideally suited to 
detect their impact on the proteome. Specifi cally, due to individual protein turnover ti mes, the 
kineti cs with wich microRNA induced changes become apparent at steady-state protein levels 
may diff er substanti ally. 
pSILAC quantifies changes in protein production in-III.2.1.  
duced by miRNAs
To overcome these problems, the mass spectrometry-based quanti tati ve pSILAC approach (cf. 
III.1) ideally fi lls in this technical gap. To briefl y recap, pSILAC employs diff erent stable-isotope 
labeled amino acids to metabolically pulse-label diff erenti ally treated cell populati ons. Global 
diff erences in protein producti on integrated over the measurement ti me aft er the pulse can 
then be detected (SCHWANHAEUSSER et al., 2009). 
In 2005 Johnson and co-workers (LIM et 
al. 2005) demonstrated that ectopic over-
expression of single microRNAs results in 
widespread, mostly mild down-regulati on 
of hundreds of mRNAs. To assess the 
impact of microRNAs onto the proteome 
with pSILAC, fi ve miRNAs were individually 
over-expressed in HeLa cells (cf. Material 
& Methods II.8). These miRNAs are ti ssue-
specifi c and either virtually absent in HeLa 
cells (miR-1, miR-155) or appreciably 
expressed in various ti ssues (miR-16, miR-
30a, let-7b) including HeLa cells (LANDGRAF 
et al., 2007). 
To check for effi  cient transfecti on of small 
RNAs, HeLa cells were fi rst transfected 
with fl uorophore-conjugated dsRNA (cf. 
Fig. III.6) according to the applied miRNA 
transfecti on protocol (cf. Material & 
Methods II.9). Fluoresence microscopy 
confi rmed successful delivery of small 
20 x
Untransfected
(fluorescence)
Untransfected
(phase contrast)
40 x
Block-IT
(phase contrast)
Block-IT
(fluorescence)
20 x
Fig. III.6 | Analysis of transfecti on effi  ciency. HeLa cells were 
transfected with fl uorophore-conjugated dsRNA termed Block-
IT according to the miRNA transfecti on protocol (cf. Material & 
Methods II.8) (left  panel). Phase contrast images are presented 
as a reference (right panel). 
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RNAs in more than 90 % of all cells.
To examine changes in protein producti on upon 
over-expression of individual miRNAs, cells 
were pulse-labeled in medium-heavy (M) SILAC 
medium 8 h post-transfecti on (cf. Fig. III.7). In 
parallel, MOCK-transfected  control cells (“water 
control”) were culti vated in heavy (H) SILAC 
medium (cf. Material & Methods II.8). Following 
a labeling ti me of 24 h, diff erenti ally treated 
HeLa cells were combined and subjected to mass 
spectrometry analysis. Representati ve pepti de 
mass spectra demonstrati ng pSILAC-based 
quanti fi cati on of changes in de novo synthesis 
of three proteins upon miRNA-1 or miRNA-155 
transfecti on are depicted in Fig. III.8 A,B and 
C. Changes in protein synthesis were revealed 
by the relati ve intensiti es of the H and the M 
peak (H/M rati o). While protein producti on of 
β-acti n was not signifi cantly altered, indicated by 
H/M rati o of 1.1, the hepatocyte growth factor 
receptor (c-MET) displayed down-regulati on in 
protein synthesis upon miRNA-1 over-expression. 
Likewise, protein producti on of the CCAAT-
enhancer-binding proteins beta (CEBPβ) was 
substanti ally repressed following miRNA-155 
transfecti on. Overall, for each of the fi ve miRNAs 
investi gated, changes in protein producti on of 
approximately  3,000 to 3,500 proteins were quanti fi ed with high confi dence (all results for 
individual microRNAs are freely accessible via web-based database search at htt p://pSILAC.
mdc-berlin.de. Alternati vely, all data sets are available as fl at-fi le for download).
To account for biological reproducibility of SILAC measurements, exemplary for miRNA-1 two 
independent transfecti on experiments were performed (cf. Material & Methods II.8). As shown 
in Fig. III. 8 D, the biological replicates showed high correlati on over the enti re dynamic range 
indicated by a Pearson correlati on coeffi  cient (R) of ~ 0.9. In order to validate at least some 
targets found with repressed protein producti on by the pSILAC approach, altogether 16 proteins 
were independently reexamined with conventi onal Western blotti  ng (cf. Material & Methods 
II.14 and Supplementary Fig. VII.1). Though Western blotti  ng shows changes in protein steady-
state levels and is hence potenti ally compromised by individual protein turnover, results did in 
all cases qualitati vely validate the pSILAC measurements, i.e. overall trends apparent from the 
blots agreed well with the pSILAC results.
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Fig. III.7 | Global analysis of changes in protein producti on induced 
by microRNAs. HeLa cells culti vated in normal, .i.e. light (L) medium 
were either transfected with a miRNA or MOCK transfected. Aft er 8 
h, transfected and control cells were pulse labeled by transferring 
them to culture medium containing medium-heavy (M) or heavy 
(H) isotope-labeled amino acids, respecti vely. Newly synthesized 
proteins will appear in the H or M form. 24 h post-transfecti on, 
samples were combined and analyzed by mass spectrometry. 
Intensity peak rati os between heavy and medium-heavy pepti des 
(H/M rati o) refl ect changes in protein producti on.
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Sequence characteristics associated with reduced protein III.2.2.  
synthesis 
Remarkably, pSILAC measurements revealed that basically all individually over-expressed 
miRNAs had rather mild eff ects on the proteome, similar to what has already been observed 
for the transcriptome (LIM et al., 2003). Exemplary for miRNA-155, Fig. III.9 A shows that overall 
changes in protein synthesis of ~ 3,300 proteins were rarely beyond 2-fold. Yet closer inspecti on 
of the histogram indicates that the distributi on of changes is asymmetric and biased towards 
negati ve fold changes. Thus, a single miRNA obviously repressed either directly or indirectly 
the producti on of several hundred proteins.
Since miRNAs are thought to regulate target mRNAs by binding to cis-regulatory sites in 
3’UTRs, a linear regression-based computati onal analysis was conducted to identi fy putati ve 
3’UTR sequence moti fs (cf. Material & Methods II.10) that correlated with the observed 
overall changes in protein producti on. More precisely, the applied algorithm termed REDUCE 
(BUSSEMAKER et al., 2001) performed an unbiased screen for all possible RNA nucleoti de moti fs 
of length one to six, assuming a model in which upstream moti fs contribute additi vely to the 
log-expression level of a gene.
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Fig. III.8 | Exemplary mass spectra of identi fi ed pepti des (sequences in parentheses). (A) Producti on of most proteins 
remained unaltered upon miRNA transfecti on as shown for a β-acti n-derived pepti de. (B, C) In contrast, synthesis of c-MET, 
EGFR and CEBP-β was reduced by miR-1 or miR-155 over-expression. (D) Analysis of biological replicates of miR-1 transfecti ons 
measured by pSILAC revealed high reproducibility of pSILAC.
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Notably, for each of the fi ve miRNAs, the most signifi cant moti f of all possible 5,460 moti fs was 
precisely the seed of the respecti ve miRNA (cf. Fig. III.9 B). For instance, the top ranking moti f 
for the miRNA-1 over-expression experiment given by “CAUUCC” was found in 714 3´UTR 
sequences and was well correlated (Regression coeffi  cient of -0.29) with down-regulati on 
of protein producti on measured by pSILAC. Exemplary for miRNA-155 over-expression, 
plotti  ng the histogram of all fold changes for proteins that contain at least one seed in their 
mRNA 3’ UTRs clearly revealed the correlati on between seed enrichment and repression in 
protein producti on (cf. Fig. III.9 C). Analysis of seed density, that is, the number of seeds per 
nucleoti de, revealed that the presence of the seed in 3´UTR exerted the strongest negati ve 
eff ect on protein synthesis (cf. Fig. III.9 D). In contrast, the same moti f analysis in 5’ UTRs had 
no signifi cant results, and searching in coding sequences (CDS) yielded the seed in only two 
experiments (let-7b, miR-16).
Towards a more quanti tati ve descripti on of miRNA mediated regulati on of seed carrying 
mRNAs, the number of proteins with at least one seed site in the 3’ UTR of respecti ve mRNAs 
Fig. III.9 | miRNAs down-regulated producti on of hundreds of proteins. (A) Histogram of changes in protein synthesis of 
3,299 proteins in HeLa cells upon miR-155 over-expression. (B) An unbiased search for 3’ UTR moti fs that correlate with 
pSILAC fold-changes yielded precisely the miRNA seed sequences. (C) Histogram of proteins with at least one miR-155 seed 
in corresponding 3´UTRs displayed a clear tendency towards down-regulati on by miR-155 over-expression. (D) Analysis of 
seed frequencies in coding sequences (CDSs), 5’ untranslated regions (UTRs) and 3’ UTRs of mRNAs and changes in protein 
synthesis upon miR-16 over-expression. (Fig. III.9 B and D were contributed by Zhou Fang, bioinformati cian at the Berlin 
Insti tute for Medical Systems Biology, BIMSB, Robert-Rössle Str. 10, D-13125 Berlin, Germany)
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was plott ed as a functi on of their pSILAC fold changes (cf. Fig. III.10 A), separately for each 
miRNA. Taking all fi ve tested microRNAs together, the producti on of more than 300 proteins 
with seeds was repressed by at least 30% (log2-fold change < -0.5). Compared to all proteins 
down-regulated by at least this much, that is, irrespecti ve of the presence or absence of the 
seed, the roughly 300 seed-carrying proteins amounted to roughly 60-70%. Hence, it remains 
an open questi on how many proteins without a seed are yet direct targets. Nevertheless, the 
pSILAC approach clearly generated lists of proteins enriched in direct targets, i.e. targets were 
the presence of a seed mediated target recogniti on. 
In order to validate that the presence of seed sites in 3´UTRs correlated with protein down-
regulati on measured by pSILAC, dual luciferase reporter constructs were generated (cf. Material 
& Methods II.11). Eight arbitrarily selected, endogenous 3´UTRs with seeds for either miRNA-1 
or let-7b were individually cloned in reporter plasmids downstream of a luciferase gene to 
analyze the seed-mediated impact of microRNAs on translati on. Luciferase reporters were co-
transfected with either miRNA-1 or let-7b in HeLa cells, while in control cells miRNA-155 was 
used instead (cf. Material & Methods II.12 and II.13).
Given the fact that the detecti on of changes in protein producti on works fundamentally 
diff erent in dual luciferase assays, the results correlated surprisingly well with measured pSILAC 
values (cf. Fig. III.10 B). Of note, only for two genes (ADPGK and RDH10) pSILAC measurements 
deviated about 20% from luciferase measurements, thereby further confi rming the validity of 
the applied approach.  
miRNAs translationally repress many direct target genesIII.2.3.  
Since the pSILAC approach detects changes at the fi nal step in expression of protein-coding 
genes, transcripti onal as well as post-transcripti onal regulati on is captured. With regard to 
Fig. III.10 | The miRNA seed explained a large fracti on of down-regulated protein synthesis. (A) Cumulati ve number of 
proteins with seeds as a functi on of changes in their producti on. For a given cut-off , this indicates the number of down-
regulated seed containing proteins (shown for -0.5 log2 fold-change). (B) Dual luciferase reporter assays for 3’ UTR mediated 
regulati on by miRNAs (± s.d., n=3). “Net pSILAC” refers to the diff erence of pSILAC log2 fold-changes for the miRNA (miR-1 
or let7b) and the control (miR-155) (error bars show 95% c.i.; cf. Material & Methods II.13). (Fig. III.10 A was contributed by 
Zhou Fang, bioinformati cian at the Berlin Insti tute for Medical Systems Biology, BIMSB, Robert-Rössle Str. 10, D-13125 Berlin, 
Germany)
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the latt er one, detecti on is irrespecti ve of whether regulati on occurs by changes in mRNA 
stability or at various steps during translati on (e.g. initi ati on or elongati on). In order to decipher 
how much control microRNAs exert explicitly on the transcripti onal and translati onal level, 
informati on on transcript levels is needed. To this end, in all pSILAC experiments the mRNA 
fold-changes between miRNA transfected and control samples were recorded in parallel by 
Aff ymetrix microarrays (cf. Material & Methods II.8 and II.15) at the beginning of the pulse 
labeling (t1 = 8 h) and at the end (t2 = 32 h). 
Exemplary for miR-1, Fig. III.11 A and B depicts the relati on between miRNA induced fold-
changes in protein producti on (measured by pSILAC) and at mRNA levels (measured with 
microarray) for thousands of genes in scatt er plots, separately for t1 and t2. Irrespecti ve of the 
ti me point, only very few genes had fold-changes of unequal sign and reasonable magnitude 
(≥ 1.3 fold), indicati ng that changes in protein producti on were also refl ected to a reasonable 
Fig. III.11 | miRNAs inhibit translati on on a genome-wide scale. (A) Changes in protein producti on between 8 and 32 h 
aft er miR-1 transfecti on with mRNA fold-changes at 8 h reveal poor overall correlati on. (B) mRNA levels at 32 h correlate 
remarkably well with changes in protein synthesis. (C) Overall fold-changes of mRNA levels and protein synthesis are similar 
(histograms). Reduced protein producti on and mRNA levels correlate with seed frequency (curves represent proteins ranked 
by fold-change and grouped into bins of 250) (D) Translati onal repression by miRNAs is revealed by subtracti ng mRNA log 
changes from log changes in protein producti on. Increased seed frequency, averaged as in (C), correlates with translati onal 
repression. Results shown for pooled data (C, D) aft er discarding genes with mRNA and pSILAC changes of unequal sign. (Fig. 
III.11 C and D were contributed by Nikolaus Rajewsky, scienti fi c head of Berlin Insti tute for Medical Systems Biology, BIMSB, 
Robert-Rössle Str. 10, D-13125 Berlin, Germany)
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extent at steady-state mRNA levels. This applied in parti cular to the later ti me point t2  were the 
correlati on between mRNA fold-changes and pSILAC fold-changes became bett er compared to 
t1. Several genes with down-regulated protein producti on but litt le mRNA fold-changes at t1 
obviously shift ed towards greater mRNA fold-changes at t2. Hence, at the fi rst ti me point t1 
miR-1 had a stronger repressive eff ect on protein producti on than on mRNA levels. Similar 
overall eff ects could be obtained for other miRNAs (cf. Supplementary Fig. VII.2). Altogether, 
the considerable scatt er given by changes in protein producti on and mRNA levels indicated 
substanti al and widespread post-transcripti onal regulati on of gene expression upon microRNA 
over-expression.
As already apparent from the scatt er plot at t2, closer inspecti on of fold changes measured 
by either microarray or pSILAC revealed similar overall frequency distributi ons (cf. Fig. III.11 
C, lower panel). Plotti  ng the average number of seeds per gene in bins of 250 genes against 
their changes in mRNA levels and protein producti on revealed that seed frequency was higher 
for more highly down-regulated genes (cf. Fig. III. 11 C). More precisely, for down-regulated 
genes log2 fold-changes in protein producti on and mRNA abundance were linearly correlated 
with the average number of seeds present in corresponding 3´UTRs. This confi rms that the 
presence of seed sites is crucial for microRNA mediated down-regulati on of gene expression. 
Unexpectedly, the slope of the curve representi ng pSILAC fold changes in Fig. III.11 C (upper 
panel) was steeper than for corresponding changes in mRNA levels. This fi nding suggests 
that on a genome-wide level, miRNAs apparently exert a stronger direct eff ect on the down-
regulati on of protein producti on than on mRNA levels alone. To quanti fy this eff ect more 
directly, for each gene the log2 fold change in mRNA level were subtracted from the log2 
fold change in protein synthesis and plott ed as a functi on of average seed numbers  per gene 
(cf. Fig. III.11 D). In doing so, the linear decline of the obtained curve towards the regime of 
equal fold-changes revealed for the fi rst ti me ever on a genome-wide scale the degree of 
translati onal control exerted by a single microRNA (miRNA-1). Hence, in additi on to mediati ng 
mRNA down-regulati on presumably via mRNA destabilizati on (LIM et al., 2005), the seed also 
mediates direct repression of protein translati on for hundreds of genes.
An endogenous miRNA knock-down confirms overex-III.2.4.  
pression experiments 
Transfecti on of single microRNAs into HeLa cells had a widespread impact on protein synthesis. 
However, one could argue that ectopic over-expression of large amounts of a miRNAs 
represents a non-physiological conditi on thereby challenging the fi ndings. To address this 
issue, the opposite strategy, that is, the knock-down of a highly expressed endogenous miRNA 
was performed (cf. Material & Methods II.8). To this end, locked nucleic acids (LNAs) (STENVANG 
et al., 2008; WAHLESTEDT et al., 2000) were used to knock-down miRNA let-7b followed by 
measuring changes in protein producti on by pSILAC. 
When comparing let-7b over-expression and knock-down a remarkable anti -correlati on for 
changes in protein producti on was apparent (cf. Fig. III.12 A). Anti -correlati on was even more 
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evident when averaging fold-changes for the over-expression and knock-down experiment over 
bins of 20 genes (cf. Fig. III.12 A insert). Though overall log2 fold changes upon knock-down 
were somewhat smaller as in the over-expression experiment, fl ipping the sign of pSILAC fold 
changes revealed converse regulati on for the vast majority of proteins. These fi ndings strongly 
suggest that the performed over-expression experiments of all tested microRNAs did also 
provide physiologically relevant results. 
Intriguingly, anti -correlati on did not only apply to seed-containing genes but also to the 
majority of all ~2,700 proteins quanti fi ed in both experiments. For example, when considering 
all ~130 proteins with a fold-change of at least 15% in both the over-expression and knock-
down experiment, the vast majority of them was “consistently” regulated, that is, those genes 
were up in one of the experiments but down in the other irrespecti ve of seeds (cf. Fig. III.12 B). 
Hence, both direct and indirect eff ects were obviously reversed. 
Altogether, the results indicated that up- and down-regulati on of stati onary let-7b levels had 
largely complementary eff ects on the proteome, i.e. let-7b levels can obviously tune protein 
producti on from thousands of genes.
Fig. III.12 | Endogenous knock-down of miRNA-let 7b. (A) Scatt er plot of changes in protein producti on in the let-7b over-
expression (OE) versus the let-7b knock-down (KD) experiment. The insert shows the same data, averaged over bins of 20 
genes. (B) “consistent” refers to proteins with pSILAC fold-changes (of at least 15%) that were up-regulated in one experiments 
but down in the other, “inconsistent” to all other cases. “miRNA target consistent” is the subset of “consistent” proteins which 
were down-regulated in the over-expression experiment but up in the knock-down.
B
all proteins proteins with
seed
proteins without
seed
# 
pr
ot
ei
ns
all data
consistent
inconsistent
miRNA target consistent
0
20
40
60
80
100
120
140A
log2 fold change of miR let7b OE
lo
g2
 fo
ld
 c
ha
ng
e 
of
 L
N
A
 le
t7
b 
K
D
-1 -0.5  0  0.5  1
-1
-0.5
 0
 0.5
 1
-1
-0.5
 0
 0.5
 1
-1 -0.5  0  0.5  1
- 71 -
Genome-wide parallel quantification of III.3. 
mRNA and protein turnover and levels in 
mammalian cells
Combined metabolic labeling of newly-synthesized RNA III.3.1.  
and proteins enables determination of half-lives
In order to measure protein and mRNA turnover in the exact same populati on of exponenti ally 
growing, non-synchronized mouse fi broblasts (NIH3T3 cells), metabolic pulse labeling with 
heavy-stable amino acids and 4sU were simultaneously applied (cf Fig. III.13 and Material & 
Methods II.17). 
Determination of cellular protein half-livesIII.3.1.1 
Subconfl uent cells grown in light (L) SILAC medium were transferred to heavy (H) SILAC medium 
and incubated for diff erent lengths of ti me to account for heterogenous protein turnover. While 
low turnover proteins require labeling ti mes of several hours to arrive at protein amounts in 
the heavy form that can be accurately quanti fi ed by mass spectrometry, the opposite applies to 
proteins with relati vely short half-lives. For high turnover proteins, short-term labeling avoids 
that the heavy protein form vastly exceeds the light form and hence limit the traceability of the 
Newly- 
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Fig. III.13 | Parallel quanti fi cati on of mRNA and protein turnover. Mouse fi broblasts were simultaneously pulse-labeled 
with heavy-stable amino acids (SILAC, left ) for diff erent lengths of ti me (t1=1.5 h, t2=4.5 h and t3=13.5 h) and the nucleoside 
analogue 4-thiouridine (4sU, right) for 2 h. Protein turnover was quanti fi ed by mass spectrometry based on H/L rati os refl ecti ng 
individual protein synthesis. For determinati on of transcript half-lives, total RNA was fracti onated into newly-synthesized and 
pre-existi ng RNA which were separately subjected to next-generati on sequencing (SOLEXA Sequencing). 
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H/L rati o. To cover a reasonable ti me range, protein samples were harvested at three diff erent 
ti me points (1.5 h, 4.5 h and 13.5 h) upon transfer to heavy SILAC medium and analyzed by 
high resoluti on mass spectrometry (cf. Material & Methods II.24.1 and II.24.4).
Representati ve mass spectra of pepti des derived from two proteins with disti nct turnover 
rates indicated by deviant incorporati on rates of the heavy label are depicted in Fig. III.14 A 
and B. The heavy form of the Ribonucleoside-diphosphate reductase subunit M (Rrm2) was 
rapidly increasing over ti me compared to the light pepti de, resulti ng in a H/L rati o of greater 
then ten aft er labeling for 13.5 h. As opposed to this, the Histone H1.2 (Hist1h1c) displayed a 
rather moderate shift  from the light to the heavy form, denoti ng the protein´s turnover to be 
lower than that of Rrm2.
Robust quanti fi cati on, however, relies not only on the instrument´s capability to precisely 
measure H/L rati os, it also necessitates that the rati os themselves are reliable. In this regard, 
parti cularly the height of the light pepti de peak can be over-esti mated for two reasons: First, 
cellular degradati on of light proteins aft er transfer to heavy medium can result to some degree 
in recycling of light amino acids. Thus, newly-synthesized proteins will not exclusively appear 
in the heavy form. Second, remaining light amino acids from the cellular precursor pool can 
also be used for protein synthesis, again resulti ng in an under-esti mati on of the heavy pepti de 
form. Since both events potenti ally compromise subsequent calculati on of protein half-lives, 
they had to be thoroughly addressed. 
Fortunately, the degree of light amino acids (re-)used for de novo protein synthesis in cells 
transferred to heavy SILAC medium can be evaluated by closer inspecti on of mass spectra 
obtained from heavy, missed cleaved trypti c pepti des (trypsin cleaves with high specifi city 
Fig. III.14 | Mass spectra of pepti des derived from proteins with diff erent turnover ti mes. While the H/L rati o of the 
Ribonucleoside-diphosphate reductase subunit M (Rrm2) showed a rapid increase over ti me (A), the Histone H1.2 (Hist1h1c) 
exhibited a rather moderate augmentati on (B). The shift  from the light to the heavy pepti de form can therefore be used as a 
measure for protein turnover.
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aft er lysine (K) and arginine (R) residues). Under ideal labeling conditi ons, such missed cleaved 
pepti des carry one additi onal heavy lysine or heavy arginine moiety (HKHR) which doubles the 
mass diff erence to the corresponding unlabeled, light pepti de (cf. Fig. III.15 A and B). However, 
if only parti al heavy labeling of a missed cleaved pepti de due to the presence of light amino 
acids was achieved, an additi onal pepti de mass between the doubly light labeled and the 
doubly heavy labeled pepti de occurs (HK or HR). The extent of such a missed cleaved and 
parti ally heavy labeled pepti de is indicati ve of the magnitude of (re-)use of light amino acids 
for protein synthesis. Exemplary for the transcripti on factor jun-B (JunB) and the DNA damage-
binding protein 1 (DdB1), Fig. III.15 A and B show that in fact parti ally heavy labeled pepti des 
could be observed. Yet these peaks were small, i.e. less than 10% of the doubly heavy peaks, 
suggesti ng that only a small fracti on of newly synthesized pepti des contained recycled and/or 
remaining light precursors.
In total, 1,471,375 fragment spectra were acquired that resulted in 229,985 pepti de 
identi fi cati ons (84,924 unique pepti de sequences). These pepti des were assigned to 6,445 
unique proteins (FDR < 1%, cf. Material & Methods II.24.5). At least three H/L pepti de rati os 
per protein over all ti me points were required for quanti fi cati on, which was met by 5,279 
proteins. Since most of the proteins were quanti fi ed at two or all three ti me points, protein 
half-lives were calculated based on linear regression applied to all H/L rati os obtained for each 
protein (cf. Material & Methods II.29.1). Fig. III.16 A exemplifi es linear regression for Rrm2 
and Hist1h1c. Though for most proteins the correlati on was very good, only proteins with 
an excellent correlati on (R2 ≥ 0.9) were kept for further analysis (cf. Fig. III.16 B). By doing 
so, 5,066 proteins remained and were used for individual half-life calculati ons. Of note, half-
Fig. III.15 | Uniform incorporati on of heavy amino acids. Protein turnover can be under-esti mated due to the presence of 
light (L) amino acids that remain in the precursor pool aft er transferring cells to heavy (H) SILAC medium (e.g. by recycling). 
The degree of L amino acids incorporated aft er transferring cells to H medium can be evaluated by inspecti on of mass spectra 
of missed cleaved trypti c pepti des which contain two labeled amino acids (K=lysine, R=arginine). In case of complete labeling 
newly-synthesized pepti des should contain only heavy lysine and heavy arginine residues (HKHR). Additi onal peaks containing 
only one heavy amino acid (HK or HR, marked in red) are indicati ve of light amino acids incorporated aft er medium exchange. 
The fi gure shows mass spectra of missed-cleaved pepti des from a high (JunB, A) and a medium (Ddb1, B) turnover protein at 
all three ti me points. In some cases, parti ally heavy labeled pepti des were observed.
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lives were also computed for proteins quanti fi ed at a single ti me-point only. Although linear 
regression was not applicable in these cases, robustly quanti fi ed single H/L protein rati os, 
that is, requiring at least three pepti de rati os at that ti me point allowed to include them in 
the analysis (cf. Material & Methods II.29.1). Individual H/L rati os obtained from up to the 
three ti me points refl ect the net outcome of a protein´s synthesis and degradati on. Assuming 
exponenti al decay on the one hand and a doubling of the overall protein amount during one 
cell cycle on the other hand enabled the calculati on of individual degradati on rate constants 
(kd) and eventually protein half-lives (cf. Material & Methods II.29.1). 
The overall distributi on of cellular protein half-lives is depicted by the histogram in Fig. III.16 
C. Protein half-lives ranged from below one to several hundred hours with a median of 45 h. 
For validati on purpose, protein stability of proteins spanning a range from one to 60 h was 
assessed by cycloheximide-chase experiments (cf. II.16 and II.25 and) (cf. Fig. III.16 D). Esti mated 
protein stabiliti es of selected candidates were overall in good concordance with turnover ti mes 
obtained by the SILAC approach. For instance, the cycloheximide-chase experiment denoted 
Fig. III.16 | Calculati on and validati on of protein half-lives. (A) Protein half-lives were calculated from log H/L rati os at all 
three ti me points using linear regression as shown for the proteins Rrm2 and Hist1h1c. As a quality test of linear regression, 
the coeffi  cient of determinati on (R2) was calculated. (B) Protein half-lives were only calculated for fi ts that sati sfi ed R2 ≥ 0.9. 
This criteria was met by 4,906 proteins. (C) Histogram of all calculated protein half-lives. (D) Comparison of protein half-lives 
measured by SILAC and traditi onal cycloheximide-chase experiments. (Fig. III.16 A and B were contributed by Dorothea Busse, 
scienti st in the group of Jana Wolf termed “Mathemati cal Modelling of Cellular Processes” at the Max-Delbrück-Centrum for 
Molecular Medicine (MDC, Robert-Rössle Str. 10, D-13125 Berlin, Germany)
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the Cyclin D1 protein (Ccnd1) to be highly unstable, i.e. the protein was almost fully degraded 
aft er 2 h. Similarly, the CCAAT/enhancer-binding protein beta (Cebpβ) was barely detectable 
8 h upon blockage of protein synthesis via cylcloheximide. Both observati ons matched very 
well to the SILAC-based determinati on of half-lives, where for Cyclin D1 and Cebpβ turnover 
ti mes of 0.8 h and 6 h were computed, respecti vely.   
Determination of cellular mRNA half-livesIII.3.1.2 
In parallel to metabollic labeling of proteins, newly synthesized RNA was pulse-labeled for 2h 
with 4sU essenti ally as described previously (DOELKEN et al., 2008) (cf. Material & Methods 
II.17). Total RNA samples were fracti onated into the newly-synthesized and pre-existi ng RNA 
fracti ons (cf. Material & Methods II.18.1 and II.18.2). In order to validate the separati on 
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Fig. III.17 | Overall distributi on and validati on of mRNA half-lives. (A) Separati on effi  ciency of total RNA into newly-synthesized 
(eluate) and pre-existi ng (fl ow through, FT) RNA fracti ons was validated by combined 4sU and 3H-cyti dine labeling. The input 
refers to the summed radioacti vity of all fracti ons (fl ow through, wash, eluate and beads) and was set to 100%. (DPM = decay 
per minute) (B) Overall distributi on of measured mRNA half-lives with a median half-life of 9 h. (C) A total of 19 RNA-Seq 
measurements of eluate/fl ow-through rati os (i.e. newly-synthesized RNA/pre-existi ng RNA rati os) were reexamined using 
quanti tati ve RT-PCR (qRT-PCR). (D) Comparison of mRNA half-lives in NIH3T3 cells obtained in this study to publicly available 
half-lives measured with microarrays (DOELKEN et al., 2008) for the same cell line.
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effi  ciency newly-synthesized RNA was co-labeled by 4sU and radioacti ve cyti dine (3H-cyti dine, 
cf. Material & Methods II.18.3). Aft er bioti nylati on and column-based affi  nity purifi cati on up 
to 70% of the radioacti vity was found in the fracti on of newly-transcribed RNA (Eluate, cf. 
Fig. III.17 A). By contrast, the bulk of radioacti vely labeled RNA was found in the fl ow through 
fracti on when labeling with 4sU was omitt ed.
Both fracti ons (newly-synthesized and pre-existi ng fracti ons) and the total RNA sample were 
analyzed by mRNA sequencing on a Solexa platf orm (cf. Material & Methods II.19). mRNA 
half-lives were calculated based on the rati os of newly-synthesized RNA/total RNA and pre-
existi ng RNA/total RNA essenti ally as described previously (DOELKEN et al., 2008; cf. Material 
& Methods II.20). In total, for 12,629 genes mRNA half-lives could be determined. The overall 
distributi on of cellular transcript half-lives for genes also detected at the protein level is shown 
by the histogram in Fig. III. 17 B. mRNA turnover ranged from 1 to 500 hours with a median of 9 
h. For validati on purpose, the eluate/fl ow-through rati os (i.e. the newly-synthesized RNA/pre-
existi ng RNA rati os) measured by RNA-Seq of 19 randomly selected mRNAs were independently 
quanti fi ed by qRT-PCR (cf. Material & Methods II.22). The obtained results agreed well (Pearson 
R=0.69) with the sequencing data (cf. Fig. III.17 C). In additi on, the calculated mRNA half-lives 
were consistent (Pearson R=0.64) with previously published data for NIH3T3 cells (DOELKEN et 
al., 2008) obtained by conventi onal microarrays (cf. Fig. III. 17 D). 
Sequence characteristics affecting mRNA and protein III.3.2.  
stability
It has been shown that mammalian mRNA and protein stability are regulated, in part, by the 
presence or absence of regulatory elements (WILUSZ et al. 2001; YANG et al., 2003; ROGERS 
et al., 1986; DICE, 1987). Such sequence features are thought to be specifi cally recognized by 
multi protein complexes governing cellular RNA or protein degradati on (KEENE, 2007; BARREAU 
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Fig. III.18 | Sequence moti fs aff ecti ng mRNA stability. mRNA half-lives were binned in groups of 100 genes and plott ed 
against the number of AU-rich elements (AREs) or Pumilio 2 (Pum2) binding sites in corresponding 3´UTR regions (A and B, 
upper panel). The negati ve correlati on was sti ll clearly apparent aft er correcti on for diff erent 3´UTR lengths to account for 
stochasti c moti f occurrences (A and B, lower panel). 
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Ι PAILLARD, 2005; DYSON AND WRIGHT, 2005). 
With regard to mRNA decay, amongst the most intensively studied sequence determinants 
driving mRNA degradati on are cis-regulatory moti fs termed AU-rich elements (AREs; stretches 
consisti ng of mainly adenine and uracil nucleoti des) predominantly found in 3´UTR regions. 
AREs were shown to be bound by numerous proteins to normally shorten mRNA life span 
(Shaw & Kamen, 1986; BARREAU et al., 2006) or, in response to specifi c extracellular signals 
also extend mRNA life span (VASUDEVAN Ι STEITZ, 2007). Similarly, the RNA-binding protein 
Pumilio 2 (Pum2) has been proposed to control mRNA stability and translati on through its 
sequence-specifi c interacti on with the 3’UTR region of target mRNAs (WANG et al. 2002).
In order to test whether the presence of such sequence features also infl uenced mRNA stability 
in NIH3T3 cells, individual 3´UTRs were screened for the relati vely well-defi ned AU-rich core 
element (“ATTTA”; BARREAU et al., 2006) and Pumilio2 binding sites (“TGTA(A|T|C|G)ATA” with 
“I” referring to “or”; HAFNER et al., 2010). The number of moti fs for each 3´UTR was counted 
and plott ed as a functi on of binned transcript half-lives (cf. Material & Methods II.31). As 
shown in Fig. III.18 A and B (upper plots), the number of ARE and Pum2 moti fs found in 3´UTRs 
was negati vely correlated with mRNA stability. Of note, the negati ve correlati on also held true 
when ARE and Pum2 moti f densiti es (i.e. “moti fs per nucleoti de”) were computed to account 
for stochasti c moti f occurrences due to vastly diff erent 3´UTR lenghts (cf. Fig. III.18 A and B, 
lower plots).
Since several sequence features potenti ally aff ecti ng mRNA stability are primarily situated in 
untranslated regions of mRNAs (KEENE, 2007), the lengths of such regions themselves were 
negati vely correlated with mRNA stability. This applied especially to 3´UTR lengths (cf. Fig. 
III.19 A), and, to a lesser degree also to 5´UTR lengths (cf. Fig. III.19 B). As opposed to this, 
the lengths of the coding sequence (CDS) only exhibited a positi ve correlati on with mRNA 
half-lives (cf. Fig. III.19 C). 
Amongst diff erent degradati on or destructi on signals (termed degrons) directi ng proteins to 
the ubiquiti n-proteasome system, PEST-moti fs and intrinsically unstructured regions (IUPs) 
have been suggested. Proteins containing PEST regions, that is, sequence stretches of 10-50 
Fig. III.19 | Impact of 3´UTR, 5´UTR and CDS lengths on mRNA stability. Binned mRNA-halfl ives (in groups of 100 genes) were 
plott ed against corresponding, binned (A) 3´UTR, (B) 5´UTR or (C) CDS sequence lengths.
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amino acids enriched in proline (P), glutamic acid (E), serine (S), and threonine (T) tend to 
be turned over rapidly (ROGERS et al., 1986; DICE, 1987) although the underlying mechanism 
remain elusive. Similarly, sequence segments enriched in most polar and charged residues but 
depleted of hydrophobic residues are considered to correlate with low protein stability. Those 
sequence stretches are assumed to be largely intrinsically disordered and hence extremely 
suscepti ble to proteolyti c degradati on (TOMPA, 2002; TOMPA et al., 2008; GSPONER et al., 
2008). 
The defi niti on of disordered regions of amino acid sequences based on the primary structure 
alone is, however, a fairly complex endeavour, since also spati al circumstances (i.e.  secondary 
and terti ary structure) considerably impact on protein degradati on. As a proxy for a protein´s 
“unstructuredness”, a publicly available mouse protein database was used that predicts 
potenti ally disordered residues in a context-specifc manner and also assigns confi dence 
values accordingly (cf. Material & Methods II.31). Comparing the overall unstructuredness of 
individual proteins with their protein half-life revealed a marked negati ve correlati on. Thus 
the degree of disorder obviously aff ects protein stability (cf. Fig. III.20 A). Interesti ngly, this 
negati ve correlati on in mouse fi broblasts was stronger than in yeast, where structural disorder 
served only as a weak signal for intracellular protein degradati on (TOMPA et al., 2008).
The assignment of PEST moti fs in amino acid sequences is also challenging, since the enrichment 
of respecti ve amino acids cannot be detected by a straightf orward search for linear sequence 
moti fs (as for AU-rich elements, see above). Alternati vely, relati ve fracti ons of amino acids per 
protein can be computed and compared to protein lifeti mes (cf. Material & Methods II.31). 
The degree of correlati on (given by the Spearman´s Rank coeffi  cient) can then be used to 
investi gate whether the presence of certain amino acids, such as P, S, and T in proteins with 
specifi c turnover characteristi cs deviates from mere stochasti c occurrence. As shown in Fig. 
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Fig. III.20 |Degradati on signals with an impact on protein stability. (A) The degree of disorder of each protein (in bins for 100 
genes) was plott ed against corresponding, binned protein half-lives. (B) The bar plot shows to what degree relati ve fracti ons 
of amino acids correlate to protein turnover. For instance, the amino acid proline frequently occurs in unstable proteins, given 
by highly signifi cant Spearman´s Rank coeffi  cient (* indicates p-values < 0.05 but ≥ 0.01; *** indicates p-values < 0.001)
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III.20 B, the relati ve fracti ons of amino acids associated with the PEST moti f exept for Threonin 
(T, Thr) were inversely correlated with protein stability indicated by stati sti cally signifi cant 
Spearman´s Rank coeffi  cients. Hence, due to the high stati sti cal signifi cance of prolin and 
serine densiti es, the results support at least parti ally the destabilizing eff ect of the PEST moti f, 
which is also in accordance with previous results derived from yeast protein half-lives (BELLE 
et al., 2006).
Estimating cellular protein and mRNA levelsIII.3.3.  
In additi on to mRNA and protein half-lives, parallel mRNA sequencing and mass spectrometry 
also allowed to esti mate cellular mRNA and protein copy numbers. Absolute cellular transcript 
and protein concentrati ons were deduced from the very same RNA-Seq and mass spectrometry 
data used for calculati on of half-lives. Hence, this is the fi rst ti me ever that half-lives and levels 
were quanti fi ed for the exact same set of cells, thereby excluding errors oft enti mes emerging 
from integrati ng experimental data from diff erent sources.
Absolute mRNA quantificationIII.3.3.1 
Most available mRNA expression data is based on traditi onal microarrays. Recently, next 
generati on sequencing emerged as more precise and reliable approach for mRNA quanti fi cati on. 
The number of reads per kilobase of exon per million mapped sequence reads (RPKM) provides 
a digital measure of cellular mRNA levels (MORTAZAVI et al., 2008; PEPKE et al., 2009). Combined 
with informati on about cellular mRNA content, RPKM values were used to calculate absolute 
cellular mRNA copy numbers essenti ally as described previously (MORTAZAVI et al., 2008; cf. 
Material & Methods II.21). 
Absolute protein quantification by intensity-based absolute III.3.3.2 
quantification (iBAQ)
As menti oned in the introducti on part, several methods have been developed in order to 
determine absolute protein levels by mass spectrometry. In essence, spectral counti ng-based 
methods like PAI, empAI and APEX rely on the observati on that abundant proteins are also 
represented by a large number of pepti des. This results in a higher number of spectral counts 
in a shotgun experiment compared to proteins with lower concentrati ons. In contrast, XIC 
(extracted ion chromatogram)-based approaches make use of a pepti de intensiti es to deduce 
absolute protein levels. 
To systemati cally benchmark the prevailing methods for absolute protein quanti fi cati on, 
a well-defi ned reference sample was employed. A suitable measure for absolute protein 
abundance should be independent of protein sequence and provide accurate data over several 
orders of magnitude. Furthermore, quanti fi cati on should not be aff ected by overall sample 
complexity. Sigma-Aldrich recently developed an improved Universal Proteomics Standard 
(UPS2) comprising 48 precisely quanti fi ed human proteins formulated into a dynamic range 
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of concentrati ons spanning six orders of magnitude. These 48 proteins were used either alone 
or in combinati on with diff erent amounts of E. coli lysate to obtain reference samples of high 
dynamic range which simulate the complexity of biological probes (cf. Material & Methods 
II.25 and II.26). All samples were subjected to in-soluti on digests and analyzed by LC-MS/MS in 
triplicates (cf. Material & Methods II.24.2 and II.24.4).
Depending on the individual experiment between 20 and 28 of the standard proteins over three 
to six orders of magnitude were identi fi ed with very high confi dence (cf. Material & Methods 
II.24.5). By plotti  ng the known amounts of standard proteins against diff erent measures for 
absolute protein abundance followed by calculati on of the coeffi  cient of determinati on R2, the 
performance of the existi ng diff erent methods for absolute protein quanti fi cati on was assessed 
(cf. Fig. III.21 and Supplementary Fig. VII.3). Since R2 refl ects to what extent the variati on in 
one variable can be explained by changes in another variable, raw spectral counts explained 
only around 40-60% of the diff erences in absolute amounts. Correcti ng spectral counts for the 
number of observable pepti des (PAI) or protein observability scores (APEX) boosted this value 
to 80-90%. In contrast to these spectral counti ng-based approaches, the sum of pepti de peak 
intensiti es explained already 80% of absolute protein abundance levels without any additi onal 
correcti on. Intensiti es of the three most intense pepti des per protein (TOP3) slightly improved 
the correlati on but also resulted in a smaller number of quanti fi able proteins as not all proteins 
were detected with three diff erent pepti des (not shown). Intriguingly, the best correlati on with 
absolute protein amounts was achieved by simply dividing the sum of all pepti de intensiti es by 
the number of theoreti cally observable pepti des. This method was termed iBAQ for intensity-
based absolute quanti fi cati on. Depending on the individual experiment iBAQ explained between 
Fig. III.21 | Intensity-based absolute quanti fi cati on (iBAQ). Correlati on between spectral counti ng-based (grey) or intensity-
based (black) methods of absolute quanti fi cati on and known amounts of standard proteins (error bars: SEM). 48 precisely 
quanti fi ed standard proteins (UPS2) either measured alone or mixed with E. coli lysate in diff erent rati os followed by digesti on 
and LC-MS/MS analysis in triplicates.
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90 and 95% of the diff erences in absolute protein amounts. Importantly, iBAQ signifi cantly 
outperformed the other tested approaches in all experiments (p < 0.002, one-tailed Wilcoxon 
signed rank test using all nine R2 values from technical and biological replicates).
Since the iBAQ approach was applicable to the mass spectrometry measurements used to 
compute protein half-lives, an accurate proxy for protein levels could be obtained from the 
very same data set. By taking into account informati on about the number of cells used in the 
experiment, protein concentrati ons obtained by iBAQ were eventually converted into cellular 
protein copy numbers (cf. Material & Methods II.26).
Correlation of protein and mRNA levels and half-livesIII.3.4.  
A direct comparison of mRNA and protein half-lives is depicted in Fig. III.22 A. Transcript 
lifeti mes displayed a signifi cantly smaller spread compared to protein half-lives. While mRNAs 
spanned a litt le more than two orders of magnitude, protein turnover was spread over more 
than fi ve orders of magnitude. Inspecti on of the histogram showing cellular mRNA and protein 
copy numbers revealed that proteins with a median copy number per cell of 10,000 were on 
average ~650 ti mes more abundant than transcripts with a median copy number per cell of only 
15 (cf. Fig. III.22 B). Also, overall protein levels displayed a greater dynamic range compared to 
Fig. III.22 | mRNA and protein half-lives and levels. Histograms of mRNA (blue) and protein (red) half-lives (A) and levels 
(B). Proteins were on average fi ve ti mes more stable and approximately 650 ti mes more abundant than mRNAs and spanned 
a higher dynamic range. Correlati ons between mRNA and protein levels (C) and half-lives (D) were analyzed using scatt er 
plots.
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overall mRNA levels. While protein concentrati ons spanned almost six orders of magnitude, 
mRNA levels were spread over less than four orders of magnitude. Relati vely few proteins had 
less than 100 copies per cell, suggesti ng that the analysis was somewhat biased against lowly 
expressed proteins. Comparing mRNA levels of detected and undetected proteins revealed 
a mild detecti on bias (cf. Supplementary Fig. VII.4) suggesti ng that the true dynamic range 
of protein levels can be expected to 
be even higher. For that reason, all 
further analysis were restricted to the 
subset of genes that was identi fi ed at 
both the mRNA and protein level.
However, apart from the diff erence 
in dynamic range, the scatt er plot 
demonstrates that overall mRNA 
and protein levels were clearly 
correlated (cf. Fig. III.22 C, R2 = 0.40 at 
log-log scale). Though this fi nding is 
consistent with earlier observati ons, 
the degree of correlati on is higher 
than any previous large scale study 
in mammals (reviewed in: DE SOUSA 
ABREU et al., 2009), indicati ng 
that parallel mRNA and protein 
quanti fi cati on provides accurate data. 
Nevertheless, since the data is also 
aff ected by technical noise, the true 
correlati on is expected to be higher. 
The coeffi  cient of determinati on (R2 
= 0.40) indicates that at least 40% 
of variance in protein levels can be 
explained by diff erences in mRNA 
levels. Interesti ngly, this value is lower 
than in yeast (73%) (LU et al., 2007), 
which may suggest a larger extent 
of post-transcripti onal regulati on 
occurring in mammalian cells. 
In contrast to levels, a correlati on 
between mRNA and protein half-
lives was virtually absent (cf. Fig. 
III.22 D, R2= 0.01). Thus, many stable 
proteins have unstable mRNAs 
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Fig. III.23 | Functi onal characteristi cs of genes with diff erent mRNA and 
protein half-lives. Genes were grouped according to their combinati on of 
mRNA and protein half-lives and analyzed for enriched biological functi ons 
according to gene ontology. A heatmap was used to visualize hierarchical 
clustering of z-transformed p-values of signifi cantly over-represented 
biological terms of genes with similar half-life characteristi cs.
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and vice versa. To test whether this seemingly random distributi on yet contains biologically 
relevant informati on, the plot was divided into certain regimes comprising gene subsets with 
diff erent combinati ons of mRNA and protein half-lives. Altogether, four regimes were defi ned 
with disti nct mRNA/protein half-lives distributi ons (cf. Fig. III.23, scatt er plot and Material & 
Methods II.27) with (i) stable mRNAs and stable proteins, (ii) unstable mRNAs and unstable 
proteins, (iii) stable mRNAs but unstable proteins and fi nally (iv) unstable mRNAs but stable 
proteins. Next, the defi ned gene subsets were individually subjected to gene ontology analysis 
(ASHBURNER et al., 2000) to examine whether a putati ve over-representati on of functi onal 
terms (cf. Material & Methods II.27). P-values of enriched biological terms were z-transformed 
and organized and visualized using hierarchical clustering (cf. Fig. III.23, heatmap).
Genes with both stable mRNAs and proteins were primarily involved in consti tuti ve cellular 
processes like translati on (i.e. ribosomal proteins), respirati on and central metabolism 
(glycolysis, citric acid cycle). Hence, many highly expressed “house-keeping” genes tended to 
encode stable mRNAs and proteins. In contrast, the subset with unstable mRNAs and proteins 
was strongly enriched for dynamically regulated genes such as transcripti on factors, chromati n 
modifying enzymes and genes with cell cycle-specifi c functi ons. Thus, many regulatory genes 
had low mRNA and protein half-lives. Intriguingly, genes with stable proteins but unstable 
mRNAs were involved in processing of mRNAs, tRNAs and non-coding RNAs. This suggests that 
many mammalian RNA-binding proteins are stable while their encoding transcripts tend to be 
short-lived, as noted recently for yeast (MITTAL et al., 2009). Finally, the set of genes with high 
mRNA and low protein stability was enriched in extracellular proteins. This is expected since 
secreted proteins have short cellular half-lives. Additi onally, this subset contained proteins 
involved in cellular homeostasis, defense response and proteolysis. 
In summary, the analysis showed that mRNA and protein half-lives are not independent. 
Instead, genes seem to have evolved specifi c combinati ons of mRNA and protein half-lives 
under functi onal constraints.
Half-lives substantially determine gene expression kineticsIII.3.4.1 
mRNA and protein half-lives are important parameters that shape the dynamic properti es of 
gene expression (LEGEWIE et al., 2008; SHALEM et al., 2008; PRICE et al., 2010). Hence, some 
genes may have evolved specifi c combinati ons of mRNA and protein half-lives in order to 
respond expediti ously to an external signal. Along these lines, mRNA stability was recently 
shown to play a criti cal role in gene inducti on under several conditi ons in mammals (HAO Ι 
BALTIMORE et al., 2009; FRIEDEL et al., 2009; ELKON et al., 2010). However, the above presented 
fi ndings regarding protein and mRNA half-lives (cf. III.3.4) suggest that also protein turnover 
plays a pivotal role in shaping the kineti cs of gene expression. Protein half-lives were on average 
considerably longer than corresponding mRNA half-lives and, in additi on, only marginally 
correlated to those. Thus, a measure with a predicti ve value for the kineti cs of gene expression 
upon perturbati ons should ideally account for both, mRNA and protein stability. 
When subjected to an abrupt change in the environmental conditi on, cells typically re-confi gure 
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gene expression followed by a transiti on into a new steady-state which is oft enti mes diff erent 
from the original “resti ng” state. The ti me that describes how fast protein levels relax towards 
the steady-state aft er perturbati on can be mathemati cally expressed by so called response 
ti mes τ (cf. Material & Methods II.29.3) (HEINRICH Ι SCHUSTER, 1996). Since response ti mes are 
solely determined by mRNA and protein decay rates, they depend on both if the protein and 
the mRNA half-lives are of similar magnitude, while it is mainly set by the slowest decay rate in 
case mRNA and protein stability diff er signifi cantly from each other (LEGEWIE et al., 2008). 
The overall distributi on of response ti mes calculated on the basis of mRNA and protein half-
lives in the present study is shown in Fig. III.24 A. Notably, the ti me-scale of response ti mes 
was more similar to the ti me-scale of protein than mRNA half-lives (cf. Fig.III.22 A), indicati ng 
that protein turnover signifi cantly infl uences the inducti on kineti cs and therefore the temporal 
patt ern of gene expression. Consistently, plotti  ng response ti mes as functi on of protein half-
lives revealed that mRNA stability can only aff ect gene expression dynamics if protein stability 
is small, that is protein half-lives < ~ 20 h (cf. Fig. III.24 B).
In order to elucidate how the response ti mes of genes relate to their biological functi ons, 
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median response ti mes for the four combinati ons of mRNA and protein half-lives used in 
chapter III.3.7 were computed (cf. Fig. III.24 C). Both gene subsets with high protein stability 
(i.e. the subset with high mRNA and high protein stability and the subset with low mRNA 
but high protein stability) also displayed relati vely high response ti mes compared to regimes 
comprising genes with lower protein stability (cf. Fig. III.24 C). Hence, genes involved in “house-
keeping” functi ons but also in various RNA-processing steps tend to have rather sluggish and 
inert gene expression kineti cs (cf. Fig. III.23). As those genes can be expected to respond 
slowly and delayed upon environmental changes, fl exibility in terms of a fast adaptati on of 
gene expression of those proteins is most likely not criti cal to the survival of the organism. The 
converse was true for genes given by regimes containing genes involved in cell cycle control, 
transcripti on but also immune defense and phosphorylati on (i.e. gene subsets with high mRNA 
and high protein turnover and gene subsets with low mRNA but high protein turnover, cf. Fig. 
III.23 and III.24 C ). Those had relati vely short response ti mes which is largely att ributable to 
their signifi cantly shorter protein lifeti mes. If in additi on to short protein half-lives genes also 
had low mRNA stabiliti es, response ti mes were shortest. In that case, rapidly induced changes 
in gene expression can obviously eff ecti vely transmit to aff ect the protein output.
Altogether, the results indicate that mRNA and protein half-lives have evolved under temporal 
constraints. Half-lives obviously opti mize the expression kineti cs of genes mediati ng the 
cellular response and adaptati on to environmental changes with regard to temporal fl exibility 
and rapidity.
Half-lives optimize gene expression towards energy constraintsIII.3.4.2 
In lower organisms, energy costs keep transcripti on and translati on rates under selecti ve 
pressure (WAGNER, 2005). Energy consumpti on may therefore also be an important parameter 
that constrains mRNA and protein half-lives in mammals. Based on the acquired data, the 
theoreti cal energy required to synthesize mRNAs (i.e. primary transcripts) and proteins 
from their building blocks (nucleoti de monophosphates and amino acids, respecti vely) were 
calculated in terms of high energy phosphates (cf. Material & Methods II.30). Notably, this 
calculati on is naturally an oversimplifi cati on since the energy consumpti on of other cellular 
processes like nucleoti de and amino acid synthesis, splicing and transport is not known in 
fi broblasts. Due to the high dynamic range of protein levels, overall energy costs (summed 
costs for mRNA and protein synthesis) were primarily determined by protein translati on. 
Specifi cally, protein synthesis consumed about 95% of the energy budget while only ~ 5% was 
needed for transcripti on (data not shown).
Given the high costs of protein synthesis it was obvious to ask whether this process is opti mized 
to minimize cellular energy consumpti on. Energy costs for protein translati on depend on 
protein abundance, half-life and length with abundance being the most important factor since 
protein levels showed the highest dynamic range (cf. Fig. III.22 B). Thus, abundant proteins 
should have in general higher half-lives than less abundant ones to minimize cellular energy 
consumpti on. To this end, proteins were divided into three abundance classes and analyzed 
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with regard to their protein half-lives and protein sequence lengths. The analysis revealed that 
abundant proteins were indeed signifi cantly more stable than less abundant ones (cf. Fig. III.25 
A, p<10-15, Wilcoxon test). Likewise, abundant proteins were also signifi cantly shorter (cf. Fig. 
III.25 B, p<10- 15). These observati ons are consistent with the hypothesis that mammalian protein 
half-lives and lengths evolved under energy constrains. In order to prove this hypothesis, all 
parameters were individually shuffl  ed (cf. Fig. III.25 C). Remarkably, shuffl  ing protein half-lives 
and lengths markedly increased theoreti cal energy consumpti on, whereas randomizing mRNA 
half-lives or lengths of primary transcripts had almost no impact. According to the functi onal 
analysis performed above (cf. III.3.4.1), predominantly abundant “housekeeping” genes tend 
to have stable mRNAs and proteins. The emerging global picture therefore is that most mRNAs 
and parti cularly proteins are designed to be rather stable unless they are involved in highly 
dynamically regulated cellular processes such as signal transducti on. Due to the trade-off  
between dynamic regulati on and energy effi  ciency this may represent an opti mal design.
Fig. III.25 | The role of protein half-lives and lengths 
for cellular energy consumpti ons. Box plots showing 
groups of diff erently abundant proteins and their 
protein half-lives (A) or protein lengths (B). Theoreti cal 
energy costs (cf. Material & Methods II.30) required 
to synthesize mRNAs (i.e. primary transcripts) and 
proteins from their building blocks (nucleoti de 
monophosphates and amino acids, respecti vely) (C). 
The impact of randomizing protein half-lives/lengths 
and mRNA half-lives/lengths on energy consumpti on is 
depicted in light grey and dark grey bars, respecti vely. 
Error bars show 95% confi dence intervals determined 
by multi ple randomizati ons and bootstrapping.
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DiscussionIV 
Establishment of pulsed SILAC (pSILAC)IV.1. 
Up to now, global methods for gene expression analysis have primarily focused on measuring 
changes at the mRNA level. However, the fi nal step in expression of protein-coding genes is 
translati on of mRNAs at the ribosome. In the present thesis, pulsed stable isotope labeling 
by amino acids in cell culture (pSILAC) with two heavy isotope labels has been established to 
directly quanti fy protein translati on on a proteome-wide scale. The method can directly detect 
changes at the level of translati on and, perhaps most importantly, irrespecti ve of whether 
regulati on is mediated by changes in mRNA stability (as seen for the transferrin receptor, TFRC, 
cf. Fig. III.4 C) or translati on initi ati on (as shown for the ferriti ns, FTH1 and FTL, cf. Fig. III.4 B). 
While conventi onal microarray analysis can detect alterati ons in mRNA levels, the translati onally 
regulated ferriti ns would have been most likely missed since corresponding transcript levels 
are known to be only marginally aff ected by iron treatment (EISENSTEIN & MUNRO, 1990). Given 
the fact that conservati ve esti mates denote approximately one third of the expressed genes 
to be post-transcripti onally regulated (INGOLIA et al., 2009), the pSILAC approach is applicable 
to a wide range of biological questi ons (MAMANE et al., 2006; VALENCIA-SANCHEZ et al., 2006). 
Combined with the microarray technique to measure changes at mRNA levels, the pSILAC 
approach should ulti mately enable researchers to disentangle between regulati on occurring at 
the level of mRNA stability and regulati on occurring at the level of translati on.
Recently, ribosome profi ling has been suggested to measure acti vely transcribed mRNAs (INGOLIA 
et al., 2009). Here, following ribosome preparati on and nuclease digesti on, mRNA fragments 
protected from digesti on by bound ribosomes are analyzed using next-generati on sequencing 
technologies or conventi onal microarrays. Despite of its unparalleled precision in pinpointi ng 
translati on start sites with nucleoti de resoluti on, detecti ng and counti ng of ribosome-bound 
mRNAs does not necessarily imply that those transcripts are acti vely translated in the fi rst 
place. For instance, binding of ribosomes to certain sequence elements like upstream open 
reading frames (uORF) was found to substanti ally aff ect translati on as ribosomes may become 
stalled in the process of translati on when encountering an uORF (KOZAK, 1991; MORRIS Ι 
GEBALLE, 2000). In fact, uORFs were recently demonstrated to have a widespread, primarily 
negati ve impact on gene expression (CALVO et al., 2008). This clearly challenges the capability 
of ribosome profi ling to exclusively measure mRNAs in the process of translati on. Unlike 
ribosome profi ling, pSILAC detects changes in protein producti on at the very end of all steps 
in protein translati on thus covering post-transcripti onal regulati on given by uORFs. On top 
of that even regulati on occurring post-translati onally like coordinated proteolysis mediated 
by post-translati onal modifi cati ons (PTMs) such as ubiquiti nylati on is captured (HERSHKO Ι 
CIECHANOVER, 1992).
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While sequencing-based methods like ribosome profi ling can basically cover the whole 
“translatome”, though not without inconsistencies as menti oned above, any stable-isotope 
based quanti fi cati on approach seeking a comprehensive, systems-wide analysis relies on 
suffi  cient mass spectrometry sampling depth. Hence, a major challenge in pSILAC is the 
detecti on of newly-synthesized proteins made against a bewildering background of pre-existi ng 
proteins. This issue applies especially to relati vely short labeling ti mes where small amounts 
of labeled, newly-synthesized proteins have to be traced in the presence of large amounts 
of unlabeled counterparts. In this case, the detecti on capability is severely limited by the 
dynamic range of the mass spectrometer. This limitati on was also apparent from the kineti c of 
luciferase inducti on measured either by pSILAC or classic luminescence (cf. Fig. III.2 C) readout 
to assess and compare quanti tati ve features of pSILAC. While overall correlati on between the 
two approaches was excellent (cf. Fig. III.2 D; Pearson R = 0.99), marked errors bars of pSILAC 
measurements shortly aft er luciferase inducti on (approximately unti l 2 h post-inducti on) 
indicated variati on in quanti fi cati on of luciferase pepti des. This observati on points towards an 
intrinsic constraint of the pSILAC approach given by limited traceability of very small amounts 
of newly-synthesized proteins. Consequently, pSILAC requires labeling ti mes of several hours 
to achieve decent amounts of newly-produced proteins which can hamper identi fi cati on and 
quanti fi cati on of transient changes in protein expression following perturbati ons. Yet pSILAC 
is not generally “blind” for newly-synthesized proteins from short labeling ti mes. For instance, 
high turnover proteins can indeed produce decent amounts of newly-synthesized pepti des 
within short ti me periods that are readily detectable by mass spectrometry. For instance, the 
heavy-labeled form of the Ribonucleoside-diphosphate reductase subunit M (Rrm2) for which 
the protein half-life has been determined in chapter III.3 was already detectable via mass 
spectrometry aft er a labeling ti me of 1.5 h (cf. Fig. III.14 A).
Monitoring luciferase inducti on by pSILAC led to another interesti ng observati on in that a 
small amount of luciferase-derived pepti des in the L (light) form (cf. Fig. III.2 A, B) could be 
detected. As luciferase was not expressed while cells were culti vated in the light medium, this 
peak most likely originates from recycling of light amino acids aft er transfer of the cells to M 
(medium-heavy) or H (heavy) medium. Alternati vely, this peak could derive from remaining 
light amino acids in the cellular precursor pool (e.g. aminoacyl-tRNAs), a pervasive problem in 
stable isotope labeling of metazoans (REEDS Ι DAVID, 1992; HELLERSTEIN, 2004). Lastly, a more 
trivial explanati on for the small L peak could be that the pTET promoter was to some degree 
“leaky”. In this context, one cannot rule out that the promoter acti vity has been induced 
through traces of tetracycline or derivati ves thereof in the culture medium. Since anti bioti cs 
are widely used in factory farming, it is conceivable that small amounts have been introduced 
to the culture medium by usage of fetal calf serum (FCS). However, in the pSILAC approach 
presented here this does not impair the accurate measurement of protein producti on for two 
reasons: First, the L peak is small (less than 10% of the heavy peaks aft er 10 h of inducti on), 
indicati ng that only a small fracti on of newly synthesized pepti des contain recycled and/or 
remaining light precursors. Second, and more importantly, light amino acids are incorporated 
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to the same extent in both samples. Hence, the abundance rati o of H versus M pepti des will 
not be aff ected by incorporati on of light amino acids.
Alternati ve strategies to study de novo protein synthesis employ selecti ve labeling and 
enrichment of newly-synthesized proteins. In recent eff orts, non-natural amino acids have been 
used to disti nguish between newly-synthesized and pre-existi ng proteins. In the bioorthogonal 
non-canonical amino acid tagging approach termed BONCAT (DIETERICH et al., 2006), cells are 
grown on medium supplemented with azidohomoalanine (AHA) as a substi tute for methionine 
to metabolically label newly-synthesized proteins. In the subsequent “click-chemistry” reacti on, 
azide-labeled proteins are covalently coupled to an alkyne-bearing affi  nity tag enabling specifi c 
isolati on of newly-produced proteins carrying such arti fi cial amino acids. 
Specifi c enrichment of newly-synthesized proteins as performed in BONCAT can indeed 
substanti ally facilitate their analysis. In doing so, sample complexity is decreasing what 
basically raises the chances of identi fying them from a large pool of pre-existi ng proteins. 
However, in order to compare newly-synthesized proteins made under perturbed cellular 
conditi ons compared to untreated control cells, two separate populati ons of newly synthesized 
proteins are isolated in BONCAT and separately analyzed by mass spectrometry. Consequently, 
informati on gained by listi ng proteins identi fi ed in one against another cell populati on is limited 
to a qualitati ve descripti on. In contrast, pSILAC does not only allow for direct qualitati ve but 
also for precise quanti tati ve comparison of protein producti on between cellular conditi ons. 
While BONCAT cannot make a point about single proteins identi fi ed in one but not in the other 
populati on due to a stochasti c sampling by the mass spectrometer, additi onal quanti tati ve 
informati on obtained in pSILAC can considerably strengthen experimental validity. Lastly, the 
methionine substi tute AHA used in BONCAT was found to induce growth arrest of E.coli during 
prolonged labeling (> 30 min) further limiti ng the versati lity of the approach (KRAMER et al., 
2009). Thus, BONCAT and pSILAC should rather be seen as complementary approaches. Given 
the increase in dynamic range and sensiti vity as a result of a lower sample complexity, BONCAT 
may be preferenti ally used to detect transient changes in protein producti on. In contrast, pSILAC 
is bett er suited for investi gati on of biological processes altering protein synthesis on the hours 
ti me-scale. Here, owing to high accuracy in quanti fi cati on, pSILAC can even determine subtle 
diff erences in protein producti on that are most likely not amenable to other methods.
Finally, it is worth menti oning that cells usually not compati ble with conventi onal SILAC labeling 
can also be approached with pSILAC which is due to the fact that pSILAC does not require full 
proteome labeling. For instance, in a collaborati on project dealing with translati onal regulati on 
exerted by microRNAs, B-cells from context-specifi c knockout and control mice were isolated 
and cultured in pSILAC medium for a few days (data not shown). It turned out that such an 
ex vivo labeling of cells, though proceeding slower compared to standard cell lines due to 
a slower cell division, was suffi  cient to work out changes in protein producti on. Hence, the 
pSILAC approach is not limited to mere analysis of immortalized, standard cell lines.
In summary, the pSILAC method presented here to globally measure relati ve changes in protein 
synthesis across diff erent cellular conditi ons is characterized by a very good dynamic range (cf. 
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Fig. III.2 C), high accuracy in quanti fi cati on (cf. Fig. III.2 D) and very good reproducibility (cf. 
Fig. III.5). Hence, pSILAC off ers a very good trade-off  performance for the demand to measure 
translati on on a global scale with a resoluti on close to methods working on a single-protein 
basis. Further improvements in MS instrumentati on and soft ware will most likely enable 
comprehensive measurement of the enti re “translatome” in the near future (COX Ι MANN, 
2007). 
Th e impact of microRNAs on the proteomeIV.2. 
In recent years, microRNAs (miRNAs) have emerged as a potent class of small regulatory RNAs 
exerti ng their repressive functi on by destabilizati on of target mRNAs and/or by inferring with 
the translati on initi ati on or elongati on step. Identi fying functi onally important miRNA targets 
is therefore key towards a comprehensive understanding of miRNA functi ons, for example for 
diseases based on oncogenic miRNAs termed “oncomirs” (ESQUELA-KERSCHER Ι SLACK, 2006). 
However, the above menti oned dual functi onality of miRNAs makes experimental target 
identi fi cati on parti cularly challenging. Based on the molecular mechanism of target recogniti on 
three main branches of large scale target identi fi cati on have emerged: RISC (RNA-induced 
silencing complex, cf. Fig. I.6) pulldown experiments, transcriptomics and proteomics. 
In RISC pulldown experiments the miRNA loaded RISC-complex is affi  nity purifi ed together 
with associated mRNAs which are subsequently analyzed by microarray (HOCK et al., 2007; 
KARGINOV et al., 2007). Such experiments provide informati on about the physical interacti on 
between endogenous miRNAs and their targets. However, it is unclear if this physical interacti on 
mediates target repression in all cases. Moreover, no informati on about the degree of target 
repression is provided.
Mainly because of diffi  culti es in large scale protein quanti fi cati on (GYGI et al., 1999; NIE et al., 
2006; TIAN et al., 2004), mRNA expression profi ling has so far been widely used as a surrogate 
for the identi fi cati on of miRNA targets (LIM et al., 2005). However, translati onally regulated 
targets not suscepti ble to mRNA degradati on would be missed. 
Arguably, the most direct way of miRNA target identi fi cati on is measuring changes at the protein 
level upon over-expression or depleti on of certain microRNAs by quanti tati ve proteomics. 
Proteins are the end-products of most genes and changes in protein levels naturally have a 
high functi onal relevance. Quanti fying the impact of microRNAs at the protein level has the 
big advantage that it captures targets regulated by both mRNA degradati on and translati onal 
repression. In a recent conceptually very similar study researchers employed mass-spectrometry 
based quanti tati ve proteomics to assess the impact of miRNAs onto the proteome (BAEK 
et al., 2008). The group used the traditi onal SILAC method to measure how miRNAs aff ect 
steady-state levels of proteins two days post-transfecti on of specifi c microRNAs. In contrast, 
in the present study a novel variant of the SILAC method termed pulsed SILAC (pSILAC, cf. 
III.1) was used to globally measure changes in cellular protein synthesis in response to miRNA 
over-expression or knock-down (SELBACH et al., 2008). The pSILAC approach is independent of 
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individual protein turnover rates which can skew the eff ect of examined microRNAs onto the 
proteome (cf. Introducti on I.2.2). In order to elucidate how much regulati on is also refl ected 
on the transcriptome, changes in mRNA levels employing conventi onal microarrays were 
monitored in parallel.
In additi on to what is already known for mRNAs levels from a previous study (LIM et al., 
2005), the present fi ndings clearly show that single miRNAs can aff ect protein producti on of 
hundreds of proteins (cf. Fig. III.9 A). Closer inspecti on of down-regulated proteins revealed 
that the presence of seed moti fs located in the 3´UTRs of mRNAs strongly correlated with 
the observed fold changes, i.e. with down-regulati on of protein producti on (cf. Fig. III.9 B, 
C, D and Fig. III.10 A). As the same held true for changes in mRNA levels (cf. Fig. III.11 C), 
the seed sequence appears as the primary moti f directi ng both mRNA degradati on as well 
as translati onal repression. In contrast, no seed enrichment was observed for up-regulated 
genes, indicati ng that the recently reported miRNA mediated acti vati on of gene expression did 
not occur under the applied experimental conditi ons (VASUDEVAN et al., 2007). 
Intriguingly, the eff ects of miRNAs on proteins were overall quite modest as changes in their 
expression levels were on average less than twofold. As pSILAC exclusively measures changes 
in protein producti on, the fi nding cannot be explained by eff ects resulti ng from regulated 
turnover. Indeed, the observed pSILAC fold changes were on average even higher as fold 
changes measured via classic SILAC upon altering cellular miRNA expression levels (BAEK et 
al., 2008). This suggests that the analysis of microRNA-mediated regulati on by classic SILAC 
was presumably compromised by protein turnover and that pSILAC is the more appropriate 
approach to study the impact of microRNAs onto the proteome.
In order to independently validate changes in protein producti on measured by pSILAC, luciferase 
reporter assays were performed with seed-carrying, endogenous 3´UTRs of nine mRNAs (Fig. 
III.10 B). Measuring of luciferase acti vity is one of the best quanti tati ve methods currently 
available to study translati onal regulati on since the method possesses high sensiti vity and 
yields linear results over several orders of magnitude (DYER et al., 2000). Notably, a very good 
correlati on of luciferase quanti fi cati on with pSILAC rati os was observed despite the fact that 
the experimental procedures diff er substanti ally and experiments were not done in parallel. In 
parti cular, there was no general trend of pSILAC to over- or underesti mate changes in protein 
translati on. However, other investi gators observed much higher fold-changes (up to 30-fold) in 
a similar system (dsRNA transfecti on in HeLa cells) with arti fi cial reporter constructs (DOENCH 
et al., 2003). One explanati on for this discrepancy is that very few (< 0.5%) 3’UTRs in the data 
set have more than three seed sites for a given miRNA, and this value is representati ve for 
the whole genome. Arti fi cial reporter constructs are, however, designed to contain up to six 
closely spaced miRNA binding sites instead of enti re, endogenous 3´UTRs with very few seed 
sites only. Hence, if a target has several seed sites, the repressive eff ect is multi plicati ve as has 
been observed in small-scale studies (DOENCH et al., 2003; RAJEWSKY 2006). Remarkably, this 
cooperati ve eff ect is also apparent from the pSILAC fold-changes as the number of seeds per 
protein is inversely correlated with the magnitude of down-regulati on (cf. Fig. III.11 C).
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The parallel analysis of changes in mRNA levels by microarrays showed that repression of protein 
producti on is frequently mirrored by decreased transcript levels suggesti ng that most targets 
can be identi fi ed with the more cost-eff ecti ve and straightf orward conventi onal microarray 
technique (cf. Fig. III.11 B). However, by directly measuring changes in protein producti on, 
pSILAC data are per se more relevant to the phenotypes than microarray data. Notably, as 
transcript abundances were monitored before (t1) and aft er (t2) the pulse-labeling, it was 
found that for basically all examined miRNAs the correlati on between mRNA fold-changes 
and pSILAC fold-changes became bett er at t2 (cf. Fig. III.11 A and B and Supplementary Figure 
VII.2). This observati on is subject of an ongoing, very controversial debate about microRNA 
functi on. It is sti ll unclear whether mRNA degradati on is an independent mechanism exerted 
by miRNAs or rather the consequence of the actual translati onal repression (EULALIO et al., 
2008). Though compelling evidence indicates that miRNA-mediated mRNA decay can in fact be 
uncoupled from translati on inhibiti on (WU et al., 2006, MISHIMA et al., 2006; WAKIYAMA et al., 
2007), the present fi ndings at least suggest a temporal arrangement of the two eff ects where 
translati onal repression seems to precede mRNA degradati on. However, since many reports 
convincingly demonstrate that the degree of relati ve contributi ons of translati onal repression 
and mRNA decay can considerably depend on structural features and the sequence context 
of individual miRNA:mRNAs hybrids (GRIMSON et al., 2007), this observati on should not be 
over-interpreted.
Aft er all, the pSILAC approach identi fi ed a number of targets where translati onal repression 
obviously is the major component of mRNA silencing. Since corresponding changes at the 
mRNA level were barely detectable, such targets would most likely go unnoti ced by traditi onal 
transcriptomics approaches. For instance, the well-known protein Dicer which is crucial for 
processing of virtually all miRNAs and silencing RNAs (siRNAs) was found to be primarily 
regulated translati onally. To be precise, the protein that carries several let-7b 3´UTRs seeds 
was one of the most strongly up-regulated targets in the let-7b knock-down experiment with 
a > 4-fold change in the pSILAC but not in the microarray data (< 1.3 fold). Therefore, Dicer is a 
likely direct translati onal target of the microRNA let-7b.
In order to elucidate whether targets with a pronounced translati onal repression have 
functi onal properti es in common, a subset of proteins with large diff erences in protein and 
mRNA fold-change (log2 fold-change pSILAC - mRNA < -0.3) were subjected to gene ontology 
analysis. Intriguingly, an over-representati on of proteins synthesized at endoplasmic reti culum- 
(ER) associated ribosomes (GO categories: “intrinsic to membrane”, “endoplasmic reti culum”) 
was found. Evidently, translati onal repression appears to be stronger for mRNAs translated at 
ER-associated ribosomes as opposed to free cytosolic ribosomes. It is tempti ng to speculate 
that mRNAs from free ribosomes but not from ER-associated ribosomes are targeted to so 
called processing bodies (p-bodies) for degradati on (EULALIO, 2007). As the ER is considered to 
lack proteolyti c acti vity, this fi nding also suggests that translati onal repression may indeed be 
fi rst in miRNA-mediated regulati on of gene expression for that subset of targets (NOTTROTT et 
al., 2006).
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Apart from the above menti oned detecti on of Dicer as a translati onal target, the knock-down 
of let-7b as a highly abundant endogenous miRNA in HeLa cells was also in a diff erent aspect 
highly informati ve. Since transfecti ons of large amounts of miRNAs represent a considerable 
manipulati on of cellular conditi ons, it was not clear to what extent the results are actually 
physiologically relevant. Adverse eff ects upon ectopic over-expression of microRNAs may arise 
from a competi ti on in RISC loading between over-expressed and endogenous miRNAs that 
could potenti ally aff ect the results. In this regard, two scenarios are conceivable: 
(i) Over-expressed miRNAs are not effi  ciently loaded into RISC, and the changes on protein 
producti on might therefore be underesti mated.
(ii) Over-expressed miRNAs are loaded into RISC to very high levels which could lead to unspecifi c 
repression of proteins which are not targets under physiological miRNA concentrati ons. 
The knock-down experiment, however, revealed that basically the same set of proteins down-
regulated in the let7b over-expression experiment due to complementary seed sites was 
found to be de-repressed following let-7b knock-down (cf. Fig. III.12 A and B). Thus, the inverse 
modulati on in protein producti on strongly suggests that arti fi cial over-expression does not 
result in non-physiological eff ects. Except for the fact that pSILAC fold changes were overall 
marginally higher in the let-7b over-expression compared to the knock-down experiment, 
the presented data likely contain many physiologically relevant direct targets. Remarkably, 
the observed anti -correlati on also held true for most of the ~2,700 proteins quanti fi ed 
in the experiments and not solely for the let-7b targets with seed-complementary sites, 
demonstrati ng that altering stati onary levels of an endogenously expressed miRNA can aff ect 
the expression of thousands of genes (cf. Fig. III.12 A). It is conceivable that let-7b controls by 
targeti ng Dicer the maturati on of diverse miRNAs which in turn aff ects a plethora of genes 
resulti ng in the observed proteome-wide changes. Yet a future challenge will be to work out 
genes that are directly targeted by miRNAs without bearing any canonical seed sites as already 
demonstrated for the transcripti on factor E2F2 and CDNK4 targeted by miR-24 and the miR-34 
family, respecti vely (LAL et al., 2009; HERMEKING, 2010).
With one miRNA inducing expression changes in hundreds of proteins, it remains an open 
questi on how many of these changes are important to the functi on of the individual miRNA. 
Despite of carrying miRNA-specifi c seed-sites, it cannot be ruled out that some, or perhaps 
many of the proteins found to be mildly regulated are actually neutral due to ti ssue-specifi city 
of microRNA targets (LAGOS-QUINTANA et al., 2002). Thus, it will be parti cularly illuminati ng to 
learn whether the proteins that are more strongly regulated have greater relevance to miRNA 
functi on, consistent with a switch-like model of miRNA acti vity (REINHART et al., 2000; VAN 
ROOIJ et al., 2007; LIU Ι OLSON, 2010). However, the observed wide-spread but mild changes 
induced by single miRNAs paint a picture of miRNAs as potent regulators that globally fi ne-
tune protein expression by subtly aff ecti ng many targets simultaneously (HOBERT, 2007).
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Dynamic properties of mammalian gene IV.3. 
expression
Gene expression is a dynamic, multi step process that involves transcripti on, translati on and 
turnover of mRNAs and proteins. All processes are subject to precisely controlled regulati on 
to adapt gene expression to changing conditi ons occurring inside and outside the organism. 
Towards a quanti tati ve descripti on of how the combined eff ects of dynamic properti es shape 
gene expression, large scale measurements of dynamic parameters are essenti al. Though 
methods to comprehensively record mRNA levels and mRNA degradati on have become 
available in recent years, the knowledge about the relati onship between mRNA and protein 
expression remains fragmentary. Due to extensive translati onal and post-translati onal 
regulati on, diff erences in protein levels can be only parti ally explained by diff erences in mRNA 
levels resulti ng from transcripti on and decay. Recent eff orts employing high-throughput 
technologies approached the connecti on between cellular transcripts and proteins by 
measuring steady-state concentrati ons. While most reports comparing mRNA and protein 
levels arrived at the conclusion that overall correlati on is poor (reviewed in: DE SOUSA ABREU 
et al., 2009; MAIER et al., 2009), they cannot refer the discrepancy to a cause. Apart from the 
fact that most studies are sti ll limited to a few hundred genes and that observati ons derived 
from prokaryotes cannot be simply transferred to eukaryotes, the actual limitati on is given 
by the measurement of steady-state concentrati ons. mRNA and protein levels consti tute the 
net outcome from coupled processes of synthesis and degradati on and can hence not alone 
provide informati on about the underlying dynamic properti es of gene expression. Alternati vely, 
mRNA and protein turnover have been separately investi gated with either drugs inhibiti ng 
transcripti on or translati on or by the use of arti fi cial fusion proteins (YANG et al., 2003; BELLE 
et al., 2006; YEN et al., 2008). However, both methods are intrinsically subopti mal since the 
use of drugs and fusion proteins comes not without costs given by severe side eff ects or by 
aff ecti ng protein stability, respecti vely.
To overcome these potenti al shortcomings, in the present study both mRNA and protein half-
lives as well as mRNA and protein concentrati ons were quanti fi ed simultaneously in mammalian 
cells on a genome-wide scale. For this to happen, stable isotope labeling by amino acids in cell 
culture (SILAC) has been combined with 4sU labeling, resulti ng in protein and mRNA turnover 
ti mes and levels for more than 5,000 genes. Since all parameters were derived from the exact 
same data set and hence from the very same set of cells, error-prone steps given by integrati ng 
quanti ti es from diff erent sources were avoided.
Proteins were pulse-labeled with heavy amino acids for diff erent lengths of ti me to cover a 
reasonable ti me range of protein turnover known to span several orders of magnitude in yeast 
(BELLE et al., 2006). In additi on, experiences about the ti me-scale protein producti on gained 
by sti mulati on of HeLa cells with iron turned out to be benefi cial (cf. III.1.4). For instance, 
translati onal up-regulati on of the ferriti ns took at least 4-6 h to arrive at H/L pepti de peak 
rati os readily detectable by the mass spectrometer (cf. Fig. III.5). Thus, in order to capture both 
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high and low turnover proteins a ti me frame for labeling spanning more than 12 h was chosen. 
While the bulk of proteins were independently quanti fi ed at all three ti me points, only about 
100 proteins were quanti fi ed at one ti me point only. Hence, only few proteins had extreme 
rati os, e.g. very high H/L rati os at the fi rst ti me point or very small rati os only detectable at the 
last ti me point, suggesti ng that the labeling ti me was suitable to measure protein turnover in 
mammalian cells. 
In order to account for all rati o measurements for half-life calculati ons, linear regression was 
applied to all H/L rati os obtained for individual proteins. As a quality test for the linear fi t, the 
coeffi  cient of terminati on R2 was used. In total, the fi t did sati sfy the relati vely conservati ve 
criterion of R2 ≥ 0.9 for 4,906 proteins, indicati ng that protein turnover could be accurately 
recorded by SILAC-based quanti tati ve mass spectrometry. As expected for very unstable 
proteins, the H/L rati os were relati vely high at the fi rst ti me point (1.5 h) and then “saturated” 
at the later ti me points, that is, the H/L rati os were no longer increasing linearly. This fi nding 
points towards an intrinsic constraint of mass spectrometry to accurately capture extreme 
rati os with insuffi  cient signal-to-noise rati os. For instance, when applying the linear regression 
to all three H/L rati os obtained for Cyclin D1 (1.4 at t1, 4.9 at t2 and 7.6 at t3) the protein half-life 
was fi rst underesti mated with 4.5 h. Hence, for proteins with an H/L rati o ≥ 0.5 at the fi rst 
ti me point (1.5 h) only this rati o was taken for calculati on of protein turnover. In doing so, 
the half-life of Cyclin D1 was determined to be about 1.2 h, which could also be confi rmed by 
cylcoheximide-chase experiments.
Robust quanti fi cati on, however, relies not only on the instruments capability to precisely 
measure H/L rati os, it also necessitates that the rati os reliably refl ect protein synthesis. Protein 
turnover can in parti cular be under-esti mated due to the presence of light (L) amino acids that 
remain in the cell´s precursor pool aft er transferring them to heavy (H) SILAC medium, e.g. 
by recycling of light proteins. However, closer inspecti on of missed-cleaved, heavy pepti des 
revealed that the measured protein half-lives were not appreciably aff ected by non-uniform 
incorporati on of heavy amino acids. This is advantageous over in vivo experiments that oft en 
require complex correcti ons for diff erent amino acid precursor pools (DOHERTY et al., 2005). 
Unlike cells in culture, where the starti ng biomass is rather small, intact animals usually provide 
a substanti al, ti ssue-specifi c pre-existi ng source of amino acids that enters the precursor pool. 
Nonetheless, the molecular basis for the outstanding regenerati ve capabiliti es of the urodele 
amphibian Notophthalmus viridescens has recently been investi gated in a ti ssue-specifi c 
context (the authors restricted their analysis to tail ti ssue) with a pulsed in vivo SILAC approach 
(LOOSO et al., 2010).
Protein half-lives measured in NIH3T3 cells with the SILAC approach were independently 
validated by cycloheximide-chase experiments. It should be menti oned that this kind of analysis 
only allows for a rough classifi cati on of protein stability. In this type of experiment cellular 
protein degradati on is monitored following inhibiti on of protein synthesis by cycloheximide. 
However, those toxic conditi ons potenti ally distort the measurements. Monitoring the decay 
of proteins over many hours can therefore be error-prone, since cells will likely become 
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apoptoti c. Despite of those potenti al limitati ons, the results obtained by the cycloheximide 
approach were in overall very good accordance with SILAC measurements (cf. Fig. III.16), 
thereby further confi rming the validity of the approach. Ulti mately, traditi onal radioacti ve 
pulse-chase experiments that enable a precise, though cumbersome determinati on of half-
lives can be used to validate individual SILAC half-lives (KENNEY, 1967).
Transcript half-lives were obtained essenti ally as described previously (DOELKEN et al., 2008) 
using 4sU to metabolically label and isolate newly-synthesized RNA from total RNA. Comparison 
of half-lives measured for NIH3T3 in this study compared to those already publicly available 
revealed a strong correlati on on a log-log scale (Pearson R = 0.64). This cannot necessarily be 
expected given the fact that diff erent cell clones, and more importantly, diff erent technologies 
(microarray vs. next-generati on sequencing) were used to measure the disti nct RNA fracti ons 
(i.e. newly-synthesized, pre-existi ng and total RNA). The determinati on of mRNA half-lives with 
the 4sU approach requires that newly-synthesized transcripts are separated from total RNA 
with equal effi  ciencies. However, transcripts containing large numbers of uridines that can 
be replaced by 4sU are inherently more prone to isolati on by affi  nity beads. This bias became 
apparent when plotti  ng the rati o of newly-synthesized/total RNA as a functi on of the number 
of uridines per transcript (cf. Fig. II.1 A). Obviously, the turnover of transcripts containing less 
uridines were signifi cantly under-esti mated. In order to alleviate the bias, LOWESS regression 
was applied to the rati os prior to half-life calculati ons (cf. Fig. II.1 B).
A comparison of mRNA and protein half-lives revealed that proteins were on average fi ve ti mes 
more stable and also spanned a higher dynamic range than mRNA half-lives (cf. Fig. III.22 A). 
Plotti  ng mRNA and protein lifeti mes against each other demonstrated that a correlati on was 
virtually absent. Yet it seemed likely that this seemingly chaoti c distributi on follows certain 
design principles. Intriguingly, the analysis of genes with certain combinati ons of mRNA and 
protein half-lives revealed that they share common biological functi ons (cf. III.3.4), suggesti ng 
that they evolved under similar constraints. Parti cularly informati ve in this regard was the fact 
that mainly genes involved in dynamically regulated processes such as transcripti on factors 
and cell cycle regulati on were characterized by low mRNA and protein stability. This indicated 
that one of the underlying design principles shaping cellular half-lives may be the ability of 
cells to modulate gene expression of specifi c genes in a temporally highly fl exible manner. 
Consistently, the analysis of response ti mes as a measure for how fast protein levels relax 
towards the steady-state aft er perturbati on revealed that expression levels of such genes can 
be rapidly adapted, suggesti ng that an exact expression ti ming is crucial for the survival of the 
enti re organism. On the contrary, genes involved in consti tuti ve processes (e.g. translati on, 
respirati on and central metabolism) were characterized by rather stable mRNAs and proteins 
and hence long response ti mes. 
By defi niti on, response ti mes can only be infl uenced by both mRNA and protein half-lives 
when they are of similar magnitude (cf. Material & Methods II.29.3), which was the case for 
the above menti oned dynamically regulated genes. Changes in gene expression occurring at 
the mRNA level, that is, by changes in transcripti on or mRNA degradati on, can thus eff ecti vely 
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transmit to aff ect the protein output. It is therefore tempti ng to speculate that those genes are 
at least to some degree transcripti onally regulated. This is consistent with a recent small-scale 
study were mRNAs and proteins of transcripti onally induced signaling species were all unstable 
(LEGEWIE et al., 2008). Moreover, in two recent reports (HAO Ι BALTIMORE et al., 2009; ELKON 
et al., 2010), mRNA stability was found to have a major impact on the temporal order of genes 
encoding proteins involved in infl ammatory processes. Amongst those genes that showed rapid 
changes in gene expression upon sti mulati on with TNFalpha, known transcripti onally regulated 
genes such as Fos (Proto-oncogene c-Fos), TTP (Tristetraproline) and JunB (Transcripti on factor 
jun-B) were found. Remarkably, a comparison of such genes with the data obtained in the 
present study revealed, that both mRNA and protein stability were of comparable magnitude 
and thus basically confer a transcripti onal regulati on. In contrast, the fact that also genes with 
high mRNA but low protein stability showed fast response kineti cs points towards a diff erent 
type of regulati on (cf. III.3.4.1.). Although changes in transcripti on will hardly aff ect mRNA 
levels in a ti mely manner, a translati onal regulati on that is independent of mRNA stability 
is conceivable. Notably, cellular homeostasis genes in this group may thus be regulated at 
the level of translati on. In fact, this set contains two ferriti ns that are well-known to be up-
regulated translati onally in response to iron (HENTZE Ι MUCKENTHALER, 2004).
Another putati ve design principle that became apparent from the functi onal analysis may 
be energy effi  ciency (WAGNER, 2005). To this end, theoreti cal energy costs required to 
synthesize mRNAs (i.e. primary transcripts) and proteins from their building blocks (nucleoti de 
monophosphates and amino acids, respecti vely) were calculated (cf. Material & Methods II.30). 
This calculati on underesti mates the real costs since the energy required for nucleoti de synthesis, 
amino acid synthesis, splicing and transport are unknown in fi broblasts and therefore omitt ed. 
Yet the analysis has led to instructi ve insights. For instance, the relati ve costs needed for mRNA 
and protein synthesis were signifi cantly lower than expected at random, that is, shuffl  ing 
protein half-lives and protein lengths markedly increased theoreti cal energy consumpti on. 
Intriguingly, due to the high dynamic range of protein levels the contributi on of mRNAs to 
overall energy costs (i.e. summed costs for mRNA and protein synthesis) was almost negligible. 
More precisely, protein synthesis consumed about 95% of the overall energy budget while only 
~ 5% was needed for transcripti on (data not shown). Along these lines, it also turned out that 
80% of the energy for translati on is required to synthesize 20% of all proteins. Hence, protein 
synthesis follows the Pareto principle (“80/20 rule”) with a small fracti on of proteins consuming 
most of the energy. If gene expression was opti mized under energeti c constraints abundant 
and therefore highly expensive proteins are expected to be more stable and shorter than less 
abundant ones. Indeed, abundant proteins were signifi cantly more stable than less abundant 
ones (cf. Fig. III.25 A) and they were also signifi cantly shorter (cf. Fig. III.25 B). The emerging 
global picture therefore is that most mRNAs and parti cularly proteins tend to be stable unless 
genes need to respond quickly to a sti mulus. Due to the trade-off  between dynamic regulati on 
and energy effi  ciency this may represent an opti mal design. 
Despite of the undeniable role of mRNA and protein turnover in regulati on of cellular functi on, 
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the basic molecular mechanisms driving degradati on are far from being well understood. In 
contrast to mRNAs, where at least some molecular determinants (e.g. cis-regulatory sequence 
features as AU-rich elements and Pum2 binding sites, cf. III.3.2) have been identi fi ed to clearly 
aff ect transcript stability, clear-cut protein degradati on signals (degrons) remain elusive so far. 
Although several putati ve degrons have been suggested (e.g. physical/sequenti al features such 
as number of residues, overall hydrophobicity, folding properti es, intrinsically unstructured 
regions, PEST moti fs, etc.), they were all found to serve as rather weak signals for intracellular 
protein degradati on (reviewed in: TOMPA et al., 2008). It seems likely that protein degradati on is 
not only determined by a single characteristi c, but is a multi -factorial process that shows large 
protein-to-protein variati ons. Yet the (simplifi ed) analysis of potenti ally unstructured amino 
acid regions performed in the present thesis suggested that the degree of disorder is inversely 
correlated with protein half-life (cf. Fig. III.20). Interesti ngly, several studies performing genome-
wide predicti ons of protein disorder came to the conclusion that intrinsically unstructured 
proteins predominantly carry out important functi ons in signal transducti on and transcripti on 
regulati on (IAKOUCHEVA et al., 2002; WARD et al., 2004; MINEZAKI et al., 2006). Given the 
high suscepti bility of unstructured regions for the intracellular degradati on machinery, this 
structural feature may represent a conceivable means and mechanism to confer dynamic gene 
expression (DYSON Ι WRIGHT, 2005) of transcripti on factors, chromati n modifying enzymes 
and proteins with cell cycle-specifi c functi ons. 
Another conceivable design principle became apparent from the observati on that many 
mammalian RNA-binding proteins were stable but encoded by unstable transcripts, as also 
recently seen in yeast (MITTAL et al., 2009). Since many RNA-binding proteins bind their own 
messenger RNA, this observati on is indicati ve of a post-transcripti onal negati ve feedback-loop 
for RNA-binding proteins. Consistent with this idea an over-representati on of RNA-binding 
protein moti fs could be observed in high-turnover mRNAs (data not shown).
In additi on to half-lives, parallel mRNA sequencing and mass spectrometry also allowed to 
esti mate cellular mRNA and protein copy numbers. Transcript levels were calculated based on 
the number of sequencing reads in conjuncti on with informati on on cellular mRNA content 
as described before (MORTAZAVI et al., 2008). For example, for the popular “housekeeping” 
mRNA encoding for of GAPDH 2,450 copies/cell were calculated. A previous study carefully 
determined GAPDH copy number in NIH3T3 cells by single-cell quanti tati ve real-ti me PCR or 
bulk measurements (MARCUS et al., 2006). Intriguingly, the calculated value fell almost exactly 
between the two previously published values for bulk and single cell data (1,840 and 2,940 
copies/cell, respecti vely). Despite this intriguing consistency, further experimental evidence 
confi rming the calculated mRNA levels in the present study would certainly be benefi cial. 
Absolute quanti fi cati on using latest next-generati on sequencing technologies is sti ll in its 
infancy. Specifi cally, it remains not enti rely clear whether the obtained RPKM values used for 
deducti on of absolute concentrati ons truly scale linearly with absolute transcript amounts 
over several orders of magnitude. To address this, spiking known concentrati ons of reference 
transcripts in the measured sample covering a huge dynamic range (four to fi ve orders of 
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magnitude) has been suggested (MORTAZAVI et al., 2008). Alternati vely, qPCR-based absolute 
quanti fi cati on can be performed. The method is, however, impracti cal for validati on of many 
transcripts and can be imprecise due to potenti ally error-prone steps (e.g. extracti on of RNA 
of defi ned amount of cells, diff erences in primer binding effi  ciencies in RT-PCR, cloning issues, 
etc.) (BUSTIN, 2000).
Similarly, obtaining informati on about absolute protein copy numbers is also challenging. 
Absolute numbers can be obtained by mass spectrometry employing diff erent approaches 
(SILVA et al., 2006; LU et al., 2007; MALMSTROM et al., 2009) which can be broadly speaking 
divided into two strategies. Quanti fi cati on can be based on (i) spectral counti ng of pepti des 
that neglect intensiti es as a possible source of informati on or (ii) can be achieved by extracti on 
of intensiti es of a subset of pepti des (e.g. the top three most intense ones) thereby neglecti ng 
all other pepti de intensiti es obtained for a protein. To overcome these limitati ons, the sum 
of peak intensiti es of all pepti des matching to a specifi c protein was used in a newly-devised 
approach termed iBAQ (“intensity-based absolute quanti fi cati on”). When divided by the 
number of theoreti cally observable pepti des, the resulti ng iBAQ values were shown to provide 
an accurate proxy for protein levels. Depending on the individual experiment to identi fy and 
quanti fy UPS2 proteins of known concentrati ons, iBAQ explained between 90 and 95% of the 
diff erences in absolute protein amounts (cf. Fig. III.21) and signifi cantly outperformed all other 
approaches. To further test the method´s ability to quanti fy proteins expressed at vastly diff erent 
cellular levels, yeast was subjected to absolute quanti fi cati on because quanti tati ve informati on 
based on tag-western-blots/GFP-fusion proteins and ribosome profi ling is available for this 
model organism (GHAEMMAGHAMI et al., 2003; INGOLIA et al., 2009). Cellular copy numbers of 
1,384 proteins determined by iBAQ ranged from less than 100 to more than 106 copies per cell 
(data not shown). The most abundant proteins were glycolyti c enzymes, translati on elongati on 
factor and ribosomal proteins, consistent with a proteome opti mized for fermentati on and 
rapid growth. Overall, the data correlated surprisingly well with translati on rates measured 
by ribosome profi ling (cf. Supplementary Fig. VII.5, R2=0.66). This correlati on is considerably 
higher than the correlati on between ribosome profi ling and the tag-western-blot/GFP-fusion 
data from the same group (cf. Supplementary Fig. VII.5, R2=0.29). The results indicate therefore 
that the relati vely simple and straightf orward iBAQ-based quanti fi cati on was more reliable 
than values obtained by the laborious tag-western-blot/GFP-fusion experiments, which are 
sti ll frequently used to globally compare mRNA and protein levels.
Despite a huge spread and a much higher dynamic range of proteins, cellular levels of mRNAs 
and proteins were clearly correlated (cf. Fig. III.22 C, R2 = 0.40 at log-log-scale). Although this 
correlati on is higher than in any previous mammalian study it is sti ll much lower than in yeast 
(73%) (LU et al., 2007). Gene expression in higher eukaryotes may show a higher degree of 
post-transcripti onal and post-translati onal regulati on. Alternati vely, it is also possible that the 
yeast system is special due to its extreme adaptati on for rapid growth (GRIFFIN et al., 2002).
However, it should also be stressed that the data set presented in this study represents average 
values derived from a populati on of dividing, non-synchronized cells. Therefore, one cannot 
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make a point about half-lives and copy numbers in individual cells or at diff erent cell cycle 
stages and cellular compartments. For instance, cyclins were found to have rather unstable 
transcripts and proteins. Since cyclins are regulated at the level of protein degradati on by 
ubiquiti n-mediated proteolysis in a cell cycle dependant manner, protein stabiliti es most 
likely undergo changes throughout the cell cycle (BLOOM Ι CROSS, 2007). Similarly, transcripts 
recruited to specifi c cellular compartments such as p-bodies or stress granules presumably 
have diff erent stabiliti es compared to their cytoplasmic counterparts (reviewed in: PARKER Ι 
SHETH, 2007. Also, at the single cell level, the role of protein degradati on for protein abundance 
may be higher. In E. coli, single cell based methods revealed that protein levels fl uctuate 
considerably (ROSENFELD et al., 2005; TANIGUCHI et al., 2010).
Altogether, the here presented data set is currently the largest and most comprehensive 
source of mRNA and protein half-lives and levels and thus provides per se a rich resource 
for the scienti fi c community that can be mined in many ways that are beyond the scope of 
this study. For instance, protein copy numbers provide valuable informati on for modeling 
of cellular processes and can provide insights into the stoichiometry of protein complexes 
(MALMSTROM et al., 2009). Half-lives can be used to assess the impact of sequence features 
being under suspicion to destabilize mRNAs or proteins. The data may even prove useful for de 
novo discovery of yet unknown sequence elements or refi nement of existi ng rules governing 
mRNA or protein degradati on. 
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Conclusions and OutlookV 
Most studies on global gene expression performed to date concentrated exclusively on 
measuring changes in steady-state mRNA levels. Although it is now clear that post-transcripti onal 
and post-translati onal regulati on play a central role, investi gati on of these events is sti ll in its 
infancy (KEENE, 2007; KOMILI Ι SILVER, 2008). The pulsed SILAC approach presented in this 
thesis to explicitly study diff erences in protein translati on is a valuable step in that directi on. 
With the use of pSILAC the impact of microRNAs onto the proteome given by control of mRNA 
stability and protein translati onal has been qualitati vely and quanti tati vely assessed. Other, 
not less important and exciti ng biological systems known to have a marked “translati onal 
dimension” are awaiti ng their examinati on. Amongst them, the study of mTOR signaling and 
hypoxic response but also the impact of RNA-binding proteins on gene expression deserve 
research eff orts, in parti cular due to their crucial role in disease development.
The study of protein synthesis in the present thesis has also been harnessed to deduce 
fundamental dynamic parameters of mammalian gene expression. By combining SILAC with 
4sU labeling in a pulsed fashion protein and mRNA half-lives and concentrati ons for more 
than 5,000 genes were obtained. This has led to the insight, that mRNA and protein half-lives 
share common biological functi ons and hence likely evolved under similar constraints. The 
four simultaneously measured parameters can now be directly used to quanti tati vely model 
mammalian gene expression dynamics, i.e. a comprehensive descripti on of transcripti on, 
mRNA degradati on, translati on and protein degradati on rates for thousands of genes is within 
reach. 
In this context, it will be exciti ng to evaluate on a global level which factor, translati on effi  ciency 
or protein half-life, dominates the correlati on between mRNA and protein abundances. Without 
regulati on at the post-transcripti onal and post-translati onal level protein and mRNA abundance 
would correlate perfectly. In this study a coeffi  cient of determinati on (R2) between mRNA and 
protein copy numbers of 0.40 has been observed. If an absence of technical and biological 
noise is assumed, this would mean that ~40% of the variance in protein levels can be explained 
by diff erences in mRNA levels (given by transcripti on and mRNA decay). The remaining 60% are 
caused by diff erent translati on rates and protein stabiliti es. In yeast, one third of all transcripts 
is assumed to be translati onally regulated with translati on effi  ciencies spanning roughly two 
orders of magnitude (INGOLIA et al., 2008). In contrast, individual mouse protein half-lives 
measured in the present study ranged from a few minutes to more than hundred hours, a more 
than 1000-fold range which is also consistent with half-life data obtained in yeast (BELLE et al., 
2006). Given the higher dynamic range of protein half-lives, it is tempti ng to speculate that 
protein turnover may aff ect the correlati on between mRNA and protein abundances to a larger 
degree. Here mathemati cal models will help to ulti mately explain the discrepancies observed 
between mRNAs and proteins. Additi onal methods like sequencing of nascent transcripts and 
ribosome profi ling will add valuable informati on (CORE et al., 2008; INGOLIA et al., 2009). With 
the rapid evoluti on of genome-scale quanti tati ve technologies, unraveling the principles of 
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transcripti onal, post-transcripti onal and post-translati onal regulati on may eventually become 
feasible.
Despite of its appealing att empt to fi nd answers to fundamental biological questi ons, all work in 
that directi on also has important practi cal implicati ons. For instance, RNA interference (RNAi) 
as a promising powerful therapeuti c agent to silence pathogenic gene products requires a 
proper understanding of the kineti cs of the process and the parameters that can aff ect the 
resulti ng gene silencing (BARTLETT Ι DAVIS, 2006). Amongst such parameters, knowledge 
about target mRNA and protein stability is key to specifi cally tailor and opti mize the treatment 
since it helps to assess to what degree and more importantly, when RNAi-induced knockdown 
phenotypes can be expected to become apparent. Notably, siRNA-mediated gene silencing 
can also result in unintended repression of genes other than the desired target, referred to 
as “off -target” eff ects (JACKSON Ι BURCHARD, 2006). As this occurs in a manner reminiscent 
of target silencing by miRNAs, the pSILAC approach can in turn be uti lized to study the extent 
of such side-eff ects on the proteome-level. This will facilitate the selecti on of siRNAs of high 
therapeuti cal relevance.
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Supplementary dataVII.4. 
Supplementary figuresVII.4.1.  
Supplementary Fig. VII.1 | Verifi cati on of targets identi fi ed by pSILAC with Western blotti  ng. HeLa cells were transfected 
with respecti ve miRNAs and LNA. WT (Wild-type) represents “water-control” (cf. Material & Methods II.8). Samples were 
analysed by Western blotti  ng with anti bodies against c-Met, EGFR, α-Adducin, CEBPβ, Twinfi lin, Annexin2, Tropomyosin, 
PICALM, SNX6, Kras, FGF2, Integrin-α2 and IMP-1. β-Acti n served as a loading control.
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Supplementary Fig. VII.2 | miRNAs inhibit translati on on a genome-wide scale. (A) Changes in protein producti on between 
8 and 32 h aft er miR-30a transfecti on with mRNA fold-changes at 8 h reveal poor overall correlati on. (B) mRNA levels at 32 h 
correlate remarkably well with changes in protein synthesis.
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Supplementary Fig. VII.3 | Correlati on between absolute amounts and values calculated by various approaches of absolute 
quanti fi cati on. Dots designate individual proteins of the standard (UPS2). Each plot is based on three technical replicates.
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Supplementary Fig. VII.5 | Comparison of yeast protein copy numbers obtained by either iBAQ based absolute quanti fi cati on 
(A) or tag-western-blot/GFP-fusion proteins (GHAEMMAGHAMI et al., 2003) (B) with ribosome profi ling (RP) data (INGOLIA et 
al., 2009).
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Supplementary Fig. VII.4 | Kernel density esti mates of mRNA levels (given as RPKM values) for all genes (black) and genes 
detected on protein level (red). The slight shift  indicates a mild detecti on bias against lowly expressed proteins. All subsequent 
calculati ons were therefore done on the set of genes detected on both the protein and mRNA level.
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Time PepƟde-Sequence Mass Mass Error[ppm] 
Log2 fold change 
luciferase pepƟdes 
Log2 fold change luciferase 
(median of pepƟde raƟos) 
 
1 h 
EIVDYVASQVTTAK 1522.79 -0.27 3.24 
5.99 
GGVVFVDEVPK 1144.61 0.06 4.33 
IQSALLVPTLFSFFAK 1781.01 0.19 7.19;5.77;6.22 
VVDLDTGK 845.45 -0.70 6.94 
2 h 
EIVDYVASQVTTAK 1522.79 -0.03 5.15;3.78 
4.65 
FEEELFLR 1081.54 -0.40 5.34 
GGVVFVDEVPK 1144.61 -0.30 5.34 
GPMIMSGYVNNPEATNALIDK 2234.07 -0.59 2.86;2.20 
IIIMDSK 818.46 0.69 5.13 
IQSALLVPTLFSFFAK 1781.01 0.55 5.05;4.25 
KGPAPFYPLEDGTAGEQLHK 2154.07 -0.49 2.88 
STLIDKYDLSNLHEIASGGAPLSK 2528.31 0.13 3.19 
TIALIMNSSGSTGLPK 1588.85 -0.38 5.11 
4 h 
EIVDYVASQVTTAK 1522.79 -0.60 1.82 
2.00 
FEEELFLR 1081.54 -0.58 2.51 
GGVVFVDEVPK 1144.61 -0.11 1.66 
IQSALLVPTLFSFFAK 1781.01 0.24 2.00;2.01;1.97;1.71;2.40 
STLIDKYDLSNLHEIASGGAPLSK 2528.31 0.29 2.11 
TIALIMNSSGSTGLPK 1588.85 -0.34 2.07 
VVDLDTGK 845.45 0.33 1.97 
6 h 
EIVDYVASQVTTAK 1522.79 0.14 0.94;0.47;1.07;1.15 
1.05 
FEEELFLR 1081.54 -0.16 1.13;0.84 
GGVVFVDEVPK 1144.61 -0.25 0.88 
IIIMDSK 818.46 0.93 1.12 
IQSALLVPTLFSFFAK 1781.01 0.15 1.05;1.02;0.95;1.25;1.20;1.25 
KGPAPFYPLEDGTAGEQLHK 2154.07 -0.55 1.02;0.66 
TIALIMNSSGSTGLPK 1588.85 -0.71 1.25 
8 h 
EIVDYVASQVTTAK 1522.79 -0.41 0.25;0.41 
0.38 
FEEELFLR 1081.54 -0.13 0.58 
GGVVFVDEVPK 1144.61 0.08 0.30;0.30 
GPMIMSGYVNNPEATNALIDK 2234.07 -0.57 0.43;0.58 
GVALPHR 748.43 -1.33 0.32 
IIIMDSK 818.46 0.30 0.37 
IQSALLVPTLFSFFAK 1781.01 0.15 0.35;0.50;0.44;0.28;0.70;0.14 
KGPAPFYPLEDGTAGEQLHK 2154.07 -0.61 0.33;0.14 
STLIDKYDLSNLHEIASGGAPLSK 2528.31 0.23 0.58 
TIALIMNSSGSTGLPK 1588.85 -0.29 0.43 
VVDLDTGK 845.45 -0.11 0.40 
10 h 
EIVDYVASQVTTAK 1522.79 -0.02 -0.15;-0.16;0.00 
-0.09 
FEEELFLR 1081.54 -0.50 -0.08 
GGVVFVDEVPK 1144.61 -0.83 -0.18 
IQSALLVPTLFSFFAK 1781.01 -0.26 0.16;0.05;-0.10 
KGPAPFYPLEDGTAGEQLHK 2154.07 -1.28 -0.39;0.05 
QGYGLTETTSAILITPEGDDKPGAVGK 2717.38 0.59 -0.19 
TIALIMNSSGSTGLPK 1588.85 -0.52 0.03 
VVDLDTGK 845.45 0.01 0.00 
YDLSNLHEIASGGAPLSK 1870.94 -0.30 -0.27 
 
Supplementary Table VII.1: Pulsed SILAC raƟos of all quanƟfied pepƟdes of luciferase aŌer doxycycline 
treatment for different length of Ɵme
Supplementary tablesVII.4.2.  
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VII SUPPLEMENT
Protein PepƟde-Sequence Mass Mass Error [ppm] 
Log2 fold change  
pepƟdes 
Log2 fold change 
proteins (median of 
pepƟde raƟos) 
 
Fe
rr
iƟ
n 
H 
(IP
I0
05
54
52
1)
 
AIKELGDHVTNLRK 1592.90 -0.30 4.13 
3.74 
ELGDHVTNLR 1152.59 -0.06 2.88;3.38;3.58;3.76;3.77;4.56 
IFLQDIK 875.51 0.01 -0.41;2.42;2.44;3.34;3.50;3.63;3.74;4.13 
KMGAPESGLAEYLFDK 1754.85 0.44 3.23 
MGAPESGLAEYLFDK 1626.76 0.03 3.07;3.58;3.74;4.19;4.35 
MGAPESGLAEYLFDKHTLGDSDNES 2682.18 -0.07 3.98;4.36 
NVNQSLLELHK 1293.70 0.00 3.48;3.52;3.54;3.62;3.71;3.73;3.77;3.95;4.03 
QNYHQDSEAAINR 1544.70 -0.01 4.01;4.08 
YFLHQSHEER 1344.62 -0.07 3.87;4.06 
Fe
rr
iƟ
n 
L 
(IP
I0
07
38
49
9)
 KLNQALLDLHALGSAR 1718.98 0.03 3.36;3.66;3.76 
3.68 LGGPEAGLGEYLFER 1606.80 0.03 2.85;3.65;3.67;3.80;3.87;3.88 
LNQALLDLHALGSAR 1590.88 -0.01 3.43;3.65;3.68;3.82;3.89 
MGDHLTNLHR 1192.58 0.12 3.44;3.88 
Tr
an
sf
er
rin
 R
ec
ep
to
r P
ro
te
in
 
(IP
I0
00
22
46
2)
 
VNILEVASGAVLR 1339.78 -0.09 -0.99;-0.20;-0.00 
-1.62 
AFTYINLDK 1083.56 -0.04 1.13 
AVLGTSNFK 935.51 -0.02 -1.94;-1.50;-1.44 
DENLALYVENQFR 1609.77 -0.09 -1.62;-1.38;0.43 
DSAQNSVIIVDK 1287.67 -0.15 -2.68;-2.55;-1.30 
EAGSQKDENLALYVENQFR 2210.06 0.05 - 1.92;-1.63 
GFVEPDHYVVVGAQR 1671.84 -0.06 -1.75;-1.58;-1.51 
HPVTGQFLYQDSNWASK 1976.94 -0.25 -2.71;-2.13;-1.60;-1.05 
ILNIFGVIK 1015.64 -0.01 -1.85;-1.83;-1.62;-1.58;-1.56;-1.55 
LAQMFSDMVLK 1281.65 0.01 -1.74;-1.23;-1.15;0.07 
LAVDEEENADNNTK 1560.69 0.02 - 2.11;-1.04 
LDSTDFTGTIK 1196.59 0.00 -2.16;-1.65;-1.60;-0.83 
LLNENSYVPR 1203.62 0.05 -2.32;-2.11;-1.96;-1.21;-0.82 
LTHDVELNLDYER 1615.78 -0.10 -2.30;-1.65;-1.64;-1.37 
LTTDFGNAEK 1094.52 0.00 - 1.46;-1.09 
LVHANFGTK 985.53 -0.10 - 1.75;-1.21 
LVYLVENPGGYVAYSK 1770.92 0.03 - 1.64 
QVDGDNSHVEMK 1357.59 0.04 - 1.44 
RLYWDDLKR 1263.67 -0.06 - 1.85;-0.63 
SAFSNLFGGEPLSYTR 1744.84 -0.03 -3.08;-1.79;-1.79;-1.77;-1.26;-0.19 
SGVGTALLLK 957.59 0.00 -2.21;-1.69;-1.56 
SSGLPNIPVQTISR 1467.80 -0.08 -1.82;-1.75;-1.71;-1.25 
VEYHFLSPYVSPK 1564.79 0.00 -2.07;-1.77;-1.76;-1.41;-1.27;-0.86 
VSASPLLYTLIEK 1432.82 0.01 -1.81;-1.66;-1.50 
 
 
 
 
 
 
 
 
 
Supplementary Table VII.2: Pulsed SILAC raƟos of all quanƟfied pepƟdes of ferriƟn H and L chain and the transferrin 
receptor aŌer iron treatment of Hela cells
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VII SUPPLEMENT
Protein PepƟde-Sequence Mass Mass Error [ppm] 
Log2 fold change  
pepƟdes 
Log2 fold change 
proteins (median of 
pepƟde raƟos) 
 
Se
rin
e/
th
re
on
in
e-
pr
ot
ei
n 
ki
na
se
 P
AK
 2
 
(IP
I0
04
19
97
9)
 
KNPQAVLDVLK 1223.72 -0.89 0.32 
0.04 
LAKPLSSLTPLIMAAK 1652.99 0.01 0.00 
LLQTSNITK 1016.59 -0.29 -0.06 
SDNVLLGMEGSVK 1347.67 0.50 -0.09 
STMVGTPYWMAPEVVTR 1923.92 -0.09 0.08 
SVIDPVPAPVGDSHVDGAAK 1929.98 0.01 0.64 
Eu
ka
ry
oƟ
c 
tr
an
sl
aƟ
on
 
in
iƟ
aƟ
on
 fa
ct
or
 5
 
(IP
I0
00
22
64
8)
 
ALNRPPTYPTK 1256.69 -0.29 0.03 
0.03 
AMGPLVLTEVLFNEK 1659.89 0.08 -0.56;0.07;0.18 
SDNKDDDIDIDAI 1447.63 0.02 -0.77;0.24 
TVIVNMVDVAK 1187.66 0.00 -0.21;0.03 
VLTLSDDLER 1159.61 0.08 -0.39;-0.21;-0.04 
VNILFDFVK 1093.62 0.05 -0.17;0.19;0.34;0.47 
Ac
Ɵn
-r
el
at
ed
 p
ro
te
in
 3
 
(IP
I0
00
28
09
1)
 
AEPEDHYFLLTEPPLNTPENR 2481.18 0.00 -0.25;-0.19;-0.16 
0.01 
DITYFIQQLLR 1408.77 -0.02 -0.42;0.10;0.15;0.32;0.46;2.11 
EFSIDVGYER 1213.56 -0.03 0.48 
FMEQVIFK 1040.54 -0.01 -0.32;-0.00;0.08 
GVDDLDFFIGDEAIEKPTYATK 2443.18 0.19 -0.27;-0.07;0.23 
HGIVEDWDLMER 1498.69 -0.02 0.02;0.05;0.49 
LKPKPIDVQVITHHMQR 2039.15 -0.14 -3.15;-0.90;-0.54;0.37 
NIVLSGGSTMFR 1280.65 -0.05 -0.40;0.09 
YSYVCPDLVK 1242.60 -0.13 -0.19 
Ra
s-
re
la
te
d 
pr
ot
ei
n 
Ra
b-
21
 
(IP
I0
00
07
75
5)
 
AAAGGGGGGAAAAGR 1070.52 -0.41 -0.71 
-0.01 
DSNGAILVYDITDEDSFQK 2128.98 0.00 0.18 
FHALGPIYYR 1235.65 0.02 -0.48;-0.09;-0.08;-0.01 
HVSIQEAESYAESVGAK 1803.86 0.02 -0.10;0.08;0.35 
MIETAQVDER 1190.56 -0.02 0.15;0.27 
RVNLAIWDTAGQER 1627.84 -0.02 -0.01 
VNLAIWDTAGQER 1471.74 0.00 -0.14;-0.06;0.37 
GM
P 
sy
nt
ha
se
  
(IP
I0
00
29
07
9)
 
DEPDWESLIFLAR 1589.77 0.10 0.05 
-0.01 
ELFVQSEIFPLETPAFAIK 2178.16 0.10 -0.01 
ELGLPEELVSR 1240.67 0.03 -2.41;0.10;0.27;0.47 
HPFPGPGLAIR 1160.65 0.11 -0.46 
LMQITSLHSLNAFLLPIK 2038.16 0.29 -0.95 
SGNIVAGIANESK 1258.65 -0.12 1.58 
VIEPLKDFHKDEVR 1723.93 -0.16 -0.25 
VVYIFGPPVK 1117.65 0.10 -2.26;0.19 
VVYIFGPPVKEPPTDVTPTFLTTGVLSTLR 3243.78 -0.01 -0.08 
 
Supplementary Table VII.3: Pulsed SILAC raƟos of all quanƟfied pepƟdes of five arbitrarily selected proteins that remain 
unaffected (log2 fold change of ~ 0) upon iron treatment of Hela cells
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